Prim Care Clin Office Pract 33 (2006) xi–xii
Preface
Robert L. Rogers, MD Joseph P. Martinez, MD Guest Editors
Primary Care physicians (PCPs) are on the front lines of patient care. In addition to treating patients with chronic illnesses, they also evaluate and treat patients with acute complaints. This includes patients with complaints that may be potentially life-threatening, such as headache, chest pain, and abdominal pain. Most of these patients will not have a life-threatening cause of their symptoms. The astute PCP must always be vigilant for that patient who presents with serious disease masquerading as a benign illness. This issue of Primary Care: Clinics in Office Practice focuses on disease entities that absolutely must be recognized by PCPs. While providing a general review of each topic, the guest editors’ goal is to focus on atypical presentations and high-risk patient populations. Most outpatient practice facilities do not have the capability to perform extensive testing to rule out all of these life-threatening conditions. The aim of this issue is to increase awareness of some of these ‘‘masqueraders’’ and to encourage PCPs to always consider the worst case first. In some cases, the worst case may be ruled out simply by considering it and discarding it as a possibility, at which point more benign diagnoses may be considered. An example is the patient who presents with headache. A focused history and physical may be all that is required to rule out subarachnoid hemorrhage, meningitis, temporal arteritis, acute glaucoma, and stroke. At this point, more benign causes such as tension headache or migraine (which are much more common etiologies of headache) may be entertained. Conversely, if a patient’s headache is labeled ‘‘tension’’ or ‘‘migraine,’’ and subarachnoid hemorrhage is never even thought of, you may not get a second chance to make the diagnosis!
0095-4543/06/$ - see front matter Ó 2006 Elsevier Inc. All rights reserved. doi:10.1016/j.pop.2006.06.011 primarycare.theclinics.com
xii
PREFACE
We have all been taught that diagnoses such as pulmonary embolus present very dramatically. This is unequivocally false. As this issue highlights, many serious, life-threatening diseases present quite subtly. Knowledge of risk factors for various diseases and an idea of their atypical presentations will serve the astute clinician well. The job of a PCP is undeniably difficult. As noted above, most patients who present with symptoms of potentially life-threatening disease will actually have a more benign entity. It is simply not feasible or prudent to refer every patient with abdominal or chest pain to the emergency department or a subspecialist. A busy PCP may go days, weeks, or even months without seeing a true emergency. The trick is to avoid becoming complacent to the point that when a patient does have an emergent condition, it is missed. The guest editors sincerely hope that this issue of Primary Care: Clinics in Office Practice will be useful in your day-to-day practice in detecting those emergencies and intervening in a timely fashion. Robert L. Rogers, MD Department of Emergency Medicine The University of Maryland School of Medicine 110 South Paca Street Sixth Floor, Suite 200 Baltimore, MD 21201 E-mail address:
[email protected] Joseph P. Martinez, MD Department of Emergency Medicine The University of Maryland School of Medicine 110 South Paca Street Sixth Floor, Suite 200 Baltimore, MD 21201 E-mail address:
[email protected]
Prim Care Clin Office Pract 33 (2006) 613–623
Hypertensive Urgencies and Emergencies David L. Stewart, MD, MPH, Sharon E. Feinstein, MD, Richard Colgan, MD* Department of Family Medicine, University of Maryland School of Medicine, 29 South Paca Street, Baltimore, MD 21201, USA
Hypertension afflicts 50 million people in the United States and approximately one billion people worldwide. Estimates are that 30% of the population is unaware they have hypertension, while only 34% of those who are being treated for hypertension are at a goal blood pressure measurement of !140/90 mmHg [1]. Although it is common for patients to be seen in the office with poorly controlled hypertension, hypertensive urgencies, and emergencies are less common. It is important for the primary care physician to recognize those patients with hypertensive urgencies and emergencies to avoid missing a life-threatening medical condition as well as not to overtreat elevations in blood pressure that may precipitate unnecessary patient morbidity.
Definitions According to JNC VII guidelines, patients with elevated blood pressures may be characterized into one of three stages: prehypertension, Stage I, and Stage II hypertension (Table 1). The degree to which a patient’s blood pressure is higher than recommended guidelines compels the clinician to further define the blood pressure elevation, with the implication being that more aggressive treatment may be necessary. Terminology for severely elevated blood pressure measurements is confusing. Although clinicians may feel that they know a hypertensive urgency or emergency when they see one, there is lack of uniformity in terms used to describe dangerously high blood pressures. The term ‘‘accelerated hypertension’’ has been used to describe individuals with chronic hypertension who had associated group 3 Keith-Wagener-Barker retinopathy, marked by retinal hemorrhages and exudates. Malignant hypertension has been used to * Corresponding author. E-mail address:
[email protected] (R. Colgan). 0095-4543/06/$ - see front matter Ó 2006 Elsevier Inc. All rights reserved. doi:10.1016/j.pop.2006.06.001 primarycare.theclinics.com
614
STEWART
et al
Table 1 Classification of blood pressure for adults BP classification
SBP mmHg
DBP mmHg
Normal Prehypertension Stage I Stage II
!120 120–139 140–159 Oor ¼ 160
and !80 or 80–89 or 90–99 orOor ¼ 100
describe those individuals with group 4 Keith-Wagener-Barker retinopathy, marked by papilledema. The term hypertensive crisis has been abandoned by some individuals because of confusion. Some interpret hypertensive crisis to mean a hypertensive emergency and others interpret it to mean hypertensive urgency. We prefer the terms normal blood pressure, prehypertension, stage 1 hypertension, and stage 2 hypertension. Stage 2 hypertension may be further delineated as hypertensive urgency and hypertensive emergency. There is no absolute blood pressure that indicates a hypertensive emergency. The typical individual presents with a severe elevation in blood pressure. Severe is defined by a blood pressure measurement O180/120 mmHg according to JNC VII. Key to the diagnosis of hypertensive emergency is evidence of target end-organ damage most commonly affecting the central nervous, cardiovascular, or renal systems. The conditions noted in Box 1 constitute evidence of end-organ damage, in the face of hypertensive emergency [2]. Hypertensive urgency is characterized by a severe elevation in blood pressure that may or may not be associated with symptoms such as severe headache, anxiety, or shortness of breath. The individual with hypertensive urgency has no physical findings that indicate impending target endorgan damage.
Box 1. Conditions constituting evidence of end-organ damage 1. Hypertensive encephalopathy 2. Intracerebral hemorrhage 3. Ischemic heart diseasedthe most common form of target organ damage associated with hypertension a. Acute myocardial infarction b. Acute left ventricle failure with pulmonary edema c. Unstable angina 4. Aortic dissection 5. Eclampsia 6. Stroke 7. Head trauma 8. Life-threatening arterial bleeding
HYPERTENSIVE URGENCIES AND EMERGENCIES
615
The most important consideration for the primary care provider is the clinical context for the patient’s elevated blood pressure. When a patient with a severe elevation in blood pressure is encountered the clinician must entertain whether the elevation is acute or chronic, and whether there is evidence of acute target end organ damage. Causes The most common cause of severe hypertension is an abrupt increase in blood pressure in patients with chronic hypertension. An important factor in hypertensive emergency and urgency is the rate at which the mean arterial pressure rises [3,4]. Noncompliance with medical therapy may therefore play a role in some patients who present with this severely elevated blood pressure [5,6]. Pathophysiology The pathophysiology of severely elevated blood pressure differs, depending on whether hypertensive urgency or emergency is present and in the case of hypertensive emergency the target end organ(s) affected. Normally with a rise in blood pressure, the blood vessels change in diameter to autoregulate the pressure flow, thus limiting damage. When the mean arterial pressure increases abruptly, the body’s ability to hemodynamically adjust to such a rapid change is thwarted, allowing for damage to the end organ [7]. Additional postulates of the mechanisms by which hypertensive emergencies create damage involve the rennin–angiotensin–aldosterone system [8]. Evaluation The role of a primary care doctor in the evaluation of severely elevated blood pressure in an outpatient setting is to distinguish as quickly as possible those patients who require aggressive blood pressure reduction from those who can be managed in the office. Rapid triage of the most concerning patients requires a concise but complete history and physical examination, supported by appropriate and available laboratory data. Although no perfect algorithm exists for the evaluation of a patient with a severely elevated blood pressure in the outpatient setting, initial steps involve the search for the presence of acute target end-organ damage, specifically heart failure, renal failure, encephalopathy, or papilledema, or the presence of any concurrent conditions that would necessitate aggressive blood pressure control such as aortic dissection, acute myocardial infarction, stroke, pheochromocytoma crisis, or preeclampsia [8]. If no hypertensive emergency is identified, there is still a determination to be made between hypertensive urgency that would require rapid but not immediate lowering of blood pressure and severe uncontrolled hypertension that would benefit from tighter long-term
616
STEWART
et al
control but does not require rapid blood pressure reduction. Figure 1 presents a flowchart for the triage of patients in the outpatient setting. Most of the hypertensive urgency and emergency review papers focus on evaluation and treatment in the emergency room setting. The approach in the outpatient setting is necessarily different, and will be limited by resources available in any given office. Because most laboratory data and imaging modalities are not readily accessible, the history and physical become the most critical tools in determining the severity of the situation. History Patients with severe elevations in blood pressure can present at any age, and may be the initial presentation for a previously undiagnosed hypertensive patient. The incidence of hypertensive urgencies and emergencies is Severe Hypertension in the Office (Blood Pressure >180/120)
Evidence of End Organ Compromise? Heart Failure Renal Failure Encephalopathy Papilledema
No
Yes
Concurrent condition which may mandate intensive blood pressure control ? Cardiovascular Aortic Dissection Acute MI
Cerebrovascular SAH/ IC hemorrhage Acute Cerebral Infarction
Other Acute renovascular hypertension Pheochromocytoma Severe Burns Severe Epistaxis Eclampsia
No
Yes
Conservative Management
Consider Transfer to ED
Oral Antihypertensive Therapy
For Rx and Invasive Monitoring
Fig. 1. Algorithm for triage of patients with severe hypertension in the office. (Modified from Gilmore RM, Miller SJ, Stead LG. Severe hypertension in the emergency department patient. Emerg Med Clin North Am 2005;23(4):1141–58; with permission.)
HYPERTENSIVE URGENCIES AND EMERGENCIES
617
greater in the elderly and African Americans. Most patients who present with severely elevated blood pressure are those with chronic essential hypertension who have been noncompliant or inadequately treated [1,5,6]. Therefore, it is critical to gain a thorough hypertension history. This includes current blood pressure medications, any recent changes, compliance with medications, and if the blood pressure had been previously controlled. The patient should be specifically asked if he or she abruptly discontinued a blood pressure medication or if they have had a previous ‘‘crisis’’ [9]. A full medical history, medication list including any nutritional supplements, and use of any illicit drugs will aid the evaluation. It is important to know if a patient currently uses a monoamine oxidase (MAO) inhibitor. Although rarely used today, when combined with foods or medications containing tyramine, MAO inhibitors can trigger a hypertensive crisis [10]. Baseline medical information is critical in assessing the acute nature of the presentation. Any previous renal insufficiency or failure, heart attacks, strokes, and any baseline deficits from a previous stroke should be noted. A patient’s outpatient chart may provide critical information in these areas as well as baseline laboratory data, especially in cases when a patient does not easily recall the information. Next, a patient’s current symptoms should be addressed with a focus on determining whether there is evidence for target end-organ damage. Chest pain, shortness of breath, a prominent apical pulse, or signs of congestive heart failure may indicate cardiovascular involvement. Visual changes, severe headache, dizziness, somnolence, or altered mental status may signify neurologic compromise. Renovascular damage may be evidenced by an acute onset of oliguria or anuria [11]. Severe headache or shortness of breath have been associated with hypertensive urgency as well, but in the presence of elevated blood pressure, these symptoms warrant further investigation to rule out myocardial infarction, congestive heart failure, or stroke [1]. Although a full discussion of the evaluation and treatment of elevated blood pressure in pregnancy is beyond the scope of this article, it is important to note that minor elevations (O140/90 mmHg) warrant further investigation. Hypertension in pregnancy can fall into several categories when it occurs after 20 weeks gestation. Preeclampsia is defined as new-onset elevated blood pressure with the presence of proteinuria (0.3 g or more of protein in a 24-hour urine collection, or R1 þ on a urine dipstick) [12,13]. Women with mild preeclampsia may be asymptomatic at the time of diagnosis [14]. Severe preeclampsia in which the blood pressure is R160/110 mmHg with significant proteinuria (R5 g of protein on 24-hour urine or 3 þ on a dipstick) can be accompanied by oliguria, blurred vision, scotomata, epigastric or right upper quadrant pain, pulmonary edema or cyanosis, impaired liver function, thrombocytopenia, and intrauterine growth restriction [12,13]. The definitive treatment for preeclampsia is delivery; however, the management of preeclampsia requires a careful consideration of the risks to the mother and the fetus [12]. The severity of the illness and the gestational age are
618
STEWART
et al
key components in decision making. If there is no proteinuria present in a patient with new hypertension after 20 weeks gestation, this is considered gestational hypertension (previously known as pregnancy-induced hypertension). Patients with chronic hypertension can develop superimposed preeclampsia before 20 weeks gestation and require special evaluation and monitoring throughout the pregnancy [13]. Physical examination First, the blood pressure measurement must be confirmed. The blood pressure should be rechecked, making sure that the patient is in the proper position and that the appropriate cuff size is used [15]. Blood pressures should be checked in both arms and some advocate measurements in the lower limbs [6]. The physical examination should focus on the organs commonly affected by elevated blood pressure seeking evidence of acute or chronic injury. Although many chronic hypertensives will have findings on fundoscopic examination, focus should be on the presence of acute changes. These include the presence of new hemorrhages (superficial or flame shaped, or deep and punctuate), retinal exudates (hard or ‘‘cotton wool’’), or papilledema [8]. A cardiovascular examination should include signs of heart failure such as pulmonary rales, elevated jugular venous pressure, and an S3 heart sound. Pulse discrepancy among limbs and a new aortic regurgitation murmur may indicate aortic dissection and requires further investigation [11]. Neurologic findings such as a change in mental status, abnormal visual fields, and focal neurologic signs point to possible intracranial hemorrhage, acute ischemic stroke, and hypertensive encephalopathy. A review of a complete history and physical is found in Box 2. Laboratory evaluation The laboratory evaluation in an outpatient setting will be limited by the resources available in any given office. An EKG should be performed in anyone with a severely elevated blood pressure or any signs or symptoms of heart involvement to identify evidence of myocardial ischemia or hypertrophy [16]. If possible, any EKG abnormalities should be compared with a baseline EKG. Some practitioners advocate using a urinalysis in the office to assess for end-organ damage. Hematuria or significant proteinuria may be indicative of acute or progressive renal failure. Gross hematuria is not usually present in a hypertensive emergency, and requires additional workup once the crisis has been managed [17]. A chest radiograph if immediately or quickly available may reveal evidence of pulmonary edema of heart failure. The presence of a widened mediastinum would be concerning for aortic dissection [18]. Further assessment with a head CT or laboratory data such as complete blood count, basic metabolic panel, urine toxicology if urgent,
HYPERTENSIVE URGENCIES AND EMERGENCIES
619
may be triaged to the emergency department. If an emergency does not exist, the above data can be collected in an outpatient setting to assist in longer term care. Treatment A large number of pharmacologic agents now exist to treat essential hypertension, making the need to treat hypertensive urgencies and emergencies less likely than several decades ago. However, the need has not totally disappeared. Hypertensive urgencies and emergencies may account for as many as 27.5% of all medical emergencies presenting to an emergency department and 3% of all emergency room visits. As many as 50% of individuals who present with a hypertensive urgency or emergency will already have a diagnosis of essential hypertension [19,20]. Both hypertensive urgencies and emergencies require immediate medical attention but use different treatment strategies. How the hypertension is treated depends on how the patient presents. The initial challenge for the clinician is to quickly and accurately determine whether the patient has target end-organ damage associated with the severely elevated blood pressure. Appropriate therapeutic decisions start with the triage process in the primary care physician’s office, and include such considerations as those listed in Box 3, which are indicative of office readiness. Hypertensive emergencies develop over hours or days, and require immediate blood pressure reduction, but not necessarily blood pressure normalization, to prevent or limit target end-organ damage. In the office, a patient with a hypertensive emergency may require the clinician to immediately evaluate the patient’s airway, breathing, or circulation because of a stroke, myocardial infarct, or other life-threatening condition. Patients with hypertensive emergency should be transported to the hospital using the emergency medical system. Such patients require continuous monitoring of blood pressure in a hospital setting where parenteral administration of antihypertensive agents are used to reduce mean arterial blood by no more than 25% within minutes to 1 hour of therapy initiation. If the patient is stable, the blood pressure is then titrated to 160/100 to 110 within the next 2 to 6 hours. If the patient remains stable, the blood pressure may be reduced to normal over the next 24 to 48 hours. Caution must be used to avoid excessive lowering of blood pressure, which may compromise renal, cerebral, or coronary blood flow. For this reason short-acting nifedipine is no longer considered acceptable in the initial treatment of severely elevated blood pressures. Caution should be used in patients with ischemic stroke in which there is no clear evidence from clinical trials to support the use of immediate antihypertensive treatment, patients with aortic dissection who should have the systolic blood pressure lowered to !100 mmHg if tolerated, and patients in whom blood pressure is lowered to enable the use of thrombolytic agents [1].
620
STEWART
et al
Box 2. Key aspects of the history and physical examination of the hypertensive patient Hypertension history Last known normal blood pressure, prior diagnosis and treatments, dietary and social factors Cardiac history Previous heart attacks, angina, arrhythmias Symptoms of dyspnea, chest pain, claudication, flank pain, back pain Neurologic history History of prior strokes, neurologic dysfunction Visual changes, blurriness, loss of visual fields, headache, nausea, and vomiting Renal history History of proteinuria, underlying renal disease Changes in urinary frequency Endocrine history Diabetes, thyroid dysfunction, Cushing’s Syndrome Family history Early hypertension in family members, cerebrovascular and cardiovascular disease, diabetes, pheochromocytoma Social history Smoking, alcohol, illicit drugs (especially cocaine, stimulants), noncompliance Medications Steroids, estrogens, sympathomimetics, nutritional supplements (eg, ephedra, mah huang), monoamine oxidase inhibitors (MAO-Is) Nutritional supplements (eg, ephedra, mah huang) Other comorbidities Organ transplant (especially cardiac or renal), current pregnancy (eclampsia or preeclampsia) Physical examination Vital Signs: blood pressure, pulse rate, weight, body habitus, buffalo hump, moon facies Cardiovascular: enlarged heart, presence of S3 heart sounds, asymmetric pulses, arrhythmias Neck: enlarged thyroid, carotid pulses, jugular venous distention Pulmonary: signs of left ventricular dysfunction (crackles, rhonchi)
HYPERTENSIVE URGENCIES AND EMERGENCIES
621
Renal: Presence of renal bruit or abdominal masses Neurologic: abnormal examination (evidence of stroke) Ophthalmologic: funduscopic examination (papilledema, hemorrhage), exophthalmia, lid lag Extremities: diminished or delayed pulses, edema, acromegaly
Adapted from Hsiao EC, Chung SA, Klag MJ. Hypertensive urgency and emergency. In: Cheng A, Zaus A. The Oster medical handbook. 1st edition. Johns Hopkins University; 2003.
Hypertensive urgency develops over days to weeks. In the office, a patient with hypertensive urgency will have a marked elevation in blood pressure with or without symptoms such as headache, shortness of breath, or anxiety. They will have no physical findings indicative of target end-organ damage. The elevated blood pressures in these individuals often make the clinician feel the need to act aggressively. There is no evidence to suggest that patients who present with severe blood pressure elevation and no indication of target end-organ damage have an increased short-term risk when their blood pressure is not aggressively lowered in the clinical setting [1]. The term ‘‘urgency’’ has often lead to aggressive dosing with intravenous or oral antihypertensives to rapidly lower the blood pressure in these individuals. Such an approach is not without risk. Oral or intravenous loading of antihypertensives in the office may lead to cumulative effects of blood pressure lowering that are not experienced by the patient until they have left the office exposing the patient to unnecessary morbidity.
Box 3. Office readiness for hypertensive urgency or emergency 1. An office process to identify and immediately assess blood pressure measurement for those patient with complaints which may indicate target end-organ damage from elevated blood pressure 2. Appropriate office equipment including accurately functioning syphgmomanometers with various blood pressure cuff sizes and electrocardiogram machine(s) 3. An office process to summon providers for emergent clinical need 4. An understanding by all clinicians of medication available for office administration 5. A clear process for activating the emergency system when transport to the emergency room is indicated
622
STEWART
et al
When presented with a patient with hypertensive urgency the clinician has to not only select the appropriate antihypertensive agent but also assess how rapidly the blood pressure should be lowered. If the patient has a current diagnosis of hypertension the clinician may choose to adjust the patient’s medication regimen, or if necessary, address issues of compliance with current medications. Such an approach will generally produce blood pressure lowering, which occurs over days to weeks. For some patients, the blood pressure elevation may warrant the reduction of blood pressure in hours to days. Such patients rarely require hospitalization. The approach is to treat with an oral antihypertensive agent, conduct serial blood pressure measurements in the office, and arrange reasonable short-term follow-up to assure long-term effectiveness of and adherence to treatment [17]. Oral hypertensive agents given in single or multiple dosages may promptly lower the blood pressure, but are associated with variable lag times before onset of action, and may be difficult to titrate because of long durations of action. The ideal pharmacologic agent selected to lower blood pressure with hypertensive urgency should have the following characteristics: no adverse effects on the patients underlying clinical profile, relative short onset of action, and relatively short duration of action. Agents most commonly used to lower blood pressure in the office setting have included clonidine, labetalol, captopril, and minoxidil. Although diuretics have little role in managing hypertensive urgency, they are known to potentiate the effect of other antihypertensive agents, and therefore may have an important role in the overall management of the patient with poorly controlled blood pressure. Once the hypertensive urgency has resolved and the blood pressure is stable, the clinician should investigate possible reasons for the patient’s elevation in blood pressure. Questions should explore factors that affect the patient’s ability to be compliant with prescribed therapy. The clinician should be satisfied that any medication prescribed will be filled and taken by the patient until seen in the office for follow-up. Be aware that financial difficulty may prohibit some patients from obtaining prescribed therapy. Once necessary medication adjustment(s) are made, close follow-up should be arranged for the patient with severely elevated blood pressure. References [1] Chobanian AV, Bakris GL, Henry R, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289(19):2560–72. [2] The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157(21):2413–46. [3] Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet 2000;356(9227):411–7. [4] Finnerty FA. Hypertensive encephalopathy. Am J Med 1972;52(5):672–81. [5] Lip GY, Beevers M, Potter JF, et al. Malignant hypertension in the elderly. QJM 1995;88(9): 641–7.
HYPERTENSIVE URGENCIES AND EMERGENCIES
623
[6] Varon J, Marik PE. The diagnosis and management of hypertensive crises. Chest 2000; 118(1):214–27. [7] Kitiyakara C, Guzman NJ. Malignant hypertension and hypertensive emergencies. J Am Soc Nephrol 1998;9(1):133–42. [8] Gilmore RM, Miller SJ, Stead LG. Severe hypertension in the emergency department patient. Emerg Med Clin North Am 2005;23(4):1141–58. [9] Calhoun DA, Oparil S. Treatment of hypertensive crisis. N Engl J Med 1990;323(17): 1177–83. [10] Chase S. Hypertensive crisis. RN 2000;63(6):62–8. [11] Kaplan NM. Hypertensive crisis. In: Zipes DP, Libby P, Bonow RO, Braunwald E, editors. Braunwald’s heart disease: A textbook of cardiovascular medicine. 7th edition. Philadelphia (PA): WB Saunders; 2005. p. 983–5. [12] ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. No. 33, January 2002. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;99(1):159–67. [13] Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183(1):S1–22. [14] Wagner L. Diagnosis and management of preeclampsia. Am Fam Physician 2004;70(12): 2317–24. [15] Kaplan NM. Clinical hypertension. 7th edition. Baltimore (MD): Williams & Wilkins; 1998. [16] Shayne PH, Pitts SR. Severely increased blood pressure in the emergency department. Ann Emerg Med 2003;41(4):513–29. [17] Elliot WJ. Hypertensive emergencies. Acute Cardiac Care 2001;17(2):435–51. [18] Bales A. Hypertensive crisis; how to tell if it’s an emergency or an urgency. Postgrad Med 1999;105(5):119–30. [19] Cherney D, Straus S. Management of patients with hypertensive urgencies and emergencies: a systematic review of the literature. J Gen Intern Med 2002;17:937–45. [20] Cheng SL. Treating HTN crisis: How long? How fast? RN 2005;68(6):37–41.
Prim Care Clin Office Pract 33 (2006) 625–642
Identifying Chest Pain Emergencies in the Primary Care Setting Michael E. Winters, MDa,b,*, Scott M. Katzen, MDb a
Department of Emergency Medicine, University of Maryland School of Medicine, 110 South Paca Street, 6th Floor, Suite 200, Baltimore, MD 21201, USA b University of Maryland Medical Center, 22 South Greene Street, Baltimore, MD 21201, USA
Patients who have acute chest pain account for approximately 2% of visits to primary care physicians [1]. Thankfully, the majority of these patients have non-life–threatening etiologies. In fact, fewer than 40% of cases are from cardiac, pulmonary, or gastrointestinal causes [2]. The most common etiology of chest pain in the primary care setting is musculoskeletal conditions, accounting for 36% of cases [2]. Nevertheless, a life-threatening etiology must be considered when evaluating any patient who has acute chest pain. Potentially catastrophic conditions that must be excluded include acute coronary syndrome (ACS), aortic dissection (AD), pulmonary embolism (PE), esophageal rupture, and pericarditis. Timely diagnosis of these life-threatening conditions is essential, because any delays in diagnosis or therapy lead to substantially higher morbidity and mortality. Over the past decade, countless studies have been published regarding these catastrophic causes of chest pain. The following will serve to update the primary care physician on current evidence-based information pertaining to ACS, AD, PE, esophageal rupture, and pericarditis. A comprehensive review of each etiology is beyond the scope of this article; rather, it focuses on recognizing atypical clinical presentations, identifying risk factors for disease, defining the utility of the history and physical examination, and understanding the limitations of office-based diagnostic testing pertaining to these five conditions. Armed with this information, the primary care physician can more effectively identify patients who harbor potentially life-threatening etiologies of chest pain.
* Corresponding author. 1406 Chessie Court, Mount Airy, MD 21771. E-mail address:
[email protected] (M.E. Winters). 0095-4543/06/$ - see front matter Ó 2006 Elsevier Inc. All rights reserved. doi:10.1016/j.pop.2006.06.006 primarycare.theclinics.com
626
WINTERS & KATZEN
Acute coronary syndrome Coronary atherosclerotic disease (CAD) is the leading cause of cardiovascular mortality in the United States, accounting for 350,000 to 450,000 out-of-hospital cardiac arrests per year [3]. Currently, there are estimated 13 million Americans living with CAD [4]. In 2001, nearly 1 million individuals in the United States had a new or recurrent coronary event [4]. Currently, ACS accounts for up to 16% of chest pain visits to a primary care physician [2]. Although acute myocardial infarction makes up just 1.5% of cases [2], it is imperative that the primary care physician identify patients who have ACS. Mortality for patients sent home with ACS is twice as high as that of patients admitted to the hospital [5,6]. Clinical presentation Clearly, ACS would be considered in the patient presenting with chest tightness that is difficult to localize, radiates to the left arm, is associated with dyspnea, and is relieved with rest or nitroglycerin. Unfortunately, up to 25% of patients who have ACS do not have classic clinical presentations [7]. Patients who have atypical presentations of ACS are more likely to be elderly, female, or diabetic [8]. Many will have different descriptions of chest discomfort, such as burning, ‘‘heartburn,’’ a knot in the center of the chest, a lump in the throat, or a bandlike sensation across the chest [8]. In addition to atypical descriptions of pain, patients frequently have primary complaints other than chest pain. Dyspnea, diaphoresis, vomiting, near syncope, and fatigue are common presenting complaints in patients who have atypical presentations of ACS. In fact, fatigue is the most common presenting symptom of elderly patients who have an ACS [8]. According to the Global Registry of Acute Coronary Events (GRACE) trial, almost 10% of patients who have ACS do not complain of chest pain [9]. Thus the primary care physician must be suspicious of ACS across a myriad of patient populations and complaints. Radiation of chest pain must be interpreted with caution. Although clinicians commonly ask about radiation of discomfort to the left upper extremity, radiation to the right upper extremity is more predictive of ACS. Radiation of chest pain to the right shoulder increases the likelihood of ACS threefold, whereas radiation to both shoulders results in a sevenfold increase in the likelihood of ACS [7]. In a prospective study of emergency department patients who had chest pain, 48 out of 51 patients who had radiation of pain to the right arm were diagnosed with ACS [10]. Factors that aggravate or alleviate chest discomfort can be misleading. Chest discomfort in the setting of eating is typically associated with gastrointestinal etiologies. Postprandial pain, however, can be a marker for significant CAD, namely left main occlusion or severe three-vessel disease [11]. Similar to the onset of pain with eating, chest discomfort that is relieved with antacids is commonly ascribed to a gastrointestinal disorder.
IDENTIFYING CHEST PAIN EMERGENCIES
627
Unfortunately, relief of pain with antacids has been shown to be unreliable in differentiating cardiac and gastrointestinal causes of chest pain [8,12]. Risk factors Established risk factors for CAD include age over 65, male gender, cigarette use, hypertension, dyslipidemia, and diabetes mellitus. In addition to these, it is crucial that that clinician know emerging risk factors for ACS. Systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and HIV have been identified as independent risk factors for CAD. For patients who have SLE, the incidence of CAD is fifty times greater than in agematched controls [13]. It is hypothesized that the combination of vascular inflammation, immune-mediated vasculopathy, increased incidence of dyslipidemias, and hypercoagulability contribute to the development of CAD in patients who have SLE [13,14]. It is for these same reasons that patients who have RA are at increased risk for CAD [15]. Although HIV is not traditionally associated with CAD, postmortem studies have demonstrated significant atherosclerotic heart disease among HIV-positive patients [16]. Furthermore, the majority of patients in these studies lacked the traditional risk factors previously discussed. Reasons postulated for the increased incidence of CAD among patients who have HIV include endothelial cell dysfunction, chronic inflammation, increased incidence of hypertriglyceridemia, and the use of highly active antiretroviral therapy [9]. Physical examination There are no physical examination findings that reliably diagnose ACS. Nonetheless, a complete physical examination, including vital signs, is necessary in patients who have suspected ACS. The presence of hypotension, although predictive of a catastrophic cause of chest pain, is nonspecific. Cardiopulmonary findings that increase the likelihood of ACS include an S3 or S4 gallop, a new mitral insufficiency murmur, or signs of congestive heart failure such as pulmonary rales and elevated jugular venous pressures [8]. Chest pain that is reproducible upon palpation of the chest wall should not immediately be attributed to a musculoskeletal etiology. Up to 15% of patients who have an acute myocardial infarction will have reproducible chest pain upon palpation [17]. Electrocardiogram All patients who have suspected ACS should have an electrocardiogram (ECG) performed as soon as possible. Failure to perform an ECG is one of the most common reasons for physicians to lose malpractice litigation involving patients who have ACS [5]. Elevation of the ST segment is the most sensitive and specific marker for ACS, and is seen in 30% to 40% of patients [18]. In patients who have 1 mm or more of new ST segment
628
WINTERS & KATZEN
elevation, the prevalence of acute myocardial infarction is 80% [5]. Additional ECG signs of ACS include flat or downsloping ST segment depression or T-wave inversions. Up to 20% of patients who have new ST segment depression or T-wave inversion have an acute myocardial infarction [5]. Thus patients who have ST segment depression or segmental T-wave inversion must be considered to have ACS until proven otherwise. Finally, a normal ECG does not rule out ACS as an etiology of chest pain. Anywhere from 20% to 33% of patients who have ACS have a normal initial ECG [19]. Office-based treatment Once ACS is suspected, preparations should be made for immediate patient transport to the closest emergency department. While awaiting transfer, patients should be placed on a cardiac monitor and given supplemental oxygen. In addition, patients should receive a chewable aspirin as soon as possible. With the exception of hypotensive patients and those taking sildenafil, sublingual nitroglycerin should be administered for persistent pain. In patients who have no absolute contraindications, a beta-blocker can be given, because it decreases the progression of AMI by 13% [18].
Aortic dissection Aortic catastrophes result in 16,000 deaths per year in the United States [20]. For AD, the incidence ranges from 5 to 30 cases per million per year [21–24]. Unfortunately, the diagnosis is missed in up to 38% of patients on initial evaluation [21]. Reasons cited for missed AD include the failure to recognize atypical presentations, the inability to identify risk factors for AD, inattention to key physical examination features, and the failure to understand the limitations of diagnostic imaging. Mortality for untreated AD is significant. For acute ascending AD, mortality increases 1% to 3% per hour during the first 24 hours following symptom onset [21,25,26]. If the diagnosis is not made, mortality reaches 30% at 48 hours, 40% by day 7, and 50% at 1 month [27]. For patients who have an uncomplicated descending AD, mortality is lower, reaching 10% by day 30 [27]. Clinical presentation The classic description of AD is the instantaneous onset of chest pain that is maximal at its inception, is described as sharp or tearing, and radiates to the interscapular region. Regrettably, this classic presentation is often the exception rather than the rule. Anywhere from 16% to 26% of patients do not recall an instantaneous onset of pain [28]. According to data from the International Registry of Acute Aortic Dissection, only 50% of patients who had an AD described pain as tearing or ripping [22]. Furthermore, the location of pain is dependent upon the segment of aorta that is involved. Patients with
IDENTIFYING CHEST PAIN EMERGENCIES
629
a dissection of the ascending aorta commonly report anterior chest pain, whereas patients who have involvement of the descending aorta frequently complain of posterior chest, back, or abdominal pain [21]. In addition to varying locations and descriptions of pain, more than one third of patients present with symptoms attributable to secondary organ involvement [29]. The two most common organ systems involved in patients who have AD are the cardiovascular and neurologic systems. Cardiovascular involvement is reported to occur in 18% to 50% of cases of AD [21,30,31]. More often this occurs in dissections of the ascending aorta, resulting in acute congestive heart failure (CHF), cardiac tamponade, myocardial infarction, or cardiogenic shock. Neurologic symptoms are reported in 18% to 30% of patients with AD [21,32,33]. Although signs of cerebral ischemia are the most common, symptoms attributable to spinal cord ischemia can be seen in up to 10% of patients [21,32]. Patients who have AD and spinal cord ischemia may present with quadriplegia, paraplegia, or unilateral parasthesias. Additional clinical presentations of AD include syncope, dysphagia, and hoarseness. Risk factors Male gender, advanced age, and chronic hypertension are established risk factors for AD. In fact, the incidence of disease is highest among male patients between the ages of 50 and 70 years [21,25,34]. Depending on the study population, hypertension is present in almost 80% of patients who have AD [21,30]. Additional recognized risk factors for AD include smoking, hyperlipidemia, aortic instrumentation, connective tissue syndromes, bicuspid aortic valve, coarctation of the aorta, decelerating trauma, and inflammatory conditions such as giant cell and Takayasu’s arteritis [21]. Pregnancy and cocaine use have recently been identified as risk factors for AD. Aortic dissection in pregnancy occurs more often during the third trimester and the initial stages of labor. In fact, 50% of dissections in women less than 40 years of age occur during pregnancy [21]. Physical examination Classic physical examination findings associated with AD include hypertension, blood pressure differentials, pulse amplitude deficits, and a new diastolic murmur. Many of these findings are transient, and thus absent in a significant percentage of patients with AD. Up to 25% of patients who have AD present with a systolic blood pressure less than 100 mm Hg [21,25,35]. Similarly, pulse amplitude deficits are found in just 25% to 30% of patients [21,28,36]. Although bilateral blood pressure measurements are standard in the evaluation for AD, a difference of 20 mm Hg between extremities is seen in up to 20% of normal individuals [25]. Fewer than one third of patients who have AD have a diastolic murmur [28]. Thus results of the physical examination in patients with suspected AD must be
630
WINTERS & KATZEN
interpreted with caution. A diagnosis of AD should never be excluded based upon a normal physical examination. Diagnostic evaluation Imaging modalities used in the evaluation of AD consist of chest radiography (CXR), computed tomography (CT), magnetic resonance imaging (MRI), transesophageal echocardiography (TEE) and aortography. Classic CXR findings of AD include a widened mediastinum, widening of the aortic knob, an aortic wall shadow that extends beyond intimal calcification, a double aortic shadow, and a left pleural effusion. Unfortunately, CXR has limited utility in the evaluation of AD. The overall sensitivity and specificity for CXR are reported to be just 64% and 86%, respectively [37]. Furthermore, 10% to 40% of patients who have an AD have a normal initial CXR [27]. In most centers, helical CT scanning is the imaging modality of choice for AD. Diagnostic accuracy of CT for AD approaches 100% [37]. Advantages to CT include its accessibility, quick study times, and the ability to provide accurate measurements. Although the sensitivity and specificity for MRI ranges from 95% to 100%, technical limitations of long study time, poor patient access, restricted cardiac monitoring, and lack of immediate availability limit its use in the detection of AD [21]. In experienced hands, TEE is an acceptable imaging modality, because sensitivity is reported to be as high as 98% [21,38]. Limitations to TEE include the inability to visualize the aorta below the celiac axis and the strong dependence on operator experience. Aortography, although long considered the gold standard in diagnosing AD, is invasive and time-consuming. Sensitivity of aortography for AD ranges from 86% to 88%, whereas specificity ranges from 75% to 94% [21]. Office-based treatment As with ACS, once AD is suspected arrangements should be made for immediate transfer to the closest emergency department. Patients should be placed on a cardiac monitor and intravenous access obtained. Antihypertensive therapy should be started immediately, except in patients who are hypotensive. Goals of antihypertensive therapy are to reduce the force of left ventricular contractions, decrease the rise of aortic pulse wave, and decrease the systemic arterial pressure to as low as tolerable [21]. Standard antihypertensive therapy includes the combination of a beta-blocker and vasodilator, namely sodium nitroprusside. To prevent rebound tachycardia, the betablocker should be started before nitroprusside. Labetolol is recognized as an acceptable alternative to combination therapy [21]. Pulmonary embolism Pulmonary embolism is the third leading cause of cardiovascular mortality in the United States [39–41]. Although exact figures are unknown, it is
IDENTIFYING CHEST PAIN EMERGENCIES
631
estimated that the incidence of PE in the United States exceeds 1 per 1000 [39,42]. This translates into over 600,000 episodes each year, accounting for approximately 100,000 to 200,000 deaths [43,44]. Unfortunately, many cases of PE are not diagnosed. In fact, it is commonly cited that only 30% of emboli are diagnosed antemortem [45,46]. Mortality for undetected, and thus untreated, PE is significant, and ranges from 18% to 35% [47]. Although recent literature indicates mortality rates for ambulatory patients are lower [46], untreated PE remains a significant concern. It is imperative that primary care physicians be knowledgeable regarding current concepts and controversies in the evaluation of patients who have suspected PE. Clinical presentation Arguably, the most important step in diagnosing PE is to consider it as a diagnostic possibility. As such, the clinician must recognize that the clinical presentation of PE is variable and often nonspecific. Patients who have PE frequently present with such nonspecific symptoms as palpitations, cough, anxiety, lightheadedness, back pain, hiccoughs, or syncope [39,48]. In fact, syncope is reported in up to 13% of patients who have PE [39,49]. Moreover, PE may masquerade as an exacerbation of a chronic medical condition, namely CHF or chronic obstructive pulmonary disease (COPD) [50]. Because these illnesses predispose patients to venous thromboembolic (VTE) disease, PE must always be considered as an etiology of a CHF or COPD exacerbation. Although chest pain, dyspnea, and hemoptysis are classically associated presentations, they are unreliable and inconsistent findings among patients with PE. In a study of 500 patients, Miniati and colleagues [51] reported that 22% of patients who had PE did not complain of chest pain. Similarly, dyspnea can be absent in up to 8% of patients [39,52]. Fewer than 10% of patients who have PE have hemoptysis as a component of their clinical presentation [39,40,49]. Thus, the lack of these classic clinical presentations should not be used to exclude the diagnosis. The primary care physician must maintain suspicion for PE across a myriad of patient complaints. Risk factors Once PE is considered a diagnostic possibility, a directed history and physical examination must be performed. Central to the history in patients who have suspected PE is the identification of risk factors for VTE disease. Failure to assess and document risk factors is one of the most frequently cited reasons for missed PE [53]. Classic risk factors include malignancy, trauma, recent surgery, prolonged immobilization, pregnancy, oral contraceptive therapy, diseases that alter blood viscosity, inherited thrombophilias, and a prior history of VTE disease [39,40,42,43]. Of these, a prior history of VTE is the strongest risk factor for current disease [39,54]. Although textbooks emphasize these classic risk factors, it is important to
632
WINTERS & KATZEN
recognize that advanced age, obesity, hypertension, cigarette smoking, and medical conditions such as pneumonia, stroke, and CHF are risk factors for VTE disease [42]. In fact, obesity is the most common reversible risk factor for PE in our society [42]. Unfortunately, many patients who have suspected PE reveal no risk factors for disease, despite an exhaustive search. This should not dissuade the physician from pursuing a diagnostic evaluation, because up to 12% of patients who have PE lack any identifiable risk factors [39,55]. Physical examination Physical examination findings in patients who have suspected PE must be interpreted with caution. Many patients with PE, especially young patients and those who have normal cardiopulmonary reserve, can appear deceivingly well despite a large clot burden. Furthermore, classic vital sign abnormalities such as tachypnea and tachycardia are inconsistent findings among patients who have PE. In fact, tachypnea is absent in up to 13% of patients diagnosed with PE [39,46,54]. Similarly, tachycardia is absent in up to 30% of patients over 40 years of age [39]. In patients younger than 40 years of age who have PE, up to 70% have normal heart rates [39,56]. Additional examination findings that can be misleading include fever, wheezing, rales, or signs of consolidation. Stein and coworkers [57] reported that up to 14% of patients who have PE are febrile upon presentation. Nonetheless, no physical examination finding is considered sensitive or specific for PE. Clinical prediction rules Before pursuing a diagnostic evaluation, the clinician must classify the patient into low, intermediate, or high clinical probability of disease. Patients classified as low probability have a disease prevalence ranging from 5% to 10%, whereas those with an intermediate probability have a prevalence of 25% to 40% [43]. Patients felt to have a high clinical probability have a prevalence of PE ranging from 70% to 90% [43]. Classifying patients into one of these three groups has traditionally been based upon clinical gestalt. Within the past several years numerous scoring systems have been published in an attempt to standardize the clinical assessment of probability. The oldest and most frequently used scoring system is the Wells clinical prediction rule [58]. Although criticized for its subjectivity regarding the likelihood of alternative diagnoses, the Wells rule has been prospectively validated and can be used in the outpatient setting. Other scoring systems, although useful, require results from the electrocardiogram, chest radiography, or arterial blood gas measurement, making their application more challenging in the outpatient setting. Unfortunately, there is currently no consensus on the best clinical prediction rule for PE. For clinicians who chose not to use a standardized scoring system, clinical gestalt remains a reasonable alternative. In a recent review, clinical gestalt was found to have
IDENTIFYING CHEST PAIN EMERGENCIES
633
similar accuracy in discriminating among patients who had low, intermediate, or high probability of PE [59]. Electrocardiogram The primary role of the electrocardiogram in patients with suspected PE is to exclude alternative diagnoses, namely acute myocardial infarction. Unfortunately, the majority of patients who have PE have nonspecific abnormalities, thereby limiting the utility of the electrocardiogram. The most common abnormality seen in patients who have PE is T-wave inversions, most notably in leads V1 to V4 [39,60]. Additional nonspecific abnormalities include ST segment changes, left or right axis deviations, sinus tachycardia, and right bundle branch block [48]. The classic S1Q3T3 abnormality is neither sensitive nor specific for PE, and is found in only a small percentage of patients. Pulmonary embolism should never be excluded simply because patients lack an S1Q3T3 abnormality on their electrocardiogram. D-dimer D-dimer is a cross-linked degradation product formed by plasmin, and is a marker of endogenous fibrinolysis [46]. It is elevated in nearly all patients with pulmonary embolism [42,43]. Unfortunately, it is also elevated in a number of other conditions, such as pregnancy, trauma, postoperative states, cancer, inflammatory conditions, and advancing age [43]. Thus, D-dimer is a sensitive, but not specific, serum marker for PE. Over the past several years multiple D-dimer assays have been developed and evaluated. At present, the most sensitive D-dimer assay is the standard, or rapid, enzyme-linked immunosorbent assay (ELISA). Latex agglutination and whole-blood assays are less sensitive and should not be used in the evaluation of patients who have suspected PE. The greatest utility of D-dimer is in the outpatient evaluation of the patient who has low clinical probability of PE. Several studies have demonstrated that a normal ELISA d-dimer level, combined with a low clinical probability, can safely rule out PE. Dunn and colleagues [61] demonstrated a 99.6% negative predictive value for a normal ELISA D-dimer level in patients suspected of having PE. These results indicate that a normal D-dimer level is as predictive as a normal ventilation-perfusion scintigraphy or negative duplex ultrasound [46]. For patients who have intermediate or high clinical probability, there is currently not enough evidence to safely rule out the diagnosis of PE based upon a normal D-dimer level. Diagnostic imaging Available imaging modalities used in the evaluation of patients who have suspected PE include CXR, ventilation-perfusion scintigraphy, helical CT, venous ultrasound, and pulmonary angiography. Like that of the
634
WINTERS & KATZEN
electrocardiogram, the utility of chest radiography lies in its ability to exclude alternative diagnoses such as pneumothorax. Unfortunately, the chest radiograph is often abnormal, with the findings nearly always nonspecific. Common abnormalities include atelectasis, pulmonary infiltrates, elevation of the hemidiaphragm, pleural effusion, and cardiomegaly [48]. Perhaps most worrisome is that up to 12% of patients who have PE have an entirely normal chest radiograph [62]. Pulmonary embolism should be strongly suspected in patients presenting with cardiopulmonary complaints and a normal chest radiograph. Ventilation-perfusion scintigraphy has been used for over 3 decades in the evaluation of the patient who has suspected PE. When the results are definitive, normal or high probability, ventilation-perfusion scanning is useful. Unfortunately, the majority of patients suspected of having PE do not have definitive studies. In fact, anywhere from 50% to 70% of scans are indeterminate [61]. Thus, ventilation-perfusion scanning fails to provide a definitive answer in almost 70% of patients [46,61]. Furthermore, ventilation-perfusion scanning has been shown to have poor interobserver correlation [63]. It is for these reasons that many centers have replaced ventilation-perfusion scanning with helical CT in the evaluation of patients with suspected PE. Helical CT has become the preferred diagnostic imaging modality in patients who have suspected PE. Advantages to CT over ventilation-perfusion scanning include the ability to directly visualize thrombi, to detect abnormalities that may indirectly indicate thrombus, and to provide an alternative etiology for the presenting symptoms [43]. Initial studies using CT reported widely varying degrees of sensitivity and specificity, ranging from 57% to 100% and 78% to 100% respectively [43]. Nearly all of these studies used older-generation, single-slice conventional scanners in which false negative rates up to 30% have been reported [64]. Current-generation multidetector-row CT scanners have dramatically faster scanning times, less motion artifact, higher resolution, and better peripheral visualization. As a result of this improved technology, current CT scanners can image down to sixth order branches, significantly increasing the detection of subsegmental pulmonary emboli [64]. Thus far, animal studies demonstrate that CT is at least as accurate as pulmonary angiography in the detection of small peripheral emboli [64]. In addition to improved visualization, the interobserver agreement for CT is significantly higher than that of ventilation-perfusion scanning [63]. Outcome data are mounting on the safety of withholding anticoagulation in patients with a negative helical CT [65,66]. Based upon several retrospective and prospective studies, the negative predictive value of a normal CT scan approaches 98% [67]. In fact, the frequency of PE diagnosed after a normal CT scan is lower than for a normal or low-probability ventilation-perfusion scan [63,64]. Combining CT venography of the lower extremities, or lower extremity venous ultrasound, with chest CT for a more thorough evaluation for VTE disease is a common practice in many medical
IDENTIFYING CHEST PAIN EMERGENCIES
635
centers. The feasibility of this approach has been demonstrated in several studies [64,68]. The Prospective Investigation of Pulmonary Embolism Diagnosis II (PIOPED-II) study is a recently completed prospective multicenter study that will serve to solidify the role of CT in the evaluation of patients with suspected PE. The utility of lower extremity venous ultrasonographic screening in patients who have suspected PE, but without leg symptoms, is controversial. Venous ultrasound has been shown to be insensitive for diagnosing DVT in asymptomatic patients [64,69]. Furthermore, venous ultrasound may provide false positive results, or may detect residual abnormalities from a previous thrombosis. As such, the possibility of embolism cannot be reliably excluded based upon a negative lower extremity ultrasound. With the technological advances in CT scanning, the use of pulmonary angiography in the evaluation of patients who have suspected PE is declining. Long hailed as the gold standard diagnostic imaging modality for PE, pulmonary angiography is not without risks or limitations. Morbidity and mortality rates for the procedure range from 3.5% to 6% and 0.2% to 0.5%, respectively [64]. Major nonfatal complications include hematoma at the puncture site, respiratory failure, and contrast-induced nephropathy [43]. Furthermore, pulmonary angiography requires expertise in both performance and interpretation, which is often not available at many centers. Office-based treatment Once the primary care physician suspects PE as a diagnostic possibility, arrangements should be made for transport to the closest emergency department. Patients should be placed on a cardiac monitor and given supplemental oxygen. Intravenous access should be obtained and the patient should receive intravenous fluids. For patients in whom PE is considered the most likely diagnosis, heparin therapy should be initiated while pursuing definitive imaging. Although low-molecular–weight heparin preparations have advantages over unfractionated heparin, either is sufficient for the initial treatment of patients who have suspected PE.
Esophageal perforation Esophageal perforation is the most fatal perforation of the gastrointestinal tract [70]. Often, the diagnosis is delayed or missed entirely. Any delay in diagnosis leads to unacceptably high morbidity and mortality. When the diagnosis is delayed by just 24 hours, mortality exceeds 60% [71]. Reasons cited for delays in diagnosis include the failure to recognize atypical presentations, a failure to identify patient risk factors, and a failure to understand the limitations of traditional diagnostic imaging. Although esophageal perforation accounts for a small percentage of cases, the primary care physician must be able to identify this life-threatening etiology of chest pain.
636
WINTERS & KATZEN
Clinical presentation The clinical presentation of esophageal perforation is dependent upon the location of perforation. Patients who have a thoracic esophageal perforation present with the classic symptoms of chest pain, dyspnea, and odynophagia. Patients who have a cervical esophageal perforation, however, may only complain of neck pain, neck spasm, hoarseness, or dysphagia [71,72]. Those who have perforation of the intra-abdominal esophagus may only have midepigastric discomfort, thereby potentially leading to a misdiagnosis of pancreatitis, gastritis, peptic ulcer disease, or gastroesophageal reflux disease. With such a variable clinical presentation, it is easy to see how even the seasoned clinician can miss the diagnosis of esophageal perforation. Risk factors Identified risk factors for esophageal perforation include recent medical procedures, foreign body ingestion, caustic ingestion, trauma, esophageal malignancy, and immunocompromised states. Medical procedures are the greatest risk factor for esophageal perforation, accounting for up to 75% of cases [71,72]. Procedures that have a risk of perforation are pneumatic dilatation, sclerotherapy, upper endoscopy, surgical procedures of the head and neck, nasogastric tube insertion, and endotracheal intubation [71,72]. Patients who are profoundly immunocompromised, such as those who have advanced HIV, are at risk for esophageal perforation. These patients have a higher incidence of esophageal infection due to Candida, herpes simplex virus, and Mycobacterium tuberculosis, which have been shown to predispose patients to perforation [73]. Physical examination Classic physical examination findings in patients who have esophageal perforation are fever and subcutaneous emphysema. Unfortunately, both are inconsistent and unreliable findings in patients who have perforation. In an institutional review of cases of esophageal perforation, Eroglu [74] found that only 33% were febrile upon presentation. In patients who have a cervical esophageal perforation, only 60% have subcutaneous emphysema on examination [71]. For those who have a thoracic perforation, just 30% have evidence of subcutaneous emphysema [71]. Therefore, a normal physical examination does not rule out the possibility of esophageal perforation. Diagnostic evaluation Definitive diagnosis of esophageal perforation is challenging. Because the majority of patients report pain somewhere in the thoracic region, CXR is often obtained as the initial imaging modality. Chest radiograph abnormalities suggestive of perforation include a new pleural effusion, pneumothorax,
IDENTIFYING CHEST PAIN EMERGENCIES
637
or pneumomediastinum [70]. These CXR abnormalities, however, may take several hours to become evident on plain radiography. As a result, up to 12% of patients who have a perforation have a normal initial CXR [70]. To exclude an esophageal perforation, most primary care physicians rely on a water-soluble, contrast-enhanced esophagram. Because of the mechanical properties of water-soluble agents, false-negative results can occur. In fact, anywhere from 15% to 25% of esophagrams are initially negative in patients who have an esophageal perforation [70,71,75]. If clinical suspicion remains high, many radiologists recommend obtaining a CT scan. CT has been shown to compliment contrast-enhanced esophageal radiography, and is able to detect additional findings of perforation such as periaortic air, mediastinal fluid collections, and esophageal thickening [76]. Office-based treatment Once an esophageal perforation is suspected, rapid transport to the closest emergency department should be arranged. While awaiting transfer, patients should be placed on cardiac monitor, given supplemental oxygen, and intravenous access should be obtained. Definitive treatment for a perforation centers on emergent surgical repair. If available, broad spectrum antibiotics should be administered, but should not delay timely transport. Antibiotics should be given intravenously and cover gram-positive, gram-negative, and anaerobic organisms. Pericarditis Although generally not an immediate life-threatening condition, pericarditis must be considered in patients who have acute chest pain. Often, patients with pericarditis develop a pericardial effusion that, if severe, can result in cardiac tamponade and hemodynamic collapse. In addition to an effusion, patients can develop constrictive pericarditis, thereby mimicking tamponade physiology. The exact incidence of pericarditis is difficult to determine, because disease prevalence is dependent upon the study population. For patients presenting to an emergency department with acute chest pain, pericarditis accounts for approximately 5% of cases [77]. Clinical presentation Acute chest pain is the most common presenting symptom of pericarditis [78]. Pain is typically described as the sudden onset of sharp, anterior chest pain that is exacerbated by cough, deep inspiration, or the supine position. Although this classic presentation is helpful, it is not present in all patients who have pericarditis. Often, the pain caused by pericarditis is similar to the symptoms of an ACS. Furthermore, radiation of pain in pericarditis is common. In fact, pain that radiates to the trapezius ridge is frequently seen in pericarditis caused by inflammation of the phrenic nerve [77,79]. Patients
638
WINTERS & KATZEN
who have significant amounts of pericardial fluid may present with nonspecific complaints. More often these patients complain of generalized weakness, dyspnea with exertion, cough, or even dysphagia [80]. Risk factors Although the majority of cases are caused either by viral or idiopathic etiologies, a number of medical conditions place patients at risk for pericarditis. These include collagen vascular diseases such as systemic lupus erythematosus and rheumatoid arthritis, renal insufficiency, malignancy, and recent myocardial infarction [77]. In addition, a thorough review of medications is necessary, because several medications have been shown to incite pericarditis. Physical examination The textbook cardiac examination finding in patients who have pericarditis is the pericardial friction rub. It is classically described as a highpitched, scratchy sound that is heard best at the left sternal border during expiration [77]. A rub is reportedly 100% specific for the diagnosis of pericarditis [79]. Unfortunately, a pericardial rub often varies in intensity and intermittently disappears, thereby limiting its overall sensitivity. Thus the diagnosis of pericarditis should not be excluded based upon the absence of a friction rub. In addition to listening for a rub, the clinician should look for signs of cardiac tamponade. ‘‘Beck’s triad’’ of tamponade is hypotension, muffled heart sounds, and jugular venous distention. If tamponade is suspected, the patient should be examined for the presence of pulsus paradoxus. Although considered the hallmark of cardiac tamponade, the prevalence of pulsus paradoxus ranges from 12% to 75% of patients who have tamponade [79]. Electrocardiogram Electrocardiographic abnormalities in pericarditis are classically divided into four stages. Unfortunately, fewer than 50% of patients demonstrate all four stages on their ECG [81]. The most common abnormalities seen in pericarditis are diffuse ST segment elevation and PR segment depression. These findings are absent in up to 20% of patients who have acute pericarditis [77]. Depending upon the study, up to 16% of patients who have pericarditis have an entirely normal ECG [82]. As such, acute pericarditis should not be excluded based upon a normal ECG. Office-based treatment Unlike the previously discussed life-threatening etiologies of chest pain, patients who have acute pericarditis often do not require immediate hospitalization. For those that have viral or idiopathic etiologies, the course of
IDENTIFYING CHEST PAIN EMERGENCIES
639
pericarditis is generally benign. These patients can effectively be treated with nonsteroidal anti-inflammatory medications [83]. In recent years, a number of studies have attempted to risk stratify patients who have acute pericarditis. Patients at high risk of complications should be admitted for observation and further treatment. Prognostic signs that indicate patients at high risk include subacute onset, immunosuppressed states, trauma, oral-anticoagulation therapy, serologic evidence of myopericarditis, severe pericardial effusion, or evidence of tamponade [83]. To evaluate for the presence of a pericardial effusion, it is recommended that all patients with suspected pericarditis receive an echocardiogram [77].
Summary The majority of patients presenting to a primary care physician with acute chest pain will have non-life–threatening etiologies. Nevertheless, catastrophic cause of chest pain such as ACS, AD, PE, esophageal perforation, and pericarditis must be considered in the differential diagnosis. Often, these deadly conditions have atypical clinical presentations that must be recognized. Furthermore, the physical examination can be deceptively benign in patients harboring a catastrophic etiology of chest pain. By identifying these atypical presentations, recognizing the utility of the physical examination, and understanding of the limitations of traditional diagnostic imaging, primary care physicians can effectively diagnose patients who have life-threatening cause of acute chest pain. References [1] Woodwell DA. National ambulatory medical care survey: 1998 summary. Adv Data 2000; 19:1–26. [2] Klinkman MS, Stevens D, Gorenflo DW. Episodes of care for chest pain: a preliminary report from MIRNET. Michigan Research Network. J Fam Pract 1994;38:345–52. [3] Callans DJ. Out-of-hospital cardiac arrestdthe solution is shocking. N Engl J Med 2004; 351(7):632–4. [4] Clinical performance measures: chronic stable coronary artery disease. American College of Cardiology, American Heart Association, Physician Consortium for Performance Improvement. Available at: www.acc.org/clinical/measures/CAD/cadmeasures.pdf. Accessed: December 1, 2005. [5] Lee TH, Goldman L. Evaluation of the patient with acute chest pain. N Engl J Med 2000; 342(16):1187–95. [6] Lee TH, Rouan GW, Weisberg MC, et al. Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency department. Am J Cardiol 1987;60:219–24. [7] Panju AA, Hemmelgarn BR, Guyatt GH, et al. Is this patient having a myocardial infarction? JAMA 1998;280(14):1256–63. [8] Meisel JL. Diagnostic approach to chest pain in adults. Availabale at: http://www.utdol. com/utd/content/topic.do?topickey¼pri_card/2346&type¼A&selectedTitle¼1~88. Accessed December 2005.
640
WINTERS & KATZEN
[9] Brieger D, Eagle KA, Goodman SG, et al. Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group. Insights from the Global Registry of Acute Coronary Events. Chest 2004;126:461–9. [10] Berger JP, Buclin T, Haller E, et al. Right arm involvement and pain extension can help to differentiate coronary diseases from chest pain of other origin: a prospective emergency ward study of 278 consecutive patients admitted for chest pain. J Intern Med 1990;227:165–72. [11] Berlinerblau R, Shani J. Postprandial angina pectoris: clinical and angiographic correlations. J Am Coll Cardiol 1994;23:627–9. [12] Castrina FP. Unexplained noncardiac chest pain. Ann Intern Med 1997;126:663–4. [13] Mattu A, Petrini J, Swencki S, et al. Premature atherosclerosis and acute coronary syndrome in systemic lupus erythematosus. Am J Emerg Med 2005;23:696–703. [14] Karrar A, Sequiera W, Block JA. Coronary artery disease in systemic lupus erythematosus: a review of the literature. Semin Arthritis Rheum 2001;30:436–43. [15] Chung CP, Oeser A, Raggi P, et al. Increased coronary-artery atherosclerosis in rheumatoid arthritis. Arthritis Rheum 2005;52(10):3045–53. [16] Passalaris JD, Sepkowitz KA, Glesby MJ. Coronary artery disease and human immunodeficiency virus infection. Clin Infect Dis 2000;31:787–97. [17] Aufderheide TP, Gibler WB. Acute ischemic coronary syndromes. In: Rosen P, Barkin R, editors. Emergency medicine concepts and clinical practice. 4th edition. St. Louis (MO): Mosby; 1998. p. 1655–716. [18] Masud SP, Mackenzie R. Acute coronary syndrome. J R Army Med Corps 2003;149(4): 303–10. [19] Norell M, Lythall D, Coghlan G, et al. Limited value of the resting electrocardiogram in assessing patients with recent onset chest pain: Lessons from a chest pain clinic. Br Heart J 1992;67(1):53–6. [20] National Center for Health Statistics. Vital statistics of the United States, 2000. Available at: http://wonder.cdc.gov/wonder/sci_data/mort/mcmort/type_txt/mcmort03/techap99.pdf. Accessed December 1, 2005. [21] Khan IA, Nair CK. Clinical, diagnostic, and management perspectives of aortic dissection. Chest 2002;122(1):311–28. [22] Hagan PG, Nienaber CA, Isselbacher EM, et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 2000;283:897–903. [23] Eisenberg MJ, Rice SA, Paraschos A, et al. The clinical spectrum of patients with aneurysms of the ascending aorta. Am Heart J 1993;125:1380–5. [24] Bickerstaff LK, Pairolero PC, Hoiler LH, et al. Thoracic aortic aneurysms: a population based study. Surgery 1982;92:1103–8. [25] Rogers RL, McCormack R. Aortic disasters. Emerg Med Clin North Am 2004;22(4): 887–908. [26] Pitt MP, Bonser RS. The natural history of thoracic aortic aneurysm disease: an overview. J Card Surg 1997;12:270–8. [27] Nienaber CA, Eagle KA. Aortic dissection: new frontiers in diagnosis and management: Part I: From etiology to diagnostic strategies. Circulation 2003;108(5):628–35. [28] Haro LH, Krajicek M, Lobl JK. Challenges, controversies, and advances in aortic catastrophes. Emerg Med Clin N Am 2005;23:1159–77. [29] Khan IA. Clinical manifestations of aortic dissection. Journal of Clinical and Basic Cardiology 2001;4:265–7. [30] Hennessy TG, Smith D, McCann HA, et al. Thoracic aortic dissection or aneurysm: clinical presentation, diagnostic imaging and initial management in a tertiary referral center. Ir J Med Sci 1996;165:259–62. [31] Rahmatullah SI, Khan IA, Nair VM, et al. Painless limited dissection of the ascending aorta presenting with aortic valve regurgitation. Am J Emerg Med 1999;17:700–1. [32] Alverez Sabin J, Vazquez J, Sala A, et al. Neurologic manifestations of dissecting aneurysm of the aorta. Med Clin (Barc) 1989;92:447–9 [in Spanish].
IDENTIFYING CHEST PAIN EMERGENCIES
641
[33] Prendes JL. Neurovascular syndromes in aortic dissection. Am Fam Physician 1981;23: 175–9. [34] Auer J, Berent R, Eber B. Aortic dissection: incidence, natural history and impact of surgery. Journal of Clinical and Basic Cardiology 2000;3:151–4. [35] Garcia-Jiminez A, Paraza-Torres A, Martinez-Lopez G, et al. Cardiac tamponade by aortic dissection in a hospital without cardiothoracic surgery. Chest 1993;104:290–1. [36] von Kodolitsch Y, Schwartz AG, Nienaber CA. Clinical prediction of acute aortic dissection. Arch Intern Med 2000;160:2977–82. [37] Higgins CB. Modern imaging of the acute aortic syndrome. Am J Med 2004;116:134. [38] Vignon P, Gueret P, Vedrinne JM, et al. Role of transesophageal echocardiography in the diagnosis and management of traumatic aortic disruption. Circulation 1995;92:2959–68. [39] Laack TA, Goyal DG. Pulmonary embolism: an unsuspected killer. Emerg Med Clin North Am 2004;22:961–83. [40] Wells PS, Rodger M. Diagnosis of pulmonary embolism: when is imaging needed? Clin Chest Med 2003;24:13–28. [41] Gillum RF. Pulmonary embolism in the United States, 1970–1985. Am Heart J 1987;113: 1262–4. [42] Goldhaber SZ, Elliott CG. Acute pulmonary embolism: Part I, epidemiology, pathophysiology, and diagnosis. Circulation 2003;108 2726–29. [43] Fedullo PF, Tapson VF. The evaluation of suspected pulmonary embolism. N Engl J Med 2003;349:1247–56. [44] Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975;17: 259–70. [45] Morgenthaler TI, Ryu JH. Clinical characteristics of fatal pulmonary embolism in a referral hospital. Mayo Clin Proc 1995;70:417–24. [46] Boie ET. Initial evaluation of chest pain. Emerg Med Clin North Am 2005;23:937–57. [47] Calder KK, Herbert M, Henderson SO. The mortality of untreated pulmonary embolism in emergency department patients. Ann Emerg Med 2005;45:302–10. [48] Tapson VF. Acute pulmonary embolism. Cardiol Clin 2004;22:353–65. [49] Brilakis ED, Tajik AJ. 82-year old man with recurrent syncope. Mayo Clin Proc 1999;74: 609–12. [50] Bosomworth J. Diagnosing pulmonary embolism in a rural setting. Can J Rural Med 2005; 10:100–6. [51] Miniati M, Prediletto R, Fromichi B, et al. Accuracy of clinical assessment in the diagnosis of pulmonary embolism. Am J Respir Crit Care Med 1999;159:864–71. [52] Susec O, Boudrow D, Kline JA. The clinical features of acute pulmonary embolism in ambulatory patients. Acad Emerg Med 1997;4:891–7. [53] Sullivan D. Pulmonary embolismdmedical error and risk reduction part I. Available at: www.thesullivangroup.com. Accessed December 5, 2005. [54] Colucciello SA. Protocols for deep venous thrombosis: a state of the art review: Part I: Risk factor assessment, physical examination, and current diagnostic modalities. Emerg Med Rep 1999:13–24. [55] Morgenthaler TI, Ryu JH. Clinical characteristics of fatal pulmonary embolism in a referral hospital. Mayo Clin Proc 1995;70:417–24. [56] Green RM, Meyer TJ, Dunn M, et al. Pulmonary embolism in younger adults. Chest 1992; 101:1507–11. [57] Stein PD, Afzal A, Henry JW, et al. Fever in acute pulmonary embolism. Chest 2000;117: 39–42. [58] Wolf SJ, McCubbin TR, Feldhaus KM, et al. Prospective validation of Wells Criteria in the evaluation of patients with suspected pulmonary embolism. Acad Emerg Med 2004;44(5): 503–10. [59] Chunilal SD, Eikelboom JW, Attia J, et al. Does this patient have pulmonary embolism? JAMA 2003;290(21):2849–58.
642
WINTERS & KATZEN
[60] Ferrari E, Imbert A, Chevalier T, et al. The ECG in pulmonary embolism: predictive value of negative T waves in the precordial leadsd80 case reports. Chest 1997;111:537–43. [61] Dunn KL, Wolf JP, Dorfman DM, et al. Normal d-dimer levels in emergency department patients suspected of acute pulmonary embolism. J Am Coll Cardiol 2002;40:1475–8. [62] Ramzi DW, Leeper KV. DVT and pulmonary embolism: Part I: Diagnosis. Am Fam Physician 2004;69(12):2829–36. [63] Blachere H, Latrabe V, Montaudon M, et al. Pulmonary embolism revealed on helical CT angiography: comparison with ventilation-perfusion radionuclide lung scanning. American Journal of Roentgenology 2000;174:1041–7. [64] Schoepf UJ, Goldhaber SZ, Costello P. Spiral computed tomography for acute pulmonary embolism. Circulation 2004;109:2160–7. [65] Tillie-Leblond I, Mastora I, Radenne F, et al. Risk of pulmonary embolism after a negative spiral CT angiogram in patients with pulmonary disease: a 1-yr follow up study. Radiology 2002;223:461–7. [66] Moores LK, Jackson WL, Shorr AF, et al. Meta-analysis: outcomes in patients with suspected pulmonary embolism managed with computed tomographic pulmonary angiography. Ann Intern Med 2004;141:866–74. [67] Ost D, Rozenshtein A, Saffran L, et al. The negative predictive value of spiral computed tomography for the diagnosis of pulmonary embolism in patients with nondiagnostic ventilation-perfusion scans. Am J Med 2001;110:16–21. [68] Cham MD, Yankelevitz DF, Shaham D, et al. Deep venous thrombosis: detection by using indirect CT venography: the Pulmonary Angiography-Indirect CT Venography Cooperative Group. Radiology 2000;216:744–51. [69] Mac Gillavry MR, Sanson BJ, Buller HR, et al. Compression ultrasonography of the leg veins in patients with clinically suspected pulmonary embolism: is a more extensive assessment of compressibility useful? Thromb Haemost 2000;84:973–6. [70] Singh H, Warshawsky ME, Herman S, et al. Spontaneous esophageal rupture: Boerhaave’s syndrome. Clinical Pulmonary Medicine 2003;10(3):177–82. [71] Duncan M, Wong RKH. Esophageal emergencies: things that will wake you from a sound sleep. Gastroenterol Clin North Am 2003;32(4):1035–52. [72] Williamson W, Ellis H. Esophageal perforation. In: Taylor MB, editor. Gastrointestinal emergencies. 2nd edition. Baltimore (MD): Lipincott, Williams & Wilkins; 1997. p. 31–49. [73] Grubbs BD, Baldwin DR, Trenkner SW, et al. Distal esophageal perforation caused by tuberculosis. J Thorac Cardiovasc Surg 2001;121:1003–4. [74] Eroglu A. Esophageal perforation: the importance of early diagnosis and primary repair. Dis Esophagus 2004;17:91–4. [75] Gimenez A, Franquet T, Erasmus J, et al. Thoracic complications of esophageal disorders. Radiographics 2002;22:S247–58. [76] Ghanem N, Altehoefer C, Springer O, et al. Radiological findings in Boerhaave’s syndrome. Emerg Radiol 2003;10:8–13. [77] Lange RA, Hills LD. Acute pericarditis. N Engl J Med 2004;351(21):2195–202. [78] Braunwald E, Zipes DP, Libby P. Heart disease: a textbook of cardiovascular medicine. 6th edition. Philadelphia: W.B. Saunders Company; 2001. p. 1823–76. [79] Spodick DH. Acute pericarditis: current concepts and practice. JAMA 2003;289(9):1150–3. [80] Spodick DH. Acute cardiac tamponade. N Engl J Med 2003;349(7):684–90. [81] Marinella MA. Electrocardiographic manifestations and differential diagnosis of acute pericarditis. Am Fam Physician 1998;57:699–710. [82] Bruce MA, Spodick DH. Atypical electrocardiogram in acute pericarditis: characteristics and prevalence. J Electrocardiol 1980;13:61–6. [83] Imazio M, Demichelis B, Parrini I, et al. Day-hospital treatment of acute pericarditis: a management program for outpatient therapy. J Am Coll Cardiol 2004;43(6):1042–6.
Prim Care Clin Office Pract 33 (2006) 643–657
Evaluation of the Dyspneic Patient in the Office Saiyad Sarkar, MD, Pamela J. Amelung, MD* Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Maryland School of Medicine, 10 N. Greene Street 3D-122, Baltimore, MD 21201, USA
Dyspnea literally means disordered breathing. It is a term generally applied to the sensations experienced by individuals who complain of unpleasant or uncomfortable respiratory sensations. Dyspnea occurs in healthy individuals (ie, with exercise or at high altitude), but respiratory patients experience dyspnea at lower levels of exercise or altitude. Dyspnea may be considered part of the warning system for humans to recognize when they are at risk of receiving inadequate ventilation. Dyspnea has been shown to be an independent predictor of mortality [1], and has been found to be related to quality of life more than pulmonary function tests [2]. A precise or widely accepted definition of dyspnea does not exist, because patients use an array of terms to describe their breathing sensation, and the term dyspnea represents a number of qualitatively distinct sensations. The specific descriptive words used by patients to describe their breathing may provide insight into the underlying pathophysiology of their disease [3,4]. The American Thoracic Society has defined dyspnea in the following way: ‘‘Dyspnea is a term used to characterize a subjective experience of breathing discomfort that is comprised of qualitatively distinct sensations that vary in intensity. The experience derives from interactions among multiple physiological, psychological, social and environmental factors, and may induce secondary physiological and behavioral responses’’ [5]. For the purpose of this article, the authors use the terms ‘‘dyspnea’’, ‘‘breathlessness,’’ and ‘‘shortness of breath’’ interchangeably.
* Corresponding author. E-mail address:
[email protected] (P.J. Amelung). 0095-4543/06/$ - see front matter Ó 2006 Elsevier Inc. All rights reserved. doi:10.1016/j.pop.2006.06.007 primarycare.theclinics.com
644
SARKAR & AMELUNG
Prevalence of dyspnea Breathing discomfort is a common symptom experienced by patients, and can be quite distressing. It has more than 30 attributed causes involving multiple organ systems [6]. There are no precise data on the prevalence of dyspnea. The actual scope of the problem varies among clinical settings and patient subgroups. Population-based surveys have estimated the prevalence to be between 17% and 38% [7–9]. In an ambulatory setting the prevalence of dyspnea was 3.7% [10]. Morbidity associated with dyspnea can range from minor to disabling. Dyspnea is often associated with cardiac and respiratory diseases, but it can also be caused by obesity and deconditioning. As these conditions increase, the population with the complaint of dyspnea will rise too.
Mechanisms of dyspnea The difficulty in determining the cause of shortness of breath results from the complex and poorly understood pathophysiology involved in the production of the sensation of breathlessness. The mechanism of dyspnea originates with the activation of sensory systems involved with respiration. One or more receptors can be individually or collectively stimulated to initiate an afferent signal to the central nervous system (CNS). This afferent impulse is then transmitted to the central nervous system. Here the message is processed and efferent impulse is directed to the respiratory system. The major receptor sites considered in the sensation of dyspnea include chemoreceptors, mechanoreceptors, and lung receptors. Chemoreceptors are located both centrally (medulla) and peripherally (carotid and aortic bodies), and are responsible for detection of changes in oxygen and carbon dioxide. Stimulation of these receptors causes changes that adjust breathing to maintain blood gas and acid-base homeostasis. An increase in carbon dioxide stimulates central receptors and results in an increase in ventilation. Hypoxia stimulates respiration through its effects on the peripheral chemoreceptors, which may cause breathlessness in patients who have underlying lung disease. It has also been observed that supplemental oxygen administration relieves dyspnea in some patients who have lung disease, even in the absence of any changes in ventilation. Various mechanoreceptors, including chest wall receptors, may also be important in the generation of the sensation of dyspnea [11]. Upper airway receptors can modify the sensation of dyspnea, based on clinical observations that patients sometimes report a decrease in the intensity of their shortness of breath when sitting by a fan or open window. Afferent information from pulmonary vagal receptors project to the CNS and are important in shaping the pattern of breathing and to the sensation of dyspnea [12,13]. These impulses, with afferent impulses generated from various receptors, are received and processed in the CNS. The motor cortex or brainstem respiratory neurons are thought
EVALUATION OF THE DYSPNEIC PATIENT IN THE OFFICE
645
to transmit a signal to the sensory cortex, which might contribute to a ‘‘sense of effort’’ to breathing [14,15]. This sensation increases whenever the central motor command is increased or whenever the respiratory muscles become weak or fatigued. Based on response to the afferent information, the CNS sends an efferent impulse via the phrenic nerve to the diaphragm and other respiratory muscles to increase respiration. It is not completely understood how this impulse affects different aspects of breathing. In 1963 the concept of ‘‘length-tension inappropriateness’’ was proposed by Campbell and Howell [16]. According to their theory, there was a disassociation between the force or tension generated by the respiratory muscles and the lung volume generated by that force. Currently, mismatch between afferent information to the CNS and outgoing motor command is thought to lead to the sensation of breathlessness. The afferent feedback from peripheral sensory receptors may allow the brain to assess the effectiveness of the motor commands issued to the ventilatory muscles; that is, the appropriateness of the response in terms of flow and volume for the command. When changes in respiratory pressure, airflow, or movement of the lungs and chest wall are not appropriate for the outgoing motor command, the intensity of dyspnea is heightened. In other words, dissociation between the motor command and the mechanical response of the respiratory system may produce a sensation of respiratory discomfort. Today the theory has been generalized to include not only information arising in the ventilatory muscles, but information emanating from receptors throughout the respiratory system, and has been termed ‘‘neuromechanical dissociation’’ [14,17]. Approach to patients who have dyspnea In the outpatient setting, dyspnea is a common symptom. Establishing a cause can at times be difficult, because dyspnea is a symptom of a myriad of disorders, ranging from the completely benign to the relatively serious; however, asthma, congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), pneumonia, cardiac ischemia, psychogenic, and interstitial lung disease have been found in some series to account for approximately 85% of all cases of shortness of breath [18–22]. For a dyspneic patient presenting to the office, the initial goal is to determine the severity of the dyspnea and the need for urgent intervention such as intubation. The clinical approach to the patient depends on the acuteness of the problem. Although most patients who are unstable usually present to local hospitals, primary care physicians must be prepared and equipped to triage, manage, and stabilize patients who have acute dyspnea. Evaluation of acute dyspnea For acute shortness of breath, an initial quick evaluation should consist of assessment of airway patency and auscultation of the lungs. The
646
SARKAR & AMELUNG
breathing pattern and rate should be determined and use of accessory muscles noted. Cardiac rhythm, vital signs, and pulse oximetry should be monitored. The mental status should be evaluated, and a brief history of cardiac and pulmonary disease obtained if not already known. Unstable patients typically have hypotension, hypoxemia, tracheal deviation, altered mental status, unstable arrhythmia, stridor, retractions, cyanosis, or absent breath sounds signaling the acuity of their problem. These patients should be administered oxygen, have intravenous (IV) access established, and be given initial treatment as appropriate (bronchodilators, diuretics). Consideration should be given to needle decompression if the initial diagnostic impression is pneumothorax, and to intubation if necessary. Unstable patients should be transported to the closest emergency department for further evaluation and treatment. Trained health care personnel should accompany the patient and continue management until supervision is transferred to the emergency department team. For acute problems, the differential diagnosis is relatively narrow; they are in general related to disease of the respiratory or cardiac systems. The differential diagnosis of these two systems will cover the most common diseases encountered with acute shortness of breath: COPD, asthma, pneumonia, pulmonary embolism, pneumothorax, heart failure, and myocardial infarction. There are many other physical causes of acute shortness of breath, however, including acute renal failure, diabetic ketoacidosis, septicemia, or other metabolic acidoses with respiratory compensation. Acute dyspnea may also be psychogenic in origin, although this should be a diagnosis of exclusion (Table 1). Once an emergent situation has been excluded, the assessment of the stable patient who complains of acute shortness of breath includes a medical history, physical examination, and appropriate laboratory testing. A comprehensive patient history is the starting point for evaluating dyspnea. It is imperative to characterize the dyspnea in terms of descriptive qualities, onset, frequency, intensity, duration, triggers (exposures), provoking activities (ambulation, eating, changing position), associated respiratory symptoms, and strategies or actions (medications, positions) that provide relief. Intermittent dyspnea may be caused by asthma or heart failure, whereas persistent or progressive dyspnea suggests other chronic conditions, such as COPD, interstitial fibrosis, or pulmonary hypertension. Nocturnal dyspnea is may be indicative of asthma, CHF, or gastroesophageal reflux. Dyspnea occurring independent of physical activity suggests possible psychological etiology, or possibly allergic or mechanical problems. Dyspnea occurring mainly after exercise suggests exercise-induced asthma. A complete history should emphasize any coexisting cardiac and pulmonary symptoms. For example, the presence of cough may imply asthma or pneumonia; cough combined with a change in character of sputum may be caused by exacerbation of COPD. The symptoms of fever, sore throat, and acute dyspnea may suggest epiglottitis. Chest pain during dyspnea
647
EVALUATION OF THE DYSPNEIC PATIENT IN THE OFFICE
Table 1 Acute dyspnea: etiologies and characteristics Disorder
History findings
Cardiac: CHF, ACS, arrhythmia, anemia pericarditis COPD exacerbation
Chest pain, orthopnea, PND, edema, palpitations
Asthma exacerbation
Pneumonia
Pulmonary embolism
Pneumothorax
Upper airway obstruction: laryngospasm, aspirated foreign body Psychogenic: hyperventilation, anxiety, panic attacks
Worsening dyspnea, increased sputum volume, increased sputum purulence History of asthma, allergy history, increased reliance on beta-agonists, chest tightness Fever, cough, purulent sputum
Pleuritic chest pain, lower extremity pain/swelling, predisposing risk factors Pleuritic chest pain
History of choking, gurgling respirations, persistent pneumonias Emotional upset, feeling impending doom, neurotic personality
Physical examination
Chest radiograph
Cyanosis, crackles, edema, JVD, murmurs, S3 or S4, HJR, hypertension Pursed-lip breathing, wheezing, barrel chest, decreased breath sounds, prolonged expiratory phase Wheezing, cough, tachycardia, prolonged expiratory phase
Cardiomegaly, pleural effusion, interstial edema
Fever, crackles, decreased breath sounds, increased fremitus Wheezing, friction rub, lower extremity swelling
Parenchymal infiltrate
Unilateral hyperresonance, absent breath sounds, tracheal shift Stridor, wheezing
Air in pleural space with collapsed lung, shift of mediastium
Sighing
Hyperinflated lungs
Hyperinflated lungs
Normal, atelectasis, effusion, wedge-shape density
Visualized foreign body, air trapping, hyperinflation
Normal
Abbreviations: ACS, acute coronary syndrome; CHF, congestive heart failure; HJR, hepatojugular reflux; JVD, jugular venous dyspnea; PND, paroxysmal nocturnal dyspnea.
648
SARKAR & AMELUNG
may be caused by coronary or pleural disease, depending on the quality and description of the pain. Pleuritic chest pain could be caused by pneumothorax, pulmonary embolism, pneumonia, or pleuritis. Palla and colleagues [23] found that dyspnea or tachypnea with pleuritic chest pain occurred in 97% of patients who had clinically significant pulmonary embolism. Anginal chest pain accompanied by shortness of breath may signify ischemia associated with left ventricular dysfunction. Lusiani and coworkers [24] found that parxosymal dyspnea or pulmonary edema may be the only clinical presentation in 10% of patients who have myocardial infarction. Based on this information, along with the physical examination, the physician should be able to categorize the cause of the acute dyspnea as either suspected pulmonary, suspected cardiac, or other. Although cardiopulmonary disease may be most likely, it is important that consideration of causes of acute dyspnea other than cardiopulmonary be kept in mind. Inquire about indigestion or dysphagia, which may indicate gastroespophageal reflux with aspiration. Anxiety symptoms may imply psychogenic causes of dyspnea, but organic etiologies always should be excluded. For example, Saisch and colleagues [25] found that the most common complaint in patients diagnosed with acute hyperventilation syndrome was dyspnea. Additional information about social history (cigarette smoking, occupation, current or previous inhalational exposures, hobbies, and so forth) is essential. Table 1 summarizes clues in the history that help in the diagnosis in dyspnea. The physical examination should include the neck, thorax, lungs, heart, and extremities. Selected abnormal findings on the physical examination and clinical relevance are shown in Table 1. The general appearance and vital signs can be used to determine the severity of dyspnea by observing respiratory effort, use of accessory muscles, mental status, and ability to speak. The neck area might reveal a shift of the trachea, jugular venous distention, an enlarged thyroid gland, or adenopathy. Auscultate for stridor, because it may be indicative of an upper airway obstruction. Inspection of thorax might show an increased anterior-posterior diameter or chest wall deformity. Palpate the chest for subcutaneous emphysema and crepitus, and percuss for dullness, an indication of consolidation or effusions. On the other hand, hyperresonance on percussion suggests pneumothorax or bullous emphysema. Auscultation of breath sounds should focus on intensity, timing of the respiratory phases, and any adventitial sounds. Absent breath sounds may be consistent with pneumothorax or pleural effusion. Wheezing indicates turbulent airflow, which can be caused by asthma, COPD, and left ventricular failure. Key features of the heart examination include point of maximal impulse, the presence of any heart murmur, and a possible gallop. Rapid or irregular pulse may signify a dysarrhythmia. An S3 gallop suggests a left ventricular dysfunction in congestive heart failure. A loud P2 may be heard in patients who have pulmonary hypertension and cor pulmonale. Check the lower extremities for cyanosis or clubbing. Digital clubbing can be notable for cancer or a chronic respiratory condition
EVALUATION OF THE DYSPNEIC PATIENT IN THE OFFICE
649
other than COPD. Edema of lower extremities suggests congestive failure if symmetric and thromboembolic disease if asymmetric. Using information obtained from the medical history and physical examination, the physician should be able to form a working hypothesis as to the most likely cause of the dyspnea. Developing a differential diagnosis is important to focus further diagnostic testing. This is preferable to ordering a battery of tests at the initial evaluation. The office work-up depends on the modalities available. The initial diagnostic work-up usually includes a chest radiograph, a resting electrocardiogram, and a complete blood count. On the other hand, if a diagnosis of asthma or COPD is initially suspected, then pulmonary function testing (PFT) and pulse oximetry are important first steps. The prevalence of positive chest radiographic findings in patients who present to acute care clinics with complaints of chest-related symptoms has been shown to be 34.8% for all ages and up to 47% for patients over the age of 40 years [26]. Although the chest radiograph is usually not diagnostic, it can provide useful information about cardiac size and configuration, lung parenchyma, pulmonary vasculature, the pleural space, mediastinum, and position of the diaphragm. The 12-lead resting electrocardiogram rarely establishes an initial diagnosis, but it does provide important data about ischemia, arrhythmias, and chamber size. The complete blood count screens for anemia, which can effect the oxygen carrying capacity and exert a physiologic stress that may contribute to dyspnea. On the other hand, polycythemia may be the only clue to hypoxia, and indicates a more chronic, rather than acute, process. Additional testing depends on whether a primary pulmonary or cardiac disease is considered as the most likely cause for breathlessness. Left heart failure owing to ischemia or cardiomyopathy, pericardial effusion, and valvular dysfunction can all lead to dyspnea. Although the history, physical examination, and basic laboratory tests may be helpful to evaluate these conditions, sending the patient for an echocardiogram will provide extremely useful information about chamber size, ventricular function, valvular function, possible pericardial effusion, and an estimate of pulmonary artery systolic pressure. Studies have shown several potential mechanisms for dyspnea in patients who have cardiac disease: an elevated pulmonary venous pressure, respiratory muscle weakness, bronchial hyperresponsiveness, and an augmented ventilatory response to exercise associated with an increased dead space to tidal volume ratio [27–30]. Concomitant obstructive airway or restrictive disease may also be present in patients who have cardiac disease. For example, Myers and Froelicher [29] looked at exercise hemodynamic determinants of exercise capacity in patients who have heart failure, and found that relative hyperventilation is commonly observed during exercise in patients who have heart failure, and is related to ventilationperfusion mismatching in the lung caused by a higher-than-normal fraction of physiologic dead space [29]. Also, Snashall and Chung [30] described how airway narrowing may be precipitated by acute elevation of pulmonary or bronchial vascular pressures. This appears to be mainly caused by reflex
650
SARKAR & AMELUNG
bronchoconstriction, and can occur in left ventricular failure, mitral stenosis, and pulmonary edema. Therefore selected pulmonary function tests may also be indicated to evaluate dyspnea in patients who have suspected cardiac disease. Establishing heart failure as a cause of dyspnea in patients presenting to primary care clinics is not always possible based on symptoms and physical findings, and patients may need to be sent for laboratory testing. With heart failure ventricular cells are recruited to secrete both atrial natriuretic peptide and brain natriuretic peptide (BNP). These markers are secreted from both the left and the right cardiac ventricle in response to ventricular volume expansion and pressure overload. Recent studies have suggested that these neurohormones are reliably elevated in the setting of congestive heart failure and may be very helpful in its diagnosis [31–33]. The use of rapid BNP testing in addition to clinical judgment increased the accuracy of the clinical evaluation. McCullough and colleagues [34] evaluated the value of rapid measurement of plasma BNP for distinguishing between heart failure and a pulmonary cause of dyspnea in approximately 1600 patients presenting with a major complaint of acute dyspnea. The final diagnosis was heart failure in 47%, no heart failure in 49%, and noncardiac dyspnea in patients who had a past history of left ventricular dysfunction in 5%. The study demonstrated that plasma concentrations of BNP were markedly higher in patients who had clinically diagnosed heart failure (both left and right) compared with those who did not have heart failure (mean of 675 versus 110 pg/ml). Intermediate values were found in the patients who had baseline left ventricular dysfunction but not acute exacerbation (346 pg/ml). A value greater than 100 pg/ml diagnosed heart failure with a sensitivity, specificity, and predictive accuracy of 90%, 76%, and 83%, respectively. The predictive accuracy of plasma BNP for heart failure was equivalent to or better than other parameters such as cardiomegaly on chest radiograph, a history of heart failure, or rales on physical examination [34]. Currently, with the rapid assay most dyspneic patients who have heart failure have values above 400 pg/ml, whereas values below 100 pg/ml have a very high negative predictive value for heart failure as a cause of dyspnea. A pulmonary function test is the starting point for evaluation of suspected respiratory disease. In the acute setting, simple office spirometry may be the only test easily available. The presence of acute airways obstruction will be suggested by the finding of reduced forced expiratory volume in one second (FEV1) and reduced FEV1 to forced vital capacity (FVC) ratio. This will typically indicate acute asthma or an exacerbation of COPD. As an alternative to spirometry, peak expiratory flow rates (PEFR) can be measured with a simple handheld device. These measurements are especially useful in acutely dyspneic patients who have known baseline measurements so that comparisons can be made. The flow-volume loop is most useful in the evaluation of upper-airway obstruction. Although an abnormal flow-volume loop may not be diagnostic, it can provide clues to specific diagnoses
EVALUATION OF THE DYSPNEIC PATIENT IN THE OFFICE
651
such as obstruction, restriction, or intrathoracic/extrathoracic airways obstruction. The utility of measuring D-dimer as a noninvasive method to diagnosis deep venous thromboembolism and pulmonary embolism has been studied extensively. D-dimer is a specific degradation product released into the circulation when cross-linked fibrin undergoes endogenous fibrinolysis. Perrier and colleagues [35] have shown that a D-dimer level measured by an enzyme-linked immunosorbent assay of less than 500 ng/ml has a negative predictive value of greater than 95% of excluding a pulmonary embolism in a patient who has low pretest clinical probability. A negative quantitative rapid enzyme-linked immunosorbent assay (ELISA) result is as diagnostically useful as a normal lung scan or negative duplex ultrasonograpy finding for excluding venous thromboembolism (VTE). The D-dimer is unidirectional in that a negative test is useful in ruling out pulmonary embolism, but a positive test does not have a sufficiently high specificity or positive likelihood ratio to be helpful in increasing the certainty of a diagnosis of pulmonary embolism. D-dimer results are unlikely to be helpful in patients who have had recent surgery (within 3 months) or who have malignancy, because these patients often have values above 500 ng/ml [36]. Evaluation of chronic dyspnea The patient who has chronic shortness of breath may be more difficult to diagnose because the dyspnea typically develops over weeks to months, patients alter their activities in response to the dyspnea so the severity may not apparent, and dyspnea is frequently out of proportion to any physiologic impairment that is found. In spite of this difficulty, however, the majority of patients who have chronic shortness of breath will have either asthma, COPD, interstitial lung disease, or cardiomyopathy [21]. The history is important in chronic dyspnea, but should be considered only part of the systematic evaluation that is necessary; the initial physician impression of the etiology of dyspnea based on the history alone was correct only 66% of the time in one study [21]. Patients may have difficulty describing the exact sensation of their dyspnea. They should be questioned about the onset, frequency and duration of breathlessness, as well as triggers and strategies that provide relief. Intermittent dyspnea is more likely caused by reversible events, such as bronchoconstriction, pleural effusion, CHF, or even chronic recurrent thromboemboli. Progressive dyspnea more likely stems from COPD, neuromuscular disorders, or interstitial lung disease. Associated symptoms should be sought, including cough, sputum, wheezing, orthopnea, chest pain, heartburn, and paroxysmal nocturnal dyspnea. In general, the sensation of increased work or effort of breathing is common to most dyspneic patients; however, if asked to choose from a list of descriptors, the sensation that most accurately describes their dyspnea, patients who have different diseases will choose different groups of descriptors [37,38].
652
SARKAR & AMELUNG
Physical examination should focus on the neck, chest, lungs, heart, and extremities. Obvious findings such as rales in CHF or distant breath sounds in COPD and pleural effusion should be noted, but also note if deep inspirations cause cough, which may indicate asthma or interstitial lung disease. Wheezing may only become apparent after the patient is asked to forcefully exhale. Careful evaluation of the heart sounds is needed to detect pulmonary hypertension, and clubbing should not be overlooked. Table 2 outlines the history and physical findings in chronic dyspnea. Testing in chronic dyspnea should be targeted in attempt to answer specific questions. For example, if asthma or COPD is suspected, spirometry should be ordered; a reduced FEV1 and FEV1/FVC ratio indicates obstructive airway disease. Bronchoprovocation can diagnose reactive airways Table 2 Chronic dyspnea: etiologies and characteristics Disorder
History findings
Right and left heart failure (CHF)
Chest pain, orthopnea, PND, edema
COPD
Tobacco use, chronic cough
Asthma
Childhood history, allergy history Gradual onset of dyspnea, occupational & environmental exposure
ILD
Malignancy
Psychogenic: hyperventilation, anxiety, panic attacks Anemia
Cough, hemoptysis, shortness of breath, fatigue, fevers, night sweats, weight loss Emotional upset, feeling impending doom, neurotic personality Fatigue, dyspnea with exertion
Abbreviation: ILD, interstitial lung disease.
Physical examination Cyanosis, crackles, edema, JVD, murmurs, S3 or S4, HJR, hypertension Pursed lip breathing, wheezing, barrel chest, decreased breath sounds Wheezing, cough
Chest radiograph Cardiomegaly, pleural effusion, interstial edema
Hyperinflated lungs
Decreased breath sounds, clubbing
Hyperinflated lungs Decreased lung volumes, increased interstial markings, fibrosis Mass, hilar adenopathy
Sighing
Normal
Tachycardia, pale conjunctiva
Normal
Fine inspiratory crackles
EVALUATION OF THE DYSPNEIC PATIENT IN THE OFFICE
653
disease caused by asthma if spirometric values are normal. Flow volume loops obtained during spirometry can suggest upper airway obstruction. Restrictive lung disease can be suggested by spirometric results (reduced FVC and normal or increased ratio of FEV1/FVC ratio), but the measurement of lung volumes is necessary to confirm restriction (reduced FVC and total lung capacity). A reduced diffusing capacity, (DLco) is usually a sensitive indicator of an abnormality in pulmonary gas exchange. It may be helpful to identify patients who have emphysema (ie, a reduced DLco in the presence of obstructive airway disease). In a patient who has normal spiromety and lung volumes but a reduced DLco, the differential diagnosis could include anemia, early interstitial lung disease and pulmonary vascular disease. The measurement of inspiratory (PImax) and expiratory (PEmax) mouth pressures is important in the evaluation of neuromuscular causes of dyspnea. Cardiac etiologies of dyspnea include left heart failure, ischemia, pericardial effusion, and valvular disease. As for acute dyspnea, an echocardiogram can be extremely useful in the evaluation of chronic dyspnea, and provides useful information about chamber size, valvular function, and cardiac function. An electrocardiogram (EKG) will reveal evidence of ischemia or arrhythmia. An EKG done in conjunction with stress or exercise may unmask a cardiac condition not evident at rest. Chest radiograph (CXR) may show an enlarged heart, pulmonary vascular congestion, or vascular pruning consistent with pulmonary hypertension. If directed testing is not possible because the cause of dyspnea is unclear from the history and physical examination, the basic work-up should include spirometry and diffusing capacity, a CXR, a resting 12-lead EKG, and oximetry as initial screening tests. If the results of these tests are normal, then anxiety/hyperventilation, deconditioning, and respiratory muscle weakness are the likely etiologies. As previously suggested, PImax and PEmax should be measured to evaluate respiratory muscle strength. Muscle weakness can be isolated to the respiratory system or can be part of a systemic process. For example, Flaherty and coworkers [39] described 28 patients referred for unexplained breathlessness who had normal spirometry, lung volumes, and gas exchange, but had reduced values for PImax and PEmax. Based on muscle biopsies, it was confirmed that these patients were diagnosed with mitochondrial myopathy, affecting their muscles of respiration. If the source of dyspnea cannot be determined despite a complete pulmonary and cardiac evaluation, cardiopulmonary exercise testing (CPET) can be performed. The test will hopefully simulate the patient’s experience of breathlessness and differentiate between pulmonary, cardiac, psychogenic, and deconditioning as the source of the patient’s dyspnea. It can also be useful if the severity of the patient’s dyspnea is greater than expected from the results of objective measurements, or if the patient likely has both cardiac and respiratory factors contributing to dyspnea. CPET stresses the oxygen transport system, a complex network in which pathology at any point could generate dyspnea. Measured responses to exercise are taken from various
654
SARKAR & AMELUNG
systems, so CPET can help identify whether the major abnormality lies in the pulmonary or cardiac system. It can point to deconditioning, or peripheral vascular or muscular disease as potential contributors as well. Other less commonly used tests in the work-up of chronic dyspnea include ventilationperfusion scanning (chronic thromboembolic disease), thyroid function tests (occult hyper- or hypothyroidism) or gallium scanning (inflammatory lung disease or infection).
Treatment of dyspnea Treatment of the underlying disease is the most effective method of alleviating dyspnea: bronchodilators for acute or chronic dyspnea related to asthma or COPD, diuretics for breathlessness caused by acute or CHF, oxygen and antibiotics for shortness of breath related to pneumonia. If the specific cause of the dyspnea is elusive, or if a specific treatment is not available, then treatment should be aimed at treating the symptom. Patients who have chronic dyspnea can be taught a variety of methods to help them alleviate or cope with their breathlessness. Pursed-lips breathing can increase the tidal volume, decrease the respiratory rate, and improve saturation in patients who have COPD, thereby relieving their dyspnea [40]. Diaphragmatic breathing is another strategy to help reduce dyspnea. Patients can be taught energy conservation techniques to both reduce their respiratory effort and improve their respiratory muscle function. Pulmonary rehabilitation, or physical training, has been shown to reduce dyspnea, based on ability to perform activities of daily living and perform exercise testing [41,42]. The physical training need not be extreme to afford benefit; even simple resistance training with weights has been shown to improve muscle strength and endurance [43,44]. Patients should understand that reaching goals may take months of training, and therefore motivation and commitment on their part is essential. Oxygen can be used to reduce respiratory drive, thereby reducing dyspnea. Oxygen can improve respiratory muscle function [45] and pulmonary artery pressure [46]. Oxygen is usually dosed to prevent desaturation, but higher levels may improve exercise performance [47]. Psychotropic medications, including anxiolytics and antidepressants, have not proven to be of benefit in relieving dyspnea [48]; however, these may be considered in patients who exhibit these symptoms in relation to their dyspnea. Although the role of opiates is well-accepted in relieving terminal dyspnea, the benefits have been inconsistent and side effects frequent when studied in long-term but nonterminal dyspneic patients [49].
Summary Dyspnea is a nonspecific symptom of any disease involving the respiratory system. Although diseases of the lungs, chest wall, pleura, diaphragm,
EVALUATION OF THE DYSPNEIC PATIENT IN THE OFFICE
655
upper airway, and heart are most common, diseases of many other organ systems (eg, neuromuscular, skeletal, renal, endocrine, rheumatologic, hematologic, and psychiatric) may involve the respiratory system and present with dyspnea. Dyspnea should be evaluated systematically, and a thorough history and physical examination and baseline tests of heart and lung function are necessary to establish a complete database. More sophisticated testing may be needed when the cause is not readily apparent from the initial work-up. Treatment is best and most effective when geared toward a specific etiology, but if this is not possible, nonspecific treatment of the symptom pf dyspnea may afford the patient some benefit.
References [1] O’Connor GT, Anderson KM, Kannel WB. Prevalence and prognosis of dyspnea in the Framingham Study [abstract]. Chest 1987;92(Suppl 2):90S. [2] Guyatt GH, Townsend M, Berman LB, et al. Quality of life in patients with chronic airflow limitation. Br J Dis Chest 1987;81:45–54. [3] Simon PMSRM, Weiss JW, Fenel V, et al. Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis 1990;142(5):1009–14. [4] Mahler DA, Harver A, Lentine T, et al. Descriptors of breathlessness in cardiorespiratory diseases. Am J Respir Crit Care Med 1999;159:321–40. [5] American Thoracic Society. Dyspnea-mechanisms, assessment and management. A consensus statement. Am J Respir Crit Care Med 1999;159:321–40. [6] Mulrow C, Lucey C, Farnett L. Discriminating causes of dyspnea through clinical examination. J Gen Intern Med 1993;8:383–92. [7] Renwick DS, Connoly MJ. Do respiratory symptoms predict chronic airflow obstruction and bronchial hyperresponsiveness in older adults? J Gerontol 1999;54:M136–9. [8] Dow LCD, Osmond C, Holgate ST. A population survey of respiratory symptoms in the elderly. Eur Respir J 1991;4:267–72. [9] Horsley JR, Sterling IJ, Waters WE, et al. Respiratory symptoms among elderly people in the New Forest area as assessed by postal questionnaire. Age Ageing 1991;20:325–31. [10] Kroenke K, Manglesdorff D. Common symptoms in ambulatory care: incidence, evaluation, therapy and outcome. Am J Med 1989;86:262–6. [11] Sibuya M, Yamada M, Kanamara A, et al. Effect of chest wall vibration on dyspnea in patients with chronic respiratory disease. Am J Respir Crit Care Med 1994;149:1235–40. [12] Banzett RB, Lansing RW, Brown R. High-level quadriplegics perceive lung volume change. J Appl Physiol 1987;62:567–73. [13] Manning HL, Shea SA, Schwartzstein RM, et al. Reduced tidal volume increases air hunger at fixed PC02 in ventilated quadriplegics. Respir Physiol 1992;90:19–30. [14] Schwartzstein RM, Manning HL, Weiss JW, et al. Dyspnea: a sensory experience. Lung 1990;168:185–99. [15] Manning HL, Mahler DA, Harver A. Dyspnea in the elderly. In: Mahler DA, editor. Pulmonary disease in the elderly patient. New York: Marcel Dekker; 1993. p. 81–112. [16] Campbell EJM, Howell JBL. The sensation of breathlessness. Br Med Bull 1963;19:36–40. [17] O’Donnell DE. Exertional breathlessness in chronic respiratory disease. In: Mahler DA, editor. Dyspnea. New York: Marcel Dekker; 1998. p. 97–148. [18] DePaso W, Winterbauer R, Lusk J, et al. Chronic dyspnea unexplained by history, physical examination, chest roentgenogram and spirometry. Chest 1991;100:1293–9. [19] Fedullo A, Sinburne A, McGuire-Dunn C. Complaints of breathlessness in the emergency department. N Y State J Med 1986;86:4–6.
656
SARKAR & AMELUNG
[20] Pearson S, Pearson E, Mitchell J. The diagnosis and management of patients admitted to the hospital with acute breathlessness. Postgrad Med J 1981;57:419–24. [21] Pratter M, Curley F, Dubois J, et al. Cause and evaluation of chronic dyspnea in a pulmonary disease clinic. Ann Intern Med 1989;149:2277–82. [22] Schmitt B, Kushner M, Wiener S. The diagnostic usefulness of the history of the patient with dyspnea. J Gen Intern Med 1986;1:386–93. [23] Palla A, Petruzzelli S, Donnamaria V, et al. The role of suspicion in the diagnosis of pulmonary embolism. Chest 1995;107(Suppl 1):21S–4S. [24] Lusiani L, Perrone A, Pesavento R, et al. Prevalence, clinical features and acute course of atypical myocardial infarction. Angiology 1994;45:49–51. [25] Saisch SG, Wessley S, Gardner WN. Patients with acute hyperventilation presenting to an inner-city emergency department. Chest 1996;110:952–7. [26] Benacerraf B, McLoud T, Rhea J, et al. An assessment of the contribution of chest radiography in outpatients with acute chest complaints: a prospective study. Radiology 1981;138: 293–9. [27] Hammond MD, Bauer KA, Sharp JT. Respiratory muscle strength in congestive heart failure. Chest 1990;98:1091–4. [28] McParland C, Krishnan B, Wang Y, et al. Inspiratory muscle weakness and dyspnea in chronic heart failure. Am Rev Respir Dis 1992;146:467–72. [29] Myers J, Froelicher VF. Hemodynamic determinants of exercise capacity in chronic heart failure. Ann Intern Med 1991;115:377–86. [30] Snashall PD, Chung KF. Airway obstruction and bronchial hyperresponsiveness in left ventricular failure and mitral stenosis. Am Rev Respir Dis 1991;144:945–56. [31] Maisel A. B-type natriuretic peptide levels: diagnostic and therapeutic potential. Cardiovasc Toxicol 2001;1:159–64. [32] Meuller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004;350(7):647–54. [33] Mueller T, Gegenhuber A, Poelz W, et al. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart 2005;91(5): 606–12. [34] McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 2002;106(4):416–22. [35] Perrier A, Roy PM, Aujesky D, et al. Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. Am J Med 2004;116(5):352–3. [36] Shutgens RE, Esseboom EU, Haas FJ, et al. Usefulness of a semiquantitative D-dimer test for the exclusion of deep venous thrombosis in outpatients. Ann Intern Med 2002;112(8): 617–21. [37] Elliott MW, Adams L, Cockcroft A, et al. The language of breathlessness. Use of verbal descriptors by patients with cardiopulmonary disease. Am Rev Respir Dis 1991;144(4): 826–32. [38] Simon PM, Schwartzstein RM, Weiss JW, et al. Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis 1990;142(5):1009–14. [39] Flaherty KR, Wald J, Weismann IM, et al. Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy. Am J Respir Crit Care Med 2001;164(3): 425–32. [40] Teip BL, Burns M, Kao D, et al. Pursed lips breathing training using ear oximetry. Chest 1986;90(2):218–21. [41] ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines. Chest 1997;112:1363–96. [42] American Thoracic Society. Pulmonary rehabilitationd1999. Am J Respir Crit Care Med 1999;159:1666–82.
EVALUATION OF THE DYSPNEIC PATIENT IN THE OFFICE
657
[43] Stewart K. Resistance training effects on strength and cardiovascular endurance in cardiac and coronary prone patients. Med Sci Sports Exerc 1989;21(6):678–82. [44] Simpson K, Killian K, McCartney N, et al. Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation. Thorax 1992;47(2):70–5. [45] Bye PT, Esau SA, Levy RD, et al. Ventilatory muscle function during exercise in air and oxygen in patients with chronic air-flow limitation. Am Rev Respir Dis 1985;132(2):236–40. [46] Dean NC, Brown JK, Himelman RB, et al. Oxygen may improve dyspnea and endurance in patients with chronic obstructive pulmonary disease and only mild hypoxemia. Am Rev Respir Dis 1992;146(4):941–5. [47] Dewan NA, Bell CW. Effect of low flow and high flow oxygen delivery on exercise tolerance and sensation of dyspnea. A study comparing the transtracheal catheter and nasal prongs. Chest 1994;105(4):1061–5. [48] Man GCW, Hsu K, Sproule BJ. Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease. Chest 1986;90(6):832–6. [49] Woodcock AA, Johnson MA, Geddes DM. Breathlessness, alcohol and opiates. N Engl J Med 1982;306:1363–4.
Prim Care Clin Office Pract 33 (2006) 659–684
Acute Abdominal Pain Mark H. Flasar, MDa,b,*, Raymond Cross, MDa,b, Eric Goldberg, MDa,b a
Division of Gastroenterology and Hepatology, Department of Medicine, University of Maryland Medical Center, 22 South Greene Street, Baltimore, MD 21201, USA b Veterans Affairs, Maryland Health Care System, 10 North Greene Street, Baltimore, MD 21201, USA
Abdominal pain is a complaint seen commonly in the outpatient setting. Many etiologies, both acute and chronic, can be evaluated on an outpatient basis. However, several causes of abdominal pain necessitate prompt, focused, and structured evaluation, given associated morbidity and mortality. The differential diagnosis of a patient presenting with acute abdominal pain is exhaustive, necessitating that the physician understand not only the underlying pathophysiology of the pain, but also the clinical presentation, course, and initial management of more harmful causes. A focused history, physical examination, and adjunctive testing strategy will allow for those patients with concerning presentations to be identified, initially managed, and appropriately referred for continued care. Abdominal pain is an extremely common complaint in all settings of medical practice. In primary care practices in 2002, abdominal pain was a complaint in more than 13.5 million patient visits [1]. Oftentimes, patients with severe abdominal pain will self-triage to an emergency department, hospital, or contact emergency medical services. However, some patients with potentially life-threatening abdominal catastrophes will initially present to the primary care physician. Ease of access to the primary care physician and preexisting appointments occurring shortly after the pain onset offer some explanation. Abdominal pain may often be a symptom of a disease process with a benign course, but it may also herald a severe, life-threatening condition that demands prompt recognition and management. The purpose of this review is to provide the practitioner with a framework for understanding
* Corresponding author. E-mail address:
[email protected] (M.H. Flasar). 0095-4543/06/$ - see front matter Ó 2006 Elsevier Inc. All rights reserved. doi:10.1016/j.pop.2006.06.004 primarycare.theclinics.com
660
FLASAR
et al
abdominal pain, so that they may determine those patients that need a more expedited evaluation. Furthermore, the pathophysiologic mechanisms underlying abdominal pain will be reviewed. A general approach to the patient with acute abdominal pain will be outlined, and several gastrointestinal etiologies of abdominal pain will be considered in detail, focusing on the most severe and commonly encountered. A general understanding of abdominal anatomy, physiology, and pathophysiology is vital when formulating a differential diagnosis for abdominal pain. In addition, it is important to understand how abdominal pain is generated and perceived by the patient. The abdominal viscera are innervated with nocioceptive afferents within the mesentery, on peritoneal surfaces, and within the mucosa and muscularis of hollow organs. These afferents respond to both mechanical and chemical stimuli producing dull, crampy, poorly localized pain sensations. The principal mechanical stimulus is stretch, while a variety of chemical stimuli including substance P, serotonin, prostaglandins, and hydrogen ions are perceived as noxious by visceral chemoreceptors [2]. Abdominal pain occurs in three broad patterns: visceral, parietal, and referred. Visceral nocioception typically involves stretch and distension of the abdominal organs, although torsion, and contraction also contribute. The pain stimulus is carried on slow-conducting C-fibers. Patients often describe pain of visceral origin as a dull ache. The location of visceral pain is often midline, because visceral innervation of abdominal organs is typically bilateral. Pain location corresponds to those dermatomes that match the innervation of the injured organ [2]. Generally, visceral pain from organs proximal to the Ligament of Treitz, including the hepatobiliary organs and spleen, is felt in the epigastrum. Visceral pain from abdominal organs between the Ligament of Treitz and the hepatic flexure of the colon is felt in the periumbilical region. Visceral pain generated from organs distal to the hepatic flexure is perceived in the midline lower abdomen. Parietal pain is typically sharp and well localized, resulting from the direct irritation of the peritoneal lining. Parietal peritoneal afferents are A-d fibers, with a rapid conduction velocity and result in sharp pain sensation similar to skin and muscle pain. Because parietal innervation is unilateral, lateralization of pain occurs [2]. Referred pain occurs when visceral afferents carrying stimuli from a diseased organ enter the spinal cord at the same level as somatic afferents from a remote anatomic location. It is typically well localized. A single diseased organ may produce all three types of pain. For example, when a patient develops cholecystitis, gallbladder inflammation is initially experienced as a visceral pain in the epigastric region. Eventually, the inflammation extends to the parietal peritoneum, and the patient will experience parietal pain that lateralizes to the right upper quadrant. Gallbladder pain may also refer to the right shoulder. Awareness of the anatomy and innervation of the abdominal viscera allows one to formulate a differential diagnosis of abdominal pain based on the location and distribution of the pain (Table 1). However, there is
ACUTE ABDOMINAL PAIN
661
significant overlap between abdominal pain presentations. Furthermore, disease processes from organs outside of the abdominal cavity can present with abdominal pain. To considerably narrow the differential diagnosis, it is crucial to approach each patient in a systematic, logical, and deliberate manner. Having already elicited a chief complaint of abdominal pain, this begins with the patient’s history and physical examination. The history should not only include a thorough assessment of the present condition, but also a detailed assessment of underlying medical problems, medications, family history, substance abuse history, recent travel history and occupational history. Important clues to the etiology of the pain should be determined in the patient’s history by inquiring about the nature of the pain, which includes its quality, location, rapidity of onset, chronicity, radiation, intensity, exacerbating factors, alleviating factors, and associated symptoms. Chronicity of symptoms is an important factor in evaluating abdominal pain. Generally, patients with chronic symptoms can be evaluated on an outpatient basis, as the process underlying the pain rarely requires acute intervention. On the other hand, patients with new-onset of symptoms are more likely to have a significant disease process that can bring them harm in the hours to days ahead. An exception to this is an acute worsening of chronic or intermittent abdominal pain symptoms. Examples include acute mesenteric ischemia superimposed on a history of chronic intestinal angina or development of acute cholecystitis in a patient with a history of biliary colic. Additionally, identifying high-risk patients such as the elderly, pregnant, and those with immunodeficiency syndromes proves invaluable in triaging patients. Following a thorough history, a focused physical examination should be performed. The generation of a differential diagnosis will help the practitioner tailor the examination, whose purpose is to provide confirmatory or contradictory data for each disease process on their differential. Although centered on the abdomen, the examination should also focus on extraabdominal organ systems when indicated. For example, a patient with suspected mesenteric ischemia should have a cardiovascular examination assessing for arrhythmias and evidence of atherosclerotic disease. Overall, the abdominal examination should begin with general observation of the patient, followed by abdominal inspection. A patient with peritonitis often lies completely still as movement further irritates the peritoneum. Their abdomen will be visually rigid. On the other hand, a patient with renal colic may writhe in pain, may not be able to be consoled to comfort, and have a nonrigid abdomen. Once initial observation is complete, a review of the vital signs is imperative. Any significant abnormality of vital signs should prompt the physician to consider a more life threatening process. Auscultation of the abdomen determines whether intestinal peristalsis is appropriate and whether any abdominal bruits are present. Next, palpation of the abdomen should be performed to distinguish pain, a subjective sensation, from tenderness, which is an objective finding.
662
FLASAR
et al
Table 1 Diagnosis of abdominal pain based on location and distribution Right upper quadrant
Middle upper abdomen
Left upper quadrant
Peptic ulcer disease Biliary disease Biliary colic Choledocholithiasis Cholecystitis Cholangitis Liver disease Hepatitis Neoplasm Abscess Congestive hepatopathy Lung disease Pneumonia Subphrenic abscess Pulmonary embolism Pneumothorax Abdominal wall Herpes zoster Muscular Stain Kidney disease Pyelonephritis Perinephric abscess Nephrolithiasis Colonic causes Colitis Right sided diverticulitis
Peptic ulcer disease Pancreatitic disease Pancreatitis Pancreatic neoplasm Biliary disease Biliary colic Choledocholithiasis Cholecystitis Cholangitis Esophageal disease Reflux esophagitis Infectious esophagitis Pill esophagitis Cardiac disease Myocardial ischemia or infarction Pericarditis AAA rupture/aortic dissection Mesenteric ischemia
Peptic ulcer disease Splenic disease Splenic rupture Splenic infarct Pancreatic disease Pancreatitis Pancreatic neoplasm Lung disease Pneumonia Subphrenic abscess Pulmonary embolism Pneumothorax Kidney disease Pyelonephritis Perinephric abscess Nephrolithiasis
Periumbilical Appendicitis (early) Small bowel obstruction Gastroenteritis Mesenteric ischemia AAA rupture Aortic dissection Right lower quadrant
Suprapubic
Left lower quadrant
Appendicitis Inflammatory bowel disease OB-GYN causes Ovarian tumor Ovarian torsion Ectopic pregnancy Pelvic inflammatory disease (PID) Kidney disease Pyelonephritis Perinephric abscess Nephrolithiasis Intestinal disease Right sided diverticulitis Ileocolitis Gastroenteritis Hernia
Inflammatory bowel disease OB-GYN causes Ovarian tumor Ovarian torsion Ectopic pregnancy PID Dysmenorrhea Colonic disease Proctocolitis Diverticulitis Urinary tract disease Cystitis Nephrolithiasis Prostatitis
Inflammatory bowel disease OB-GYN causes Ovarian tumor Ovarian torsion Ectopic pregnancy PID Kidney disease Pyelonephritis Perinephric abscess Nephrolithiasis Intestinal disease Sigmoid diverticulitis Ileocolitis Gastroenteritis Hernia
ACUTE ABDOMINAL PAIN
663
Table 1 (continued) Diffuse Gastroenteritis Bowel obstruction Peritonitis Mesenteric ischemia Inflammatory bowel disease Diabetic ketoacidosis Porphyria Uremia Hypercalcemia Sickle cell crisis Vasculitis Heavy metal intoxication Opiate wihdrawal Familial mediterranean fever Hereditary angioedema
When performing palpation, the location of tenderness should be used to narrow the differential diagnosis. Additionally, the presence of guarding or rebound tenderness should be noted, as these findings imply peritoneal irritation. Furthermore, palpation can determine the presence of visceral enlargement, masses, or fluid. It is often useful to begin the abdominal examination by palpating distant from, then working toward the site of pain, palpating with the fingertips. It is helpful to keep the patient’s hips and knees in a flexed position during a supine examination to help relax the abdominal musculature. Techniques such as patient distraction during examination or palpation during auscultation with the stethoscope head may help discriminate functional from organic pain. The importance of a properly executed history and physical examination cannot be underestimated. Although the sensitivity and specificity of a history and physical may not match that of an abdominal CT scan, there is no risk, minimal time required, and essentially no cost. In fact, one observational study revealed that, based on history and physical alone, physicians were able to correctly differentiate between organic and nonorganic causes of abdominal pain nearly 80% of the time [3]. Furthermore, historic features such as pain location have been shown in prospective investigation to be specific for certain disease states [4]. Once the history and physical is completed, the practitioner will usually be armed with sufficient information to sharply narrow the differential diagnosis in the majority of patients presenting with abdominal pain. The detection of the warning signs of a life-threatening process in a patient with abdominal pain is often up to the primary physician long before the emergency room physician, surgeon, gastroenterologist, or other specialist encounters the patient. Certain historic and examination findings should raise red flags that a life-threatening abdominal process is present, and
664
FLASAR
et al
prompt early triage to an emergency department or inpatient hospital bed (Table 2). Red flags from the history include fever, vomiting, inability to move the bowels (obstipation), syncope, concomitant chest or back pain, respiratory distress, excessive acute vaginal bleeding, and overt gastrointestinal bleeding. Red flags from the physical examination include any significant abnormality of the vital signs, mental status changes, involuntary guarding, rebound abdominal tenderness, complete absence of bowel sounds, and pain out of proportion to abdominal tenderness on physical examination. In patients without signs or symptoms of an acute abdominal catastrophe, an acute expedited outpatient evaluation should be performed. Selection of initial laboratory and imaging studies to evaluate abdominal pain should be guided by the differential diagnoses generated from the primary evaluation. Historically, plain abdominal radiographs have been the initial imaging test of choice. They can be obtained rapidly at a relatively low cost, and are often available to primary practitioners in the office. However, with the evolution of more sensitive and specific modalities such as CT and ultrasound, the utility of the plain abdominal series has been debated. Nonetheless, the authors feel that plain films should still be the initial imaging modality in patients with suspected visceral perforation or obstruction. The abdominal plain film series should include supine and upright abdominal films in conjunction with an upright chest (or lateral decubitus abdominal) film. Plain abdominal imaging has been estimated to be diagnostic in up to 60% of cases of suspected small bowel obstruction [5], although sensitivity is more limited in cases of low-grade obstruction [6]. The location, volume, and distribution of intraluminal air, presence and distribution of air–fluid levels, and luminal diameter can often be helpful in differentiating between an obstructive and nonobstructive process, such as partial or complete bowel obstruction, ileus, or intestinal pseudoobstruction. Unfortunately, overlap in the radiographic appearance of obstructive and nonobstructive processes limits the sensitivity and specificity of plain films in this setting. The ability of plain films to detect free air depends on the volume of free air within the peritoneal cavity. For the detection of large volumes, as would be expected with a perforated viscus, sensitivity of plain films is reported to be as high as 100%. Sensitivity is maximized if the patient is placed in the upright or decubitus position for 5 to 10 minutes before obtaining an upright chest or lateral decubitus film. This allows small volumes of air to redistribute to and collect within nondependent areas. Detection of volumes as small as 1 to 2 cc of air has been reported using this method [6,7]. CT is an imaging tool that is sensitive for the diagnosis of many etiologies of abdominal pain. Because of its widespread availability, CT is often accessible to primary care providers in the outpatient setting for same-day interpretation. With newer rapid helical scanning methods, advances in intravenous and oral contrast agents, three-dimensional reformatting, and
Table 2 Red flags in abdominal pain Physical exam
Labs
Radiography
* * * * * *
* * * * * * * * *
* * * * *
* * * * * *
Inability to maintain po intake Projectile vomiting Overt gastrointestinal blood loss Syncope Pregnancy Recent surgery or endoscopic procedure * Fever * Caustic or foreign body ingestion
Pathologic changes in vital signs Bloody, maroon, or melanotic stool Hernia (incarcerated and tender) Hypoxia Cyanosis Altered mentation Jaundice Peritoneal signs Abdominal pain out of proportion to examination
Renal failure Metabolic acidosis Leukocytosis Elevated transaminases Elevated alkaline phosphatase and bilirubin * Anemia or polycythemia * Hyperlipasemia/hyperamylasemia * Hyperglycemia/hypoglycemia
* * * *
Abdominal free air Gallbladder wall thickening Pericholecystic fluid Dilated biliary tree Bowel obstruction Dilated small bowel loops air fluid levels Intraabdominal abscess Bowel wall thickening Air in the portal venous system Pneumatosis intestinalis
ACUTE ABDOMINAL PAIN
History
665
666
FLASAR
et al
other advanced software capabilities, CT has become the initial imaging modality of choice for the evaluation of most presentations of acute abdominal pain. For example, CT diagnoses acute appendicitis with a reported sensitivity and specificity as high as 98% and 97%, respectively [8]. In fact, the superior diagnostic capability of CT is rendering plain films obsolete. Even in situations where plain films have proven diagnostic accuracy, such as perforated viscus or small bowel obstruction, many physicians now opt for CT as the initial imaging study. Computed tomography has proven to be more sensitive and specific for nearly all etiologies of acute abdominal pain [9–11]. In patients with abdominal pain suspected to be from a hepatobiliary source, abdominal ultrasonography should be considered as an initial imaging option. It is accurate for the detection of gallstones and dilation of the biliary tree. However, ultrasound is less sensitive for stones in the common bile duct. Although MRI can be highly accurate in the diagnosis of acute abdominal pain, high cost and lack of immediate availability limit its use in the primary care setting. Following clinical evaluation of patients with abdominal pain, the primary physician must appropriately triage the patient. In addition to red flags revealed by the history and physical examination, there are laboratory and radiographic ‘‘red flags’’ that should alert the physician of a potentially more serious cause of the abdominal pain (Table 2). Although cardiac, pulmonary, urologic, musculoskeletal, and gynecologic causes of abdominal pain will not be specifically addressed in this review, it is important to keep these extraabdominal disease processes in the differential diagnosis of abdominal pain. Red flags that a life-threatening extraabdominal cause of abdominal pain is present include chest pain, back pain, shortness of breath, vaginal bleeding, and hemodynamic instability. Finally, there is a spectrum of systemic medical disorders, such as adrenal insufficiency, diabetic ketoacidosis, porphyria, and sickle cell pain crisis, that can present with abdominal pain. Evidence of these disorders in the past medical history, medications, or physical examination should prompt their consideration as the cause of the patient’s pain. Although a detailed discussion of all of the potential etiologies of acute abdominal pain is beyond the scope of this review, there are some etiologies that merit a more detailed discussion. What follows is an overview of those gastrointestinal etiologies of abdominal pain that can often be seen in adults in the outpatient setting, with a focus on those etiologies prone to more serious or life-threatening complications.
Hepatopancreatobiliary Biliary colic When patients with cholelithiasis present with abdominal pain, they will most commonly have biliary colic as the cause [12]. Biliary colic occurs when
ACUTE ABDOMINAL PAIN
667
then one or more gallstones transiently occlude the cystic duct. Tonic cystic duct spasm ensues, causing pain. Patients typically experience visceral epigastric or right upper quadrant abdominal pain, often with radiation to the right shoulder or scapula. The pain is sometimes postprandial, but often there is no trigger; it is not uncommon for patients to have nocturnal pain. The term biliary colic is a misnomer, as the pain is not colicky in nature. The classic time course of pain from biliary colic is one that builds over 15 to 60 minutes, lasting up to several hours before slowly dissipating. Physical examination is typically benign, with tenderness sometimes elicited in the epigastrum or right upper quadrant of the abdomen. Patients suspected of having biliary colic should have further evaluation with liver function tests and abdominal ultrasonography. Transaminases, bilirubin, and alkaline phosphatase are usually normal, and an ultrasound can verify the presence of gallstones. Although biliary colic usually resolves without sequelae, it identifies those patients whom are at higher risk for complications of gallstone disease, such as pancreatitis or cholangitis. Therefore, referral to a general surgeon for elective cholecystectomy is recommended. Cholecystitis More than 90% of cases of acute cholecystitis are caused by gallstones. The remainder of cases are termed acalculous cholecystitis, typically occur in critically ill patients, and are rarely seen in the outpatient setting [13]. Acute cholecystitis is most commonly caused by the obstruction of the cystic duct by the offending gallstone. Prolonged obstruction of the cystic duct (O6 hours) impairs gallbladder emptying, leading to inflammation of the gallbladder mucosa. Secondary bacterial infection of the gallbladder may ensue, leading to possible empyema, gallbladder necrosis, and perforation. Acute cholecystitis results in gallbladder perforation in up to 12% of cases, with a subsequent mortality rate of 20% [7]. Emphysematous cholecystitis, characterized by air in the wall of the gallbladder, is most often seen in patients with diabetes mellitus. Approximately 75% of patients who develop acute cholecystitis have a prior history of biliary colic [14]. The pain is similar to that of biliary colic, but with a longer duration. Pain lasting longer than 6 hours signifies cholecystitis rather than biliary colic. As acute gallbladder inflammation irritates the parietal peritoneum, the pain may shift from the epigastrum to the right upper quadrant. The physical examination of patients with acute cholecystitis reveals right upper quadrant tenderness. An inspiratory arrest during deep right upper quadrant palpation is referred to as Murphy’s sign. Laboratory abnormalities include leukocytosis with a predominance of neutrophils, and elevation of alkaline phosphatase, and transaminases. Hyperbilirubinemia generally does not occur with acute cholecystitis owing to the unimpeded flow of bile through the common bile duct. An exception is Mirizzi’s syndrome, where a large stone in the cystic duct compresses or
668
FLASAR
et al
erodes into the common hepatic duct, resulting in variable degrees of biliary obstruction. Right upper quadrant ultrasonography is the test of choice to diagnose acute cholecystitis, with reported sensitivity, specificity, and accuracy approaching 95% [7]. Common findings include cholelithiasis, gallbladder wall thickening, pericholecystic fluid, and a sonographic Murphy’s sign. The latter finding occurs when ultrasound transducer pressure on the gallbladder results in tenderness. The finding of cholelithiasis and a positive sonographic Murphy’s sign has a positive predictive value of 92% for acute cholecystitis. Conversely, when both of these findings are absent, the negative predictive value is 95% [7]. Radionuclude cholescintigraphy scans, such as the HIDA scan, can be used to confirm the diagnosis of acute cholecystitis when ultrasound findings are equivocal. The sensitivity, specificity, and positive predictive value for acute cholecystitis are 95%, 99%, and 97%, respectively [15]. Patients with suspected acute cholecystitis should have an expedited evaluation with early surgical consultation. Cholecystectomy within 24 to 48 hours of presentation has been shown to reduce mortality and shorten length of hospital stay, compared with surgery performed after weeks of conservative management aimed at ‘‘cooling off’’ the gallbladder [16–18]. The benefits of early cholecystectomy have been prospectively validated for the laparoscopic approach as well [19–23]. Cholangitis Ascending cholangitis is a potentially lethal entity that occurs when the bile duct become obstructed. Once bile flow is impeded, superinfection of the stagnant bile occurs. As pus builds up under pressure, the infection can rapidly ascend into the liver and spread into the blood stream. Common pathogens include Escherichia coli, Klebsiella species, Bacteroides, Enterococcus, and other enteric pathogens [24]. The most common cause of obstruction in the United States is choledocholithiasis, accounting for approximately 85% of cases. Benign biliary strictures, choledochal cysts, biliary parasites, and neoplasms are less common causes of cholangitis [25]. The classic presentation of cholangitis is fever, jaundice, and right upper quadrant pain. These findings are collectively referred to as Charcot’s triad, which has a reported sensitivity for cholangitis as high as 75% [26]. If the obstruction is not relieved, mental obtundation and shock can occur. The combination of Charcot’s triad with these findings is known as Reynold’s pentad, which is associated with a higher morbidity and mortality rate [13]. Laboratory findings include leukocytosis with a predominance of neutrophils, elevated alkaline phosphatase, and elevation of the transaminases. An elevation of pancreatic enzymes can be seen in about one third of patients, especially with concomitant gallstone pancreatitis [27]. As the pathophysiology of this disorder involves common bile duct obstruction, conjugated hyperbilirubinemia is invariably present.
ACUTE ABDOMINAL PAIN
669
The diagnosis of cholangitis is often made clinically, and should be confirmed with cholangiography. Although ultrasonography may suggest the presence of biliary obstruction, its sensitivity for choledocholithiasis is poor [7]. Therefore, when the clinical diagnosis of ascending cholangitis is suspected, patients should undergo cholangiography even in the setting of an unremarkable right upper quadrant ultrasound. Patients suspected of having acute cholangitis should be referred quickly to an emergency department or hospitalized, as the clinical course can be rapidly progressive and fatal if left untreated. Patients with suspected cholangitis should have blood cultures drawn at presentation, so that therapy can be directed toward the offending pathogen. The definitive therapy for cholangitis is decompression of the obstructed biliary system. Endoscopic retrograde cholangiopancreatography (ERCP) is the diagnostic and therapeutic procedure of choice, and is successful in relieving the obstruction in more than 95% of cases [15]. This is typically accomplished by stone extraction or placement of a stent into the common bile duct. In cases where therapeutic ERCP is not available or is unsuccessful, options include percutaneous transhepatic cholangiography or surgical decompression. If choledocholithiasis is the cause of ascending cholangitis, patients should undergo elective cholecystectomy once the infection resolves. Acute pancreatitis Acute pancreatitis is an inflammatory disease of the pancreas that not only may cause significant morbidity but also carries a case fatality rate of 5% to 9% [28]. Gallstones and alcohol account for more than 80% of cases in the United States [15]. Less common causes of pancreatitis include medications, trauma, hypercalcemia, severe hypertriglyceridemia (O1000 mg/dL), malignancy, sphincter of Oddi dysfunction, infections, iatrogenic (ERCP), and congenital abnormalities of the pancreas such as pancreas divisum. The remainder are termed idiopathic, although as many as 75% of cases of idiopathic pancreatitis may actually be due to biliary sludge or microlithiasis [29]. Regardless of the etiology, diffuse pancreatic inflammation and edema develop. In severe cases, necrosis of pancreatic and peripancreatic tissue occurs, and multiorgan failure may ensue. Necrotizing pancreatitis occurs in up to 25% of patients with pancreatitis and has a mortality rate of 15% to 20% [28,30]. Patients typically present with the acute onset of abdominal pain, nausea, and vomiting. The pain is steady and usually in the epigastrium, although patients may also note discomfort in the right or left upper quadrants of the abdomen. Pain is classically described as a boring sensation that radiates into the back. Patients are often unable to get comfortable when lying supine, and they will lean forward in an attempt to find relief. Because of marked fluid shifts, patients may become severely volume depleted. Resultant tachycardia and hypotension with orthostatic changes may develop. Other vital sign abnormalities include low-grade fever and
670
FLASAR
et al
tachypnea. The latter is a poor prognostic sign, and may herald the development of sepsis or acute respiratory distress syndrome. The abdominal examination may reveal distension and diminished or absent bowel sounds secondary to the development of a paralytic ileus. With palpation, focal tenderness in the epigastrum is seen, although the abdomen may also be diffusely tender. With more severe cases, voluntary guarding and rebound tenderness may also be appreciated. Signs of hemorrhagic pancreatitis such as Gray Turner’s sign (flank ecchymosis), Cullen’s sign (periumbilical ecchymosis), or Fox’s sign (inguinal ecchymosis) are seen in less than 1% of cases. When acute pancreatitis is suspected clinically, levels of serum amylase or lipase should be determined. In the setting of suspected acute pancreatitis, levels greater than three times the normal values have a high specificity for acute pancreatitis. Serum lipase remains elevated for longer durations than serum amylase and is more specific for acute pancreatitis [31]. It is important to note that the magnitude of serum amylase and lipase elevation does not correlate well with disease severity. Because of the marked intravascular volume depletion secondary to third spacing, hemoconcentration often occurs in acute pancreatitis. Hematocrit levels higher than 44% are associated with a worse prognosis, indicating potentially dangerous fluid shifts [32]. Hyperbilirubinemia, elevations of the alkaline phosphatase, and alanine aminotransferase levels O150 mg/dL suggest gallstones as the etiologic cause of the pancreatitis [33]. Because of marked fluid shifts that occur with acute pancreatitis, blood urea nitrogren, creatinine, and serum electrolytes including calcium should be assessed. Imaging of the pancreas with CT can confirm the diagnosis of acute pancreatitis, but is not necessary in all cases. The authors feel that CT scanning should be reserved for patients in whom the diagnosis is in question, in cases of suspected pancreatic necrosis, or in cases of clinical deterioration despite adequate medical therapy. Use of intravenous contrast is highly recommended, and CT should therefore be deferred until the patient has received adequate volume resuscitation to prevent nephrotoxicity. Because the care of patients with acute pancreatitis is complicated by the difficulty in differentiating whether a patient’s course will be mild or severe, several scoring systems have been developed to assess the severity in acute pancreatitis and determine prognosis. The most well known of these criteria is Ranson’s criteria, which was originally developed for alcoholic pancreatitis and later modified and validated for gallstone pancreatitis. Ranson’s criteria has limited clinical value because it takes 48 hours to determine. The Imrie/Glasgow criteria and APACHE II score are two other prospective systems, but both are cumbersome to perform. A prognostic CT scoring system, known as the Balthazar criteria, has been validated for predicting severity in acute pancreatitis. The score is heavily weighted on the presence of pancreatic necrosis [34]. The cornerstone of therapy in acute pancreatitis is intravenous volume resuscitation coupled with the prevention of pancreatic stimulation. Patients should be kept strictly nothing by mouth, and
ACUTE ABDOMINAL PAIN
671
therefore require a hospital setting for treatment. Very aggressive intravenous fluid repletion is necessary to maintain intravascular volume and allow adequate perfusion of the pancreas and extrapancreatic organs such as the kidneys.
Luminal and vascular disorders Acute appendicitis Acute appendicitis is the most common abdominal surgical emergency in the United States, with over 250,000 appendectomies performed annually [35]. Most cases of appendicitis are believed to result from obstruction of the appendiceal lumen by fecaliths. Following obstruction, increased intraluminal pressure causes local ischemia, leading to transmural inflammation. Secondary bacterial infection occurs, and gangrene and perforation of the appendix may result. A thorough history and physical examination are all that is required to make a clinical diagnosis of appendicitis, thereby heightening the importance of the initial care provider’s assessment. As a result of appendiceal hypertension and distension, a crampy visceral type pain is initially felt in the peri-umbilical region. There is often associated nausea, vomiting, and fever. As the inflammatory process progresses, and directly irritates the parietal peritoneum, the quality of the pain becomes sharp and shifts to the right lower quadrant (RLQ). Almost all patients with appendicitis will lose their appetite, and if a patient exhibits hunger, the clinical diagnosis of appendicitis should be questioned. Auscultation of the abdomen reveals diminished or absent bowel sounds. Classically, the examination of patients with appendicitis reveals tenderness to palpation at McBurney’s point, anatomically located two thirds of the way from the umbilicus to the anterior superior iliac spine. Guarding, rigidity, and rebound tenderness may be present from peritoneal irritation. Rovsing’s sign may be present, which is RLQ pain upon left lower quadrant palpation. The obturator and iliopsoas signs can be elicited by internal rotation of the right hip and extension of the right hip, respectively. The finding of abdominal pain during either maneuver occurs as a result of the inflammatory process, irritating the respective muscles during passive movement. Patients who present with acute abdominal pain that migrates from the umbilicus to the right lower quadrant, whom also exhibits RLQ tenderness on palpation, should be referred for emergent appendectomy. The accuracy of the clinical diagnosis in this situation has been estimated to be nearly 95% [36]. However, this classic presentation of appendicitis occurs only in two thirds of patients [37]. Atypical presentations account for the remainder. They result from either anomalous appendiceal anatomy, or certain populations of patients that are more prone to atypical presentations of common diseases, such as the elderly, immunocompromised, or pregnant
672
FLASAR
et al
patients. For example, a retrocecal appendix that becomes inflamed may produce right flank rather than abdominal pain. Patients older than 55 years of age may present with vague symptoms and exhibit more subtle examination findings, thereby causing a delay in diagnosis. This delay can result in a higher rate of perforation compared with their younger counterparts [37]. Finally, misdiagnosis is more common in premenopausal women owing to a broadened gynecologic differential diagnosis and confusing presentations [38]. Therefore, the importance of considering this diagnosis at any age remains important. Patients with suspected appendicitis should be made nothing by mouth (NPO) and started on intravenous fluids. The prophylactic use of antibiotics is not supported by the literature, and should only be used in cases of suspected perforation. Because of the potential perforation risk, patients with a clinical diagnosis of appendicitis should undergo emergent surgical intervention. Historically, a 20% presurgical false positive rate has been considered acceptable. In patients where the clinical diagnosis is uncertain, imaging studies and observation admissions for serial abdominal examinations may decrease this false positive rate. In any woman of childbearing age, pregnancy should be ruled out with a serum or urinary b-human chorionic gonadotropin (b-HCG) test before imaging or appendectomy. Diverticulitis Nearly a third of patients over the age of 50, and two thirds by the age of 80 have diverticular disease [39]. Diverticulitis, a complication caused by the perforation of a diverticulum, affects up to 25% of patients with diverticular disease [40]. Inspissated food, stool, and increased intraluminal pressure are believed to be involved in the pathogenesis of diverticular perforation. The clinical presentation of patients with diverticulitis is dependent on the extent of the perforation. Small perforations are walled off by surrounding mesentery and pericolonic fat, while larger perforations can result in extensive intraperitoneal abscess formation and frank peritonitis. The location of abdominal pain in patients symptomatic with diverticulitis is dependent on the location of the perforated diverticulum. Diverticular disease most commonly affects the sigmoid colon, so patients most often present with crampy, left lower quadrant abdominal pain. However, patients with a redundant sigmoid colon or diverticular disease involving the right colon may complain of RLQ abdominal pain [41]. Patients may additionally complain of nausea, vomiting, fever, and anorexia. Physical examination often reveals tenderness over the inflamed area, and an inflammatory mass may be palpable in some patients. In patients with free perforation, peritoneal signs such as rebound, guarding, and rigidity may be present. Although the diagnosis can often be made on clinical grounds alone, an imaging study should be performed during a patient’s initial presentation to confirm the presence of diverticula. This can be done as an outpatient,
ACUTE ABDOMINAL PAIN
673
provided none of the aforementioned red flags are present. CT of the abdomen and pelvis with intravenous and oral contrast is the diagnostic modality of choice, with a reported sensitivity as high as 98% [42]. Colonoscopy should not be performed in patients with suspected diverticulitis, as perforation is a contraindication for endoscopy. Management of mild, uncomplicated diverticulitis can occur on an outpatient basis, and consists of a clear liquid diet and the administration of oral antibiotics that cover typical gastrointestinal pathogens. Complicated diverticulitis occurs when patients develop intraabdominal abscesses, fistula, free perforation, or intestinal obstruction. Patients with complicated diverticulitis or those with mild disease who fail to respond to above therapies require hospitalization. Patients should be started on intravenous antibiotics, made NPO, and be evaluated by a surgeon. Intraabdominal abscesses can often be managed with percutaneous drainage catheters, but surgery is sometimes required [43]. Free perforation or intestinal obstruction usually mandates emergent surgery. Obstruction Bowel obstruction occurs when the normal flow of intestinal contents is interrupted by a mechanical blockage. In patients with a history of abdominal surgery, nearly 75% of cases of small bowel obstruction (SBO) are the result of adhesive peritoneal bands [44–46]. In fact, up to 15% of patients who undergo laparotomy will be readmitted within 2 years with SBO from adhesions, while up to 3% will require operative intervention as a result [46]. Furthermore, it is estimated that the 10-year risk of developing recurrent SBO from adhesions is around 40% [47]. Hernias are the second most common cause of SBO, and account for up to 25% of cases [48]. The remainder of cases of SBO result from a number of etiologies, including Crohn’s disease, volvulus, neoplasm, intussusception, gallstones, and ischemia. The clinical presentation of large bowel obstruction (LBO) is very similar to that of SBO. Nearly 60% of cases of LBO are the result of malignancy, with colon cancer being the most common. Other causes include diverticular strictures and colonic volvulus [49]. The cecum and the sigmoid colon are the most common locations of colonic volvulus [50]. Once the bowel is obstructed, the segment of bowel proximal to the obstruction becomes increasingly distended by swallowed air, gas from bacterial fermentation, and luminal secretions. Bacterial overgrowth, bowel edema, and loss of absorptive function follow. If the obstruction is not promptly treated, then ischemia, necrosis and perforation may occur. The pain caused by SBO is a colicky, diffuse pain that waxes and wanes over 5- minute intervals. Nausea, vomiting, distention, and obstipation are often associated with the abdominal pain. Emesis is often feculent due to bacterial overgrowth. The passage of stool and flatus do not eliminate SBO from the differential diagnosis, as luminal contents distal to the
674
FLASAR
et al
blockage can still pass. Patients will often exhibit physical signs of volume depletion. Abdominal examination reveals a distended abdomen with either hyperactive high-pitched or hypoactive bowel sounds. Rushes of luminal fluid can often be heard. The abdomen is usually diffusely tender, with findings of rigidity, rebound tenderness, or guarding suggesting peritonitis. A ventral, inguinal, or periumbilical hernia should be sought as a potential etiology for the obstruction. Laboratory analysis is usually nonspecific, but common abnormalities include hemoconcentration, leukocytosis, and electrolyte imbalances. An abdominal plain film series should be the initial diagnostic imaging test in patients with suspected obstruction. Typical findings include air–fluid levels, small bowel distention, and a paucity of air in the rectal vault. In addition, evidence of complications such as intraperitoneal free air can be seen. Although most diagnoses can be made clinically with the confirmatory assistance of plain films, there are instances where plain films are not sufficient. In these instances, CT may be helpful for both diagnosing SBO and determining the etiology, with a reported sensitivity of 100% and accuracy of 90% [51,52]. Patients with evidence of bowel obstruction should be admitted to the hospital, both for decompression and observation. Patients are initially managed with strict restriction of oral intake, nasogastric tube decompression, intravenous fluids, and electrolyte repletion. Early surgical evaluation is mandatory given the perforation risk if left unattended. The philosophy that ‘‘the sun should neither rise nor set on a bowel obstruction,’’ still remains true today. Peptic ulcer disease Peptic ulcer disease (PUD) is a common affliction that significantly impacts quality of life. In 1989, more than 5 billion dollars were spent on the care of patients with PUD [53]. Helicobacter pylori infection, the most common cause of PUD, has been associated with 75% to 95% of duodenal ulcers (DU) and 65% to 95% of gastric ulcers (GU) [54–56]. Nonsteroidal anti-inflammatory medications (NSAIDs) are the second most common cause of PUD, with an estimated yearly incidence of clinically significant gastric or duodenal ulceration of approximately 1.5% [57]. Use of NSAIDs presents a particular challenge, as up to 40% of patients will not report the use of NSAIDs [58]. Acid hypersecretory syndromes such as Zollinger Ellison syndrome accounts for the majority of the remaining cases. The clinical presentation of PUD depends on the location of the ulcer, and whether complications from the ulcer develop. Complications of PUD include bleeding, obstruction, perforation, and penetration into adjacent structures. Patients with uncomplicated peptic ulcers may be asymptomatic, or they may present with pain in the upper abdomen [59,60]. The pain is typically described as a burning or gnawing pain, but patients may occasionally describe it as
ACUTE ABDOMINAL PAIN
675
crampy. Nausea and vomiting may also be seen. Relation of pain to meals is unreliable to differentiate DU from GU. Bleeding from PUD may present with melena, hematochezia, or hematemesis, with or without hemodynamic compromise. Bleeding can generally be managed medically with intravenous fluid, blood transfusions, antisecretory therapy, and endoscopic therapy. Endoscopy is also useful to determine the risk for recurrent bleeding [61]. Surgical or angiographic intervention is reserved for bleeding refractory to endoscopic therapies. Pyloric channel and duodenal bulb ulcers may cause gastric outlet obstruction. In addition to epigastric pain, patients with outlet obstruction may present with nausea, projectile vomiting, early satiety, anorexia, and weight loss. Conservative measures are often successful, although many patients will require surgery or endoscopic dilatation therapy [62,63]. Most ulcers that perforate are located in the duodenal bulb, and are often associated with NSAID use [64,65]. Patients present with the sudden onset of epigastric pain that quickly becomes diffuse as generalized peritonitis ensues. Patients can sometimes develop paradoxic improvement in their pain following perforation despite a markedly rigid and diffusely tender abdomen. Plain films are usually adequate to confirm the diagnosis of ulcer perforation. Perforations require immediate surgical evaluation. Ulcer penetration into adjacent structures occurs in up to 20% of cases of PUD, but only a small proportion become clinically apparent [66]. The most common sites of ulcer penetration include the pancreas, omentum, hepatobiliary system, colon, and adjacent vasculature. Patient presentation reflects the structure that is involved, and the therapy is site-specific. Ischemic bowel disease Depending on the location, degree, and acuity of the vascular compromise, ischemic bowel disease is classified into three distinct syndromes: acute mesenteric ischemia, chronic mesenteric ischemia, and colonic ischemia. Acute mesenteric ischemia results from the rapid loss of blood supply to the portion of the intestines supplied by the celiac, superior mesenteric, or inferior mesenteric arteries. The cause is most commonly thromboembolic disease. The consequences of acute mesenteric ischemia are severe, and include bowel necrosis, infarction, and death. Chronic mesenteric ischemia results from the gradual loss of blood supply to the portion of the intestines supplied by the celiac, superior mesenteric, or inferior mesenteric arteries. The cause is usually atherosclerosis. Patients with chronic mesenteric ischemia present with chronic postprandial abdominal pain, which is termed intestinal angina. Because eating worsens the pain, patients develop a fear of eating (sitophobia), and significant weight loss may occur. Colonic ischemia, also known as ischemic colitis, is the most commonly encountered intestinal vascular disorder [67]. Colonic ischemia occurs when there is a decrease in colonic mucosal oxygenation. In the vast majority of patients, colonic
676
FLASAR
et al
ischemia does not result from an occlusive vascular process, but rather occurs when the oxygen requirements to a specific portion of the colon are not met by the vascular supply. Colonic ischemia occurs in the portions of the colon where blood flow is least redundant, such as the splenic flexure, and rectosigmoid junction. Lower gastrointestinal bleeding, rather than abdominal pain, is the most common presenting symptom. The disorder is self-limited in the majority of cases, and the prognosis is good. Of the three ischemic bowel syndromes, acute mesenteric ischemia is the disease that presents with acute abdominal pain, and will be further discussed below. Acute interruption of blood supply in the mesenteric vasculature results from either thromboembolic disease or vasospasm. The major risk factors include advanced age, hypercoaguability, vascular disease, and cardiac disorders such as atrial fibrillation or valvular disease. Once the blood supply to the mesenteric vascular is interrupted, acute ischemia ensues. If the vascular compromise persists, bowel infarction, necrosis, and perforation may occur. Patients with acute mesenteric ischemia present with acute onset, severe periumbilical abdominal pain. Early in the disease course, the pain is often out of proportion to tenderness produced during the physical examination. If the patient presents after bowel infarction has already occurred, peritoneal signs may develop. The stool may be positive for occult blood, but hematochezia is uncommon with acute mesenteric ischemia. Common laboratory abnormalities seen with acute mesenteric ischemia include leukocytosis and an elevated hematocrit from hemoconcentration. A low serum bicarbonate, metabolic acidosis, and elevated lactate level are seen once bowel infarction has occurred. Retrospective studies evaluating the role of elevated plasma D-dimer levels in the diagnosis of early mesenteric ischemia showed initial promise, although subsequent prospective evaluations have shown D-dimer to be less helpful [68,69]. Several imaging modalities, including plain films, Doppler ultrasound, conventional CT, and MRI have been studied for the diagnosis of acute mesenteric ischemia. Unfortunately, these imaging techniques lack sensitivity and specificity to accurately make the diagnosis [70]. Mesenteric angiography is the ‘‘gold standard’’ test for diagnosing occlusive arterial mesenteric ischemia. Its sensitivity and specificity are 75% to 100% and 100%, respectively [67]. In addition to its diagnostic capabilities, angiography offers the potential for treatment. Several studies demonstrate a decreased mortality in patients who undergo angiography for suspected occlusive mesenteric arterial ischemia [71,72]. The mortality rate for patients with acute mesenteric ischemia in whom the diagnosis is not made before the onset of bowel infarction is reported to be as high as 90% [67]. Therefore, early diagnosis is crucial. Because laboratory findings may be nonspecific early in the disease course, a high index of suspicion, based upon predisposing risk factors, and clinical presentation is required. Patients with suspected acute mesenteric ischemia should have prompt angiography and surgical evaluation [73].
ACUTE ABDOMINAL PAIN
677
Abdominal aortic aneurysm It is estimated that as many as 10% of patients over the age of 65 have an abdominal aortic aneurysm (AAA). Rupture of the AAA carries an overall mortality rate of nearly 90%, which only falls to 70% if patients survive to reach the operating room [74,75]. Because of such high mortality and rapid course, a ruptured AAA is unlikely to present in an outpatient clinic. However, any severe abdominal pain complaint in a patient with a known AAA mandates immediate referral to an emergency department for evaluation. Inflammatory bowel disease Inflammatory bowel disease (IBD) encompasses ulcerative colitis (UC), Crohn’s disease (CD), and indeterminate colitis. All three disorders are chronic, characterized by disease-free intervals, followed by flares of disease. These disorders are generally managed in the outpatient setting, and abdominal pain is often a component of active disease. Nonetheless, there are several acute, potentially life-threatening complications from IBD that may present as abdominal pain in the outpatient setting. These include fulminate colitis, toxic megacolon, bowel obstruction, bowel perforation, and abscess formation. Fulminate colitis is typically associated with UC, and is the initial presenting scenario in up to 10% of patients with UC [76–78]. It is defined as abdominal pain, O10 bloody bowel movements per day, volume depletion, anemia, and any two of the following: white blood count O10,500 cells/mL, fever O38.6 C, tachycardia, and hypoalbuminemia [79]. Patients with known UC will complain of increasingly severe, crampy, generalized abdominal pain in addition to the typical complaints of bloody diarrhea, urgency, and tenesmus. Toxic megacolon occurs in colitis patients when there is pathologically dilated large bowel in conjunction with evidence of systemic toxicity. Early series reported mortality rates of 19%, although more recent series estimate overall mortality approaching 0%, owing to earlier recognition and improved management strategies [80–82]. Toxic megacolon was originally described, and is most commonly seen in the setting of UC, but can also occur with Crohn’s colitis, infectious colitis (especially Clostridium difficile), ischemic colitis, diverticulitis, and colon cancer. Toxic megacolon generally occurs early in the course of UC, with 30% of cases occurring within the first 3 months of diagnosis and 60% of cases within 3 years of diagnosis [83]. Physical examination classically reveals abdominal distension with tympany to percussion, as well as tenderness above the underlying colon. However, examination findings are less reliable in the setting of active corticosteroid therapy. In patients with peritoneal signs, perforation should be strongly suspected. The diagnosis is made based on the presence of colonic distension (O6 cm) on imaging plus any three of the following: fever
678
FLASAR
et al
(O38.6 C), leukocytosis (O10,500 cells/mL), anemia, or tachycardia (O120 beats/min), plus any one of the following: altered mental status, volume depletion, hypotension, or electrolyte abnormalities [84]. The patient with either fulminate colitis or toxic megacolon should be hospitalized immediately for aggressive medical care and surgical evaluation. They should be made NPO, started on intravenous hydration with appropriate electrolyte repletion, and in cases of toxic megacolon, should have a nasogastric tube placed to facilitate decompression. Bowel obstruction is common in CD, and is most frequently seen in the terminal ileum [85]. Obstruction most commonly results from active inflammatory intestinal strictures, postinflammatory fibrotic intestinal strictures, or peritoneal adhesive disease resulting from previous abdominal surgeries. Although far more common in CD, strictures occur in about 5% of patients with UC, with up to 30% representing malignant disease [86]. Perforation can occur both with CD and UC. In patients with UC, it is most commonly the result of toxic megacolon, and carries a mortality rate as high as 50% [87]. In patients with CD, perforation results from unrelieved small bowel obstructions. Because of the powerful immunosuppressive medications that IBD patients are frequently taking, the clinical severity of a perforation may be muted. Therefore, a high index of suspicion is needed. Intraabdominal abscess formation is common in CD, occurring in approximately 25% of patients [88–90]. They result from microperforations in patients with penetrating or stricturing disease. Patients typically present with fever, leukocytosis, and abdominal pain. Additionally, they may experience back or groin pain if the abscess involves the ileopsoas or pelvic structures, respectively. A special subset of abscess patients includes those with perianal disease, where the abscess occurs in the perirectal fascia, musculature, or adipose tissue. Approximately 30% of patients with perianal fistulizing CD will develop a perirectal abscess [91]. These patients may note low pelvic/perineal pain, defecatory urgency, or tenesmus in addition to constitutional symptoms. Severity may be blunted secondary to concomitant immunosuppressive medications. Regardless, patients with suspected perirectal or intraabdominal abscess with a history of CD warrant hospital admission for antibiotics, surgical evaluation, and advancement of medical therapy when appropriate. Irritable bowel syndrome Irritable bowel syndrome (IBS) has an estimated prevalence in the United States as high as 22%, though only one third will ever present for medical evaluation [92]. It is estimated to account for 12% of primary care visits [93]. The hallmark of the disorder is chronic abdominal pain or discomfort that is associated with altered bowel movements. The pathogenesis is not fully understood, but altered motility, visceral hypersensitivity, luminal factors, and psychologic etiologies are felt to all play a role. Affected patients
ACUTE ABDOMINAL PAIN
679
exhibit variation in the description of the abdominal pain, including cramping, bloating, aching, and even sharp localized pain. Although IBS is troubling to the patient and detrimental to everyday functioning and quality of life, IBS is not a life-threatening process. Therefore, it should be managed on an outpatient basis. Associated abnormalities such as anemia, poor nutritional status, weight loss, evidence of infection, fever, and electrolyte or metabolic abnormalities suggest an alternative diagnosis. Special populations There are several populations of patients who warrant special consideration when presenting with abdominal pain because of either underlying processes that are unique to these groups, or because presentations tend to be atypical in these groups. These include the elderly, immunosuppressed (including patients with AIDS), patients on analgesics, women of childbearing age, and pregnant women. Additionally, patients presenting under the influence of alcohol or illicit substances often exhibit atypical presentations of common disorders. Patients O65 years of age represent the fastest growing population demographic in the United States [94–97]. The elderly often delay seeking medical care, causing them to present at a potentially more dangerous point in their disease course. Compounding this, the history and physical examination have less reliability in the elderly. Many factors contribute to this, including underlying central nervous system disorders, fear of losing independence, hearing loss, depression, complex medical histories, vague description of the discomfort, polypharmacy, and change in normal physiology (eg, inability to mount leukocytosis or pyrexic response to infection). As a result, diagnostic accuracy has been reported as low as 40% in elderly patients with acute abdominal pain [98]. An important point to consider when evaluating elderly patients is that common disorders may manifest with uncommon presentations. For example, both coronary ischemia and urinary tract infections have been well-described causes of abdominal pain in the elderly. Also, it is not uncommon for an elderly patient to present with altered mental status as the lone sign of an acute abdominal process. Immunosuppressed patients and patients with immunodeficiency syndromes who present with abdominal pain generate a more expansive differential diagnosis (especially infectious causes) for their pain owing to their inability to mount a normal immune response. As in the elderly, the physical examination may be less accurate owing to an abnormal inflammatory response to pathologic processes. The differential diagnosis and evaluation of gynecologic and obstetric processes manifesting as acute abdominal pain are beyond the scope of this review. However, a few points need to be stressed. All women of childbearing age require a pelvic examination and evaluation for elevated b-HCG in the workup of acute abdominal pain. Additionally, as the gravid uterus
680
FLASAR
et al
enlarges in a pregnant patient, the normal topography of the small and large intestines may be altered due to mass effect, thereby making the location of abdominal tenderness atypical. This is classically true with appendicitis [99]. Abdominal pain is a common complaint in the outpatient setting. Although many etiologies have a benign course, some have potentially morbid and lethal complications. Care providers must understand the basis of the perception of abdominal pain, and develop a focused approach to the initial evaluation of these patients. Performing a thorough history and physical evaluation will allow the practitioner to generate a differential diagnosis that will guide further laboratory, imaging, and management decisions. References [1] Woodwell DA, Cherry DK. National Ambulatory Medical Care Survey: 2002 summary. Adv Data 2004;(346):1–44. [2] Feldman M, Friedman LS, Sleisenger MH. Sleisenger and Fordtran’s gastrointestinal and liver disease: pathophysiology/diagnosis/management. 7th edition. Philadelphia: Saunders; 2002. [3] Benedict M, Bucheli B, Battegay E, et al. First clinical judgment by primary care physicians distinguishes well between organic and nonorganic causes of abdominal or chest pain. J Gen Intern Med 1997;12(8):459–65. [4] Yamamoto W, Kono H, Maekawa M, et al. The relationship between abdominal pain regions and specific diseases: an epidemiologic approach to clinical practice. J Epidemiol 1997;7(1):27–32. [5] Maglinte DDT, Balthazar EJ, Kelvin FM, et al. The role of radiography in the diagnosis of small bowel obstruction. AJR Am J Roentgenol 1997;168(5):1171–80. [6] Miller RE, Nelson SW. The roentographic demonstration of tiny amounts of free intraperitoneal gas: experimental and clinical studies. AJR Am J Roentgenol 1971;112(3):574–85. [7] Billittier AJ, Abrams BJ, Brunetto A. Radiographic imaging modalities for the patient in the emergency department with abdominal complaints. Emerg Med Clin North Am 1996;14(4): 789–850. [8] Gupta H, Dupuy D. Advances in imaging of the acute abdomen. Surg Clin North Am 1997; 77(6):1245–63. [9] Ahn SH, Mayo-Smith WW, Murphy BL, et al. Acute nontraumatic abdominal pain in adult patients: abdominal radiography compared with CT evaluation. Radiology 2002;225(1): 159–64. [10] Tsushima Y, Yamada S, Aoki J, et al. Effect of contrast-enhanced computed tomography on diagnosis and management of acute abdomen in adults. Clin Radiol 2002;57(6):507–13. [11] Stapakis JP, Thickman D. Diagnosis of pneumoperitoneum: abdominal CT vs. upright chest film. J Comput Assist Tomogr 1992;16(5):713–6. [12] Berger MY, van der Velden JJ, Lijmer JG, et al. Abdominal symptoms: do they predict gallstones? A systematic review. Scand J Gastroenterol 2000;35(1):70–6. [13] Yusoff IF, Barkun JS, Barkun AN. Diagnosis and management of cholecystitis and cholangitis. Gastroenterol Clin North Am 2003;32(4):1145–68. [14] Raine PA, Gunn AA. Acute cholecystitis. Br J Surg 1975;62(9):697–700. [15] Kadakia SC. Biliary tract emergencies. Med Clin North Am 1993;77(5):1015–36. [16] van der Linden W, Sunzel H. Early versus delayed operation for acute cholecystitis: a controlled trial. Am J Surg 1970;120(1):7–13. [17] McArthur P, Cuschieri A, Sells R, et al. Controlled clinical trial comparing early with interval cholecystectomy for acute cholecystitis. Br J Surg 1975;62(10):850–2.
ACUTE ABDOMINAL PAIN
681
[18] Jarvinen H, Hastbacka J. Early cholecystectomy for acute cholecystitis: a prospective randomized trial. Ann Surg 1980;191(4):501–5. [19] Lai PB, Kwong KH, Leung KL, et al. Randomized trial of early versus late laparoscopic cholecystectomy for acute cholecystitis. Br J Surg 1998;85(6):764–7. [20] Lo CM, Liu CL, Fan ST, et al. Prospective randomized study of early versus late laparoscopic cholecystectomy for acute cholecystitis. Ann Surg 1998;227(4):461–7. [21] Chandler CF, Lane JS, Ferguson P, et al. Prospective evaluation of early versus delayed laparoscopic cholecystectomy for treatment of acute cholecystitis. Am Surg 2000;66(9): 896–900. [22] Brodsky A, Matter I, Sabo E, et al. Laparoscopic cholecystectomy for acute cholecystitis: can the need for conversion and the probability for complications be predicted? Surg Endosc 2000;14(8):755–60. [23] Pessaux P, Teuch JJ, Rouge C, et al. Laparoscopic cholecystectomy in acute cholecystitis: a prospective comparative study in patients with acute vs. chronic cholecystitis. Surg Endosc 2000;14(4):358–61. [24] Maluenda F, Csendes A, Burdiles P, et al. Bacteriologic study of choledocal bile in patients with common bile duct stones, with or without acute suppurative cholangitis. Hepatogastroenterology 1989;36(3):132–5. [25] Saharia PC, Zuidema GD, Cameron JL. Primary common duct stones. Ann Surg 1977; 185(5):598–604. [26] Saik RP, Greenburg AG, Farris JM, et al. Spectrum of cholangitis. Am J Surg 1975;130(2): 143–50. [27] Lipsett PA, Pitt HA. Acute cholangitis. Surg Clin North Am 1990;70(6):1297–312. [28] Banks PA. Practice guidelines in acute pancreatitis. Am J Gastroenterol 1997;92(3):377–86. [29] Ros E, Navarro S, Bru C, et al. Occult microlithiasis in ‘‘idiopathic’’ acute pancreatitis: prevention of relapses by cholecystectomy or ursodeoxycholic acid therapy. Gastroenterology 1991;101(6):1701–9. [30] Gullo L, Migliori M, Olah A, et al. Acute pancreatitis in five European countries: etiology and mortality. Pancreas 2002;24(3):223–7. [31] Steinberg WM, Goldstein SS, Davis ND, et al. Diagnostic assays in acute pancreatitis. A study of sensitivity and specificity. Ann Intern Med 1985;102(5):576–80. [32] Brown A, Baillargeon J-D, Hughes MD, et al. Can fluid resuscitation prevent pancreatic necrosis in severe acute pancreatitis? Pancreatol 2002;2(2):104–7. [33] Tenner S, Dubner H, Steinberg W. Predicting gallstone pancreatitis with laboratory parameters: a meta-analysis. Am J Gastroenterol 1994;89(10):1863–6. [34] Simchuk EJ, Traverso LW, Nukui Y, et al. Computed tomography severity index is a predictor of outcomes for severe pancreatitis. Am J Surg 2000;179(5):352–5. [35] Owings MF, Kozak LJ. Ambulatory and inpatient procedures in the United States, 1996. Vital and health statistics. Series 13. No. 139. Hyattsville (MD): National Center for Health Statistics; 1998. p. 26. [36] Paulson EK, Kalady MF, Pappas TN. Suspected appendicitis. N Engl J Med 2003;348(3): 236–42. [37] Graffeo CS, Counselman FL. Appendicitis. Emerg Med Clin North Am 1996;14(4):653–71. [38] Rothrock SG, Green SM, Dobson M, et al. Misdiagnosis of appendicitis in nonpregnant women of childbearing age. J Emerg Med 1995;13(1):1–8. [39] Freeman SR, McNally PR. Diverticulitis. Med Clin North Am 1993;77(5):1149–67. [40] Parks TG. Natural history of diverticular disease of the colon. Clin Gastroenterol 1975;4: 53–69. [41] Markham NI, Li AK. Diverticulitis of the right colon: experience from Hong Kong. Gut 1992;33(4):547–9. [42] Ambrosetti P, Jenny A, Becker C, et al. Acute left colonic diverticulitis: compared performance of computed tomography and water-soluble contrast enema: prospective evaluation of 420 patients. Dis Colon Rectum 2000;43(10):1363–7.
682
FLASAR
et al
[43] Schecter S, Eisenstat TE, Oliver GC, et al. Computerized tomographic scan-guided drainage of intra-abdominal abscesses: preoperative and postoperative modalities in colon and rectal surgery. Dis Colon Rectum 1994;37(10):984–8. [44] Bizer LS, Liebling RW, Delany HM, et al. Small bowel obstruction: the role of nonoperative treatment in simple intestinal obstruction and predictive criteria for strangulation obstruction. Surgery 1981;89(4):407–13. [45] Greene WW. Bowel obstruction in the aged patient: a review of 300 cases. Am J Surg 1969; 118(4):541–5. [46] Beck DE, Opelka FG, Bailey HR, et al. Incidence of small-bowel obstruction and adhesiolysis after open colorectal and general surgery. Dis Colon Rectum 1999;42(2): 241–8. [47] Landercasper J, Cogbill TH, Merry WH, et al. Long-term outcome after hospitalization for small-bowel obstruction. Arch Surg 1993;128(7):765–70. [48] Mucha P Jr. Small intestinal obstruction. Surg Clin North Am 1987;67(3):597–620. [49] Kahi CJ, Rex DR. Bowel obstruction and pseudo-obstruction. Gastroenterol Clin North Am 2003;32(4):1229–47. [50] Ballantyne GH, Brandner MD, Beart RW Jr, et al. Volvulus of the colon: incidence and mortality. Ann Surg 1985;202(1):83–92. [51] Frager D. Intestinal obstruction: role of CT. Gastroenterol Clin North Am 2002;31(3): 777–99. [52] Frager D, Baer JW, Medwid SW, et al. Detection of intestinal ischemia in patients with acute small-bowel obstruction due to adhesions or hernia: efficacy of CT. AJR Am J Roentgenol 1996;166(1):67–71. [53] Sonnenberg A, Everhart JE. Health impact of peptic ulcer in the US. Am J Gastroenterol 1997;92(4):614–20. [54] Borody TJ, George LL, Brandl S, et al. Helicobacter pylori-negative duodenal ulcer. Am J Gastroenterol 1991;86(9):1154–7. [55] Ciociola AA, McSorley DJ, Turner K, et al. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am J Gastroenterol 1999;94(7):1834–40. [56] Tytgat G, Langenberg W, Rauws E, et al. Campylobacter-like organism (CLO) in the human stomach. Gastroenterology 1985;88(5):1620 [abstract]. [57] Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995; 123(4):241–9. [58] Lanas AI, Remacha B, Esteva F, et al. Risk factors associated with refractory peptic ulcers. Gastroenterology 1995;109(4):1124–33. [59] Kuipers EJ, Thijs JC, Festen HP. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 1995;9(Suppl 2):59–69. [60] Hilton D, Iman N, Burke GJ, et al. Absence of abdominal pain in older persons with endoscopic ulcers: a prospective study. Am J Gastroenterol 2001;96:380. [61] Laine L, Cohen H, Brodhead J, et al. Prospective evaluation of immediate versus delayed refeeding and prognostic value of endoscopy in patients with upper gastrointestinal hemorrhage. Gastroenterology 1992;102(2):314–6. [62] Weiland D, Dunn DH, Humphrey EW, et al. Gastric outlet obstruction in peptic ulcer disease: an indication for surgery. Am J Surg 1982;143(1):90–3. [63] Boylan JJ, Gradzka MI. Long-term results of endoscopic balloon dilatation for gastric outlet obstruction. Dig Dis Sci 1999;44(9):1833–6. [64] Gunshefski L, Flancbaum L, Brolin RE, et al. Changing patterns in perforated peptic ulcer disease. Am Surg 1990;56(4):270–4. [65] Lanas A, Serrano P, Bajador E, et al. Evidence of aspirin use in both upper and lower gastrointestinal perforation. Gastroenterology 1997;112(3):683–9.
ACUTE ABDOMINAL PAIN
683
[66] Norris JR, Haubrich WS. The incidence and clinical features of penetration in peptic ulceration. JAMA 1961;178:386–9. [67] Walker JS, Dire DJ. Vascular abdominal emergencies. Emerg Med Clin North Am 1996; 14(3):571–92. [68] Acosta S, Nilsson TK, Bjorck M. Preliminary study of D-dimer as a possible marker of acute bowel ishaemia. Br J Surg 2001;88(3):385–8. [69] Acosta S, Nilsson TK, Bjorck M. D-dimer testing in patients with suspected acute thromboembolic occlusion of the superior mesenteric artery. Br J Surg 2004;91(8):991–4. [70] Lefkovitz Z, Cappell MS, Lookstein R, et al. Radiologic diagnosis and treatment of gastrointestinal hemorrhage and ischemia. Med Clin North Am 2002;86(6):1357–99. [71] Boos S. Angiography of the mesenteric artery 1976 to 1991: a change in the indications during mesenteric circulatory disorders. Radiologe 1992;32(4):154–7. [72] Clark RA, Gallant TE. Acute mesenteric ischemia: angiographic spectrum. Am J Radiol 1984;142(3):555–62. [73] Kaleya R, Sammartano R, Boley SJ. Aggressive approach to acute mesenteric ischemia. Surg Clin North Am 1992;35(6):613–23. [74] Multicentre Aneurysm Screening Study Group. The Multicentre Aneurysm Screening Study (MAS) into the effect of abdominal aneurysm screening on mortality in men: a randomised controlled trial. Lancet 2002;360:1531–9. [75] Ruttedge RA, Oller DW, Meyer AA, et al. A statewide, population-based, time-series analysis of the outcome of ruptured abdominal aortic aneurysm. Ann Surg 1996;223: 492–505. [76] Becker JM. Surgical therapy for ulcerative colitis and Crohn’s disease. Gastroenterol Clin N Am 1999;28:371–90. [77] Greenstein AJ, Kark AE, Dreiling DA. Crohn’s disease of the colon. III. Toxic dilatation of the colon in Crohn’s disease. Am J Gastroenterol 1975;63:117–28. [78] Present D. Toxic megacolon. Med Clin North Am 1993;77(5):1129–48. [79] Truelove SC, Witts LF. Cortisone in ulcerative colitis: final report on a therapeutic trial. BMJ 1955;2:1041–8. [80] Katzka I, Katz S, Morris E. Management of toxic megacolon: the significance of early recognition and medical management. J Clin Gastroenterol 1983;78:557–9. [81] Mungas JE, Mooja AR, Block GE. Treatment of toxic megacolon. Surg Clin N Amer 1976; 56:95–102. [82] Strauss RJ, Flint GW, Platt N, et al. The surgical management of toxic dilatation of the colon: a report of 28 cases and review of the literature. Ann Surg 1976;184(6):682–8. [83] Kleer CG, Appleman HD. Ulcerative colitis: patterns of involvement in colorectal biopsies and changes with time. Am J Surg Pathol 1998;22:983–9. [84] Jalan KN, Sircus W, Card WI, et al. An experience with ulcerative colitis: toxic dilation in 55 cases. Gastroenterology 1969;57:68–82. [85] Cheung O, Regueiro MD. Inflammatory bowel disease emergencies. Gastroenterol Clin North Am 2003;32:1269–88. [86] Chutkan R. Inflammatory bowel disease. Prim Care 2001;28(3):539–56. [87] Greenstein AJ, Aufses AH Jr. Differences in pathogenesis, incidence, and outcome of perforation in inflammatory bowel disease. Surg Gynecol Obstet 1985;160:63–9. [88] Cybulsky IJ, Tam P. Intra-abdominal abscesses in Crohn’s disease. Am Surg 1990;56: 672–82. [89] Lambiase RE, Cronan JJ, Dorfman GS, et al. Percutaneous drainage of abscesses in patients with Crohn’s disease. AJR. AJR Am J Roentgenol 1988;150:1043–5. [90] Ribeiro MB, Greenstein AJ, Yamazaki Y, et al. Intra-abdominal abscesses in regional enteritis. Ann Surg 1991;179:495–8. [91] Makowiec F, Jehle EC, Becker HD, et al. Perianal abscess in Crohn’s disease. Dis Colon Rectum 1997;40:443–50. [92] Borum ML. Irritable bowel syndrome. Prim Care 2001;28(3):523–38.
684
FLASAR
et al
[93] Mitchell CM, Drossman DA. Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterol 1987;92:1282. [94] Ciccone A, Allegra JR, Cochrane DG, et al. Age-related differences in diagnoses within the elderly population. Am J Emerg Med 1998;16:43–9. [95] Eliastam M. Elderly patients in the emergency department. Ann Emerg Med 1989;18: 1222–9. [96] Kamin RA, Nowicki TA, Courtney DS, et al. Pearls and pitfalls in the emergency department evaluation of abdominal pain. Emerg Med Clin North Am 2003;21:61–72. [97] deDombal FT. Acute abdominal pain in the elderly. J Clin Gastroenterol 1994;19:331–5. [98] Marco CA, Schoenfeld CN, Keyl PM, et al. Abdominal pain in geriatric emergency patients: variables associated with adverse outcomes. Acad Emerg Med 1998;5:1163–8. [99] Weingold AB. Appendicitis in pregnancy. Clin Obstet Gynecol 1983;26:801.
Prim Care Clin Office Pract 33 (2006) 685–695
Dermatologic Emergencies Brian J. Browne, MD, FACEP, Brian Edwards, MD*, Robert L. Rogers, MD, FAAEM, FACEP, FACP Department of Emergency Medicine, The University of Maryland School of Medicine, 110 South Paca Street, Sixth Floor, Suite 200, Baltimore, MD 21201, USA
Primary care physicians are the gatekeepers of the medical community. They are the physicians to whom patients first present, and they are often the physicians with whom patients have the longest lasting relationships. Primary care physicians, as a result of these long-term relationships, have been endowed with a unique responsibility to the health of their patients. By the very nature of their practice, primary care physicians do not have the resources to treat emergent life-threatening conditions. They must, however, be able to diagnose these potentially life-threatening conditions and be able to stabilize and appropriately refer a patient for urgent evaluation by specialists or emergency physicians. There are many types of emergencies encountered in the outpatient setting, ranging from cardiac to toxicologic. As important as recognizing signs and symptoms of cardiac ischemia is the ability to recognize potentially life-threatening dermatologic disorders or dermatologic manifestations of life-threatening systemic diseases. There are innumerable dermatologic conditions that can be potentially fatal. The primary care physician must be able to recognize a select few that demand immediate evaluation by emergency physicians, dermatologists, intensivists, and surgeons, among others. Included in this brief review will be the following conditions: Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis, pemphigus vulgaris, scalded skin syndrome, Rocky Mountain Spotted fever (RMSF), and Lyme disease. Many of these conditions require aggressive inpatient treatment, and must be immediately recognizable to the primary care physician. Although RMSF, Lyme disease and pemphigus vulgaris may not require rapid transfer to a higher level of care, they do demand that the clinician remain vigilant and be able to rapidly diagnose these conditions to avoid potentially serious sequelae. * Corresponding author. E-mail address:
[email protected] (B. Edwards). 0095-4543/06/$ - see front matter Ó 2006 Elsevier Inc. All rights reserved. doi:10.1016/j.pop.2006.06.002 primarycare.theclinics.com
686
BROWNE
et al
Stevens-Johnson syndrome/toxic epidermal necrolysis Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are potentially serious conditions that need to be recognized so that patients may receive appropriate referral and care. SJS was first described in 1922, in two children, aged 7 and 8 years, who presented with ‘‘an extraordinary, generalized eruption with continued fever, inflamed buccal mucosa and severe purulent conjunctivitis’’ [1]. TEN was first described by Ruskin, in 1948, and again by Lyell, in 1956, although two of Lyell’s four patients actually had scalded skin syndrome [1]. Clinically, SJS and TEN often present with prodromal symptoms such as malaise, rhinitis, odynophagia, myalgias, and arthralgias, which may often be mistaken for a viral syndrome [2]. This prodromal state may last for up to 2 weeks, and is followed by the abrupt development of a macular rash that may or may not be targetoid as classically described. This macular exanthem will mostly start centrally, followed by a spread to the extremities. The exanthem becomes confluent and significant dermal–epidermal dissociation ensues, resulting in a positive Nikolsky’s signddenudation with shear stress. Along with the cutaneous manifestations of SJS/TEN, there is almost invariable involvement of the oral mucosa in terms of blistering and progression to severe erosion. Oropharyngeal SJS/TEN can likewise progress to involvement of the esophagus and trachea leading to increased risk of respiratory failure. It is thought that TEN is merely a severe form of SJS with severity measured in terms of body surface area (BSA) affected. Stevens-Johnson syndrome has been diagnosed when the extent of involvement is !10% and TEN diagnosed when BSA involved is O30% [2]. There remains debate concerning how to classify clinically significant disease affecting between 10% and 30% of BSA. The progression phase of SJS/TEN is variable in terms of length and in terms of ultimately what percentage of BSA is involved. Mucous membrane involvement becomes more apparent during the progression phase, and is found in between 92 and 100% of those with SJS/TEN [1]. As mentioned above, involvement of the respiratory tract can occur. It is characterized by sloughing of the tracheal and bronchial epithelium, resulting in obstructive symptoms. There may be expectoration of bronchial casts, and mechanical ventilation may be required. Involvement of the conjunctivae may also occur. After the progression phase, where there is continued sloughing of the epidermis, there is the ‘‘acme phase’’ where risk of infection and sepsis is at its greatest due to the extent of denudation [2]. Subsequent to this acme phase, the patients begin a healing process of reepithelialization that can last approximately 1 week to 6 months, depending on the extent of BSA involved. The skin generally heals without significant scarring but the new epidermis may be hypo- or hyperpigmented in relation to what native epidermis remains [1]. Study of SJS/TEN has been limited by both the rarity of the ailment and the lack of agreement concerning diagnostic criteria. There have been many
DERMATOLOGIC EMERGENCIES
687
classification systems proposed, but none have been broadly accepted [1]. The incidence of SJS and TEN is therefore quite variable, depending on the classification scheme used. The incidence of SJS runs anywhere between 1.1 and 7.1 cases per million person-years, with a mean age of patients between 25 and 47 years. Older age is associated with an increased degree of skin loss. Mortality has been reported at less than 5% in SJS and 30% to 50% for TEN [3]. The etiology and pathogenesis of SJS and TEN is incompletely worked out. It is thought that the majority of cases are drug induced, with the main culprits being sulfonamide antibiotics, anticonvulsants such as phenytoin or carbamazepine, allopurinol, and nonsteroidal anti-inflammatory medications from the oxicam family [4]. Histologic examination reveals full-thickness necrosis of the epidermis with subepidermal blister formation. From a primary care perspective, the initiation of treatment involves transfer to an appropriate referral center, generally a burn center for those with TEN. As the most common etiology is drug induced, the foundation of treatment is withdrawal of the offending agent. Primary care providers must intimately know which medications their patients take, including those prescribed by consultants. Prompt withdrawal of the offending medications (those recently prescribed or those with a known risk of SJS/TEN) must be instituted as soon as clinical suspicion is aroused [3]. The second tier of treatment involves supportive care such as the multidisciplinary care found at burn centers or other dermatologic referral centers. Although these patients are at risk for fluid and electrolyte abnormalities, there is not the same degree of fluid loss as is found in burn patients. Early institution of enteral feedings, mostly by nasogastric tube, has been advocated due to the fact that SJS/TEN is a hypercatabolic state with high nutritional demands. Appropriate care of the exposed dermis is not standardized. Aggressive debridement is recommended by some, but a more expectant strategy is adopted by others. Exposed dermis should be covered with hydrocolloid dressings or gauze or skin allo-transplantation. Patients with significant involvement of body surface area are at much higher risk for sepsis due to bacterial infection. Given this high risk, the patients should be protected from iatrogenic infections. Some recommend screening bacterial and fungal cultures and advocate prophylactic antibiotics [1–3]. A third tier of treatment involves active interventions to halt the continued epidermolysis. Because SJS/TEN is thought to be an immune-mediated process, many mechanisms of immune suppression, including corticosteroids, intravenous immunoglobulin (IVIG), cyclophosphamide, cyclosporine, and plasmapheresis have been attempted [3]. Studies of the effects of these interventions have been marred by both study size and presence or absence of control groups. Specific discussion of risks and benefits of these highly specialized treatments is beyond the scope of this article. SJS and TEN are rare but clinically important conditions that need to be recognized by the primary care provider. These conditions are mostly
688
BROWNE
et al
iatrogenic in nature, caused by the medications that we prescribe. Early recognition allows time for appropriate referral to a dermatologic hospital or burn center for aggressive multidisciplinary management.
Staphylococcal scalded skin syndrome Staphylococcal scalded skin syndrome (SSSS) is a rare entity in adult and adolescent populations, with the total number of reported cases just above 50. The first case was reported in 1972 [5]. Although rare, if this condition presents in adults, it must be immediately recognized by the primary care provider or emergency physician due to a reported mortality rate of approximately 60% [6]. Similar to TEN and SJS, SSSS encompasses a spectrum from localized bullous impetigo to full-blown SSSS, depending on the distribution of exfoliative toxins. In patients that will ultimately develop widespread SSSS, they often present with fever and other nonspecific symptoms such as malaise [6]. In children, this process can often be associated with a sore throat or a severe conjunctivitis [5]. The bullous eruption begins with areas of erythema that begin centrally. These areas of erythema evolve into flaccid bullae that rupture easily, leaving large ‘‘scalded’’ areas. Given the intraepidermal nature of the cleavage plane, SSSS is associated with less morbidity than TEN even when similar surface areas are involved. These superficial skin lesions often heal over 7 to 10 days, without significant scarring. The SSSS is mediated through toxins produced by Staphylococcus aureus. Approximately 5% of all S aureus produce these toxins [7]. Two exfoliative toxins have been identified, ETA and ETB. ETA is the most common, and therefore clinically significant of the exfoliative toxins, produced by 89% of the isolates. ETB has been found to be produced by 4% of isolates. The correct diagnosis of SSSS is essential, as it must be differentiated from TEN. The latter will generally demand a higher level of care as well as fundamentally different treatment modalities. A major difference between SJS/TEN and SSSS is that mucous membrane involvement is nearly universal in SJS/TEN while absent in SSSS. Beyond that, biopsy of the lesions is the ‘‘gold standard’’ in the differentiation between TEN and SSSS. In TEN, there is epidermal necrosis with dermal sparing, while in SSSS, there is an intraepidermal, subcorneal division. SSSS mostly presents in children younger than 5 years of age, but there are reports of adult involvement [8–10]. The higher prevalence in the very young is likely due to a relative lack of antibodies to ETA and ETB. Antibodies to the exfoliative toxins are found in only 30% of children aged 3 months to 2 years, increasing to 91%t in those over 40 years of age. The low prevalence in adults is secondary to this apparent immunocompetence. Those adults at risk have compromised immune function leading to increased proliferation of S aureus. Adult patients at risk include those with advanced HIV, other deficits in cell-
DERMATOLOGIC EMERGENCIES
689
mediated immunity, malignancy, malnutrition, and others. Exfoliative toxins are renally excreted. Renal failure has been shown to be the most important risk factor for SSSS in adults [5]. Once SSSS is diagnosed, the treatment consists of two parts: treatment of the underlying infection, and supportive care. Because SSSS is, indirectly, an infectious process, the mainstay of treatment is administration of antibiotics. S aureus isolates are mostly sensitive to semisynthetic penicillins such as dicloxacillin, although there have been few reports of methicillinresistant S aureus resulting in SSSS [5,6]. Some physicians may initiate oral antibiotics in limited disease, but if the disease progresses or is already widespread, intravenous antibiotics should be used until progression ceases. Just as in SJS/TEN, supportive care is imperative. Given the intraepidermal nature of the lesions, the hemodynamic and electrolyte imbalances are not as severe as in SJS/TEN. That being said, patients with widespread denudation should be monitored closely for hypotension, electrolyte imbalances, thermal dysregulation, and bacterial superinfection of exposed surfaces.
Pemphigus vulgaris Although more of a historic dermatologic emergency, pemphigus vulgaris (PV) remains a condition associated with significant morbidity and some mortality. The term pemphigus is derived from pemphix, a Greek term meaning bubble or blister. The term pemphigus denotes a family of blistering diseases including pemphigus foliaceous, bullous pemphigoid, paraneoplastic pemphigus and, most importantly to this review, PV. The common thread linking these disorders is acantholysis, the separation of keratinocytes, mediated by host immune response. This brief review will focus mostly on PV, as it is the most potentially life-threatening PV is a bullous condition which, in 50% to 70% of patients, begins with the development of oral lesions [11]. These oral lesions begin as transient flaccid bullae that rupture easily leaving painful, superficial, and irregular nonhealing ulcerations arising from apparently healthy epithelium mainly in the buccal mucosa, lips, and palate [12,13]. Cutaneous bullous disease generally occurs subsequent to the onset of the oral lesions [14]. Flaccid bullae appear on otherwise healthy appearing skin. These bullae exhibit a positive Nikolsky’s sign and rapidly develop into painful erosions that a predilection for the scalp, chest, back and, often, the face and neck [13]. In addition to the oral and cutaneous involvement, involvement of esophageal, laryngeal, nasopharyngeal, vaginal, and rectal epithelium may also occur [15]. The natural history of this disease is one of chronicity with bullae progressing to painful erosions that heal poorly without intervention. Before the use of systemic corticosteroids, the fatality of PV reached 100%, generally due to dehydration or superinfection. Now mortality is now less than 10% [12,16].
690
BROWNE
et al
PV has has an annual incidence of 0.42 per 100,000, peaking between the fourth and sixth decades of life [16]. The disease is mostly prevalent in people of Jewish, Mediterranean, or south Asian ancestry [12]. Diagnosis of the condition is based on history and physical, combined with diagnostic studies such as biopsy and immunologic studies. The mainstay of treatment is topical corticosteroids for isolated cutaneous lesions and systemic corticosteroids for more widespread disease. Treatment has been subdivided into three basic stages: the control phase, the consolidation phase, and the maintenance phase [13]. The control phase involves aggressive titration of corticosteroids until a regression of symptoms is noted. In patients with recalcitrant disease, plasmapheresis and IVIG has been tried with success. Other immunosuppressants such azathioprine, methotrexate, mycophenolate mofetil, cyclophosphamide, and rituximab have been used with varying success [16]. The consolidation phase of treatment entails continuation of the effective dose of immunomodulators until most lesions are resolved. The maintenance phase involves tapering these medications until they can be safely stopped. While PV can be a chronic condition with a mortality rate of !10%, it is important that primary care physicians recognize and appropriately refer these patients to specialists for confirmatory testing and highly monitored treatment. Failure to do so in a timely fashion may negatively affect the health of the patient. Meningococcemia Meningococcemia in its most basic definition is the presence of Neisseria meningitidis in the blood. Invasive meningococcal disease is associated with a significant risk of mortality, and must be immediately recognized so that treatment may be initiated. Populations affected include small children and young adults [17]. Risk factors will be delineated below. The composition of the primary care provider’s practice will determine the likelihood that they will see primary presentations of meningococcemia. The clinical presentation of invasive meningococcal infection is varied, and is not necessarily associated with meningitis. Meningococcemia is often preceded by an upper respiratory tract infection. Some consider such infection, in addition to mycoplasma infection, a risk factor for meningococcemia [18]. The patient may present with nonspecific complaints including, but not limited to, flu-like symptoms such as abrupt onset of fever, lethargy, mental status changes, and a rash [17]. This rash is the pathognomonic feature of meningococcemia, the one sign that a primary care provider cannot miss. Although the flu-like prodrome occurs early in the disease process, the development of the rash is somewhat later. It begins with cutaneous pain followed by erythema, difficult to distinguish from a viral exanthem [19]. Petechiae occur in approximately 50% to 60% of patients, and often begin on the wrists, ankles, and axillae. From there, they spread to the rest of the body, generally sparing the head, palms, and soles [18]. From petechiae, the
DERMATOLOGIC EMERGENCIES
691
rash often progresses to the classic purpura, which results from microvascular thrombosis with subsequent perivascular hemorrhage [20]. Meningococcemia can rapidly progress to septic shock, characterized by hypotension, congestive heart failure, disseminated intravascular coagulation, and acute renal failure. This is associated with significant mortality. The mechanism behind invasive meningococcal disease is complex. There are three main serogroups of N meningitidis that account for the majority of infection: A, B, and C. Serogroups B and C account for approximately 90% of all cases in the United States [17]. N meningitidis is a Gram-negative diplococcus whose only known natural reservoir is the upper respiratory tract of humans. Transmission of the bacterium is mediated through transfer of pharyngeal secretions, and the majority of those colonized do not become clinically infected. The progression from colonization to infection is thought to be mediated by a multitude of factors that enable the bacterium to access the bloodstream. As mentioned above, some consider viral upper respiratory tract infection or infection with mycoplasma to be predisposing factors to invasive meningococcal infection. One of the best known risk factors is crowded living conditions such as those found in colleges, prisons, or the military. Host defense against invasive meningococcal disease is mediated by complement in the presence of a strain specific antibody. This mechanism explains the preponderance of disease burden in children less than 2 years of age, given their relative lack of immunocompetence. Young adults are likewise susceptible to meningococcal infection, but this may simply be due to the predominance of crowded living conditions in this age group. Once a meningococcal bacteremia is established in the absence of a functional bactericidal response, endotoxin derived from the lipopolysaccharide cell well initiates a cascade that ultimately leads to septic shock and the cutaneous manifestations of meningococcemia. Meningococcemia is a rare condition, occurring in approximately 1.3 of every 100,000 individuals in the United States [20]. Although rare, these patients will often present to outpatient offices. The cornerstone of treatment of meningococcemia is early recognition. Patients will present with nonspecific symptoms, and the primary care physician must be aware of any cutaneous manifestations such as petechiae or purpura. In patients that arouse the clinical suspicion of meningococcemia, the primary care physician must arrange transport to a referral center equipped with an intensive care unit for invasive monitoring and ventilatory support. If unable to affect immediate transfer, the primary care physician should draw blood cultures and, if possible, deliver antibiotics while awaiting transfer. Appropriate choices include either penicillin G or ceftriaxone, depending on local susceptibilities. Rocky Mountain spotted fever RMSF is a tick-borne illness caused by inoculation of the host with Rickettsia rickettsii by either the American dog tick, Dermacentor variabilis, or
692
BROWNE
et al
the wood tick, Dermacentor andersonii, in the East and West, respectively [21]. The clinical presentation is variable, but there are pathognomonic symptoms and signs that must be recognized. Classically, the patient will present with headache, fevers, and a characteristic rash. This triad of symptoms occurs in only 44% of patients [22]. Thirty percent of patients will have no history of a known tick bite [21]. The characteristic rash begins approximately 3 to 4 days after disease onset, and initially presents as blanchable erythematous macules. This classically begins at the wrists and ankles, spreading distally to the palms and soles, and finally migrating centrally creating the characteristic diffuse rash [23]. The macular exanthem evolves into a petechial rash and, in some instances, ecchymoses. Beyond the rash, there are a multitude of other nonspecific symptoms such as headache, myalgias, malaise, and abdominal pain (sometimes mimicking an acute abdomen) [21]. If untreated, RMSF will progress to significant end organ involvement, including skin necrosis, myocarditis, meningo-encephalitis, acute renal failure, and pulmonary manifestations such as hemorrhage, edema, and acute respiratory distress syndrome. The case fatality rate still approaches 25% [22]. The clinical manifestations of Rickettsia rickettsii are a direct result of this Gram- negative rods tropism for endothelial cells. Upon introduction of the bacteria via the salivary secretions of the tick, it invades the endothelial cytoplasm and spreads cell to cell, resulting ultimately in a lymphocytoplasmic vasculitis [21]. This vasculitis can affect multiple organ systems, and contributes directly to the variable pathology found in this illness. RMSF was first described in Montana, but it has since been found to be endemic to Maryland, North Carolina, Tennessee, Virginia, South Carolina, and Oklahoma. Infection mostly occurs in children between the ages of 5 and 9 years, and mostly from April to September [24]. Those at higher risk include those who live in or near wooded areas, those who pursue recreation in such areas, and those who have close contact with dogs. It is not necessary to have a history of a known tick bite to pursue a diagnosis of RMSF, especially if the patient resides in an endemic area and has classic symptoms such as those mentioned above. For a clinician to accurately diagnose RMSF a strong degree of clinical suspicion must be maintained, especially depending on the area of practice. If highly suspicious, primary care physicians must initiate treatment based solely on their history and physical examination. Before initiating treatment the physician should send samples to their laboratory for indirect fluorescent antibody testing. The mainstay of treatment is administration of tetracycline antibiotics, notably doxycycline, for 7 to 10 days. For those allergic or intolerant to doxycycline, chloramphenicol may be used [25]. Lyme disease Lyme disease, like RMSF, is a tick-borne illness. It results from the transmission of Borrelia burgdorferi to human hosts from mice and deer
DERMATOLOGIC EMERGENCIES
693
via the Ixodes scapularis and Ixodes pacificus species of tick [23]. Lyme disease progresses through definable stages. Stage I (early localized stage) occurs within 7 to 10 days after the tick bite. It is characterized by the development of erythema migrans at the site of the tick bite. This rash will occur in approximately 75% of those affected, and is described as a macular rash with a central area of clearing [24]. Alternately, erythema migrans has been described as a central red patch surrounded by seemingly normal skin that is, in turn, surrounded by migrating erythematous band [23]. Along with the above-mentioned rash, Lyme disease is associated with a number of nonspecific complaints similar to those found in RMSF, including flulike symptoms, headaches, and arthralgias. Stage II (early disseminated stage) occurs weeks after the initial exposure, and it is characterized by central nervous system symptoms such as meningitis or Bell’s palsy. Other complications noted at this stage can include myocarditis, atrioventricular nodal block, migratory arthralgias, and myalgias, motor or sensory radiculopathy, as well as disseminated annular lesions [23,24,26]. Stage III (late chronic disease) is characterized by profound fatigue, prolonged arthralgias, encephalopathy, polyneuropathy, and possibly leukoencephalitis [26]. The natural reservoir of B burgdorferi can be found in the white footed mouse and the expanding deer populations in the northeastern region of the United States, ranging primarily from Maine to Maryland. There are also foci of endemicity in the Midwest and Western states. According to Centers for Disease Control data, there are approximately 15,000 cases diagnosed yearly, mostly in the spring and summer months [27]. The age groups statistically at most risk are those between the ages of 2 to 15 and 30 to 59 years. The accurate and timely diagnosis of Lyme disease is imperative in the prevention of disseminated diseasedstages II and III. The ability to diagnose this disease rests on the primary care clinician’s knowledge of the prevalence of the Lyme disease in their area and their ability to establish a pretest probability based on that prevalence and the clinical presentation of the patient. Patients residing in endemic areas who present with symptoms concerning for Lyme disease and objective signs such as erythema migrans or atrioventricular block should be treated without serologic testing. Those from areas of high endemicity with symptoms of Lyme disease, but without erythema migrans should be referred for serologic testing with confirmatory Western blot testing before initiation of treatment. The value of testing individuals from areas with moderate to low endemicity with nonspecific symptoms without erythema migrans is controversial. Testing should be considered if symptoms persist longer than 2 weeks. In patients who experience a known tick bite, but who are asymptomatic, there is no indication for prophylactic treatment. These patients, however, do need to be monitored for the development of symptoms for approximately 30 days [26]. If the tick has been attached for less than 24 to 48 hours, the chances of disease transmission are extremely low.
694
BROWNE
et al
The treatment of stage I Lyme disease involves antibiotic therapy for 2 to 3 weeks. The antibiotic of choice is doxycycline 100 mg twice daily. For those allergic to or intolerant of doxycycline, amoxicillin 500 mg three times daily may be administered. Intravenous antibiotic therapy may be required for advanced disease with complications such as neurologic involvement, atrioventricular block, and meningitis [24,26,28,29]. Although not a true emergency, Lyme disease is a condition that must be recognized early in its presentation to avoid serious complications. The ability to diagnose this condition is founded upon a firm understanding of the prevalence of the disease in that area and maintenance of a high clinical suspicion. This brief review encompasses a variety of dermatologic diseases, some frankly emergent such as TEN, SSSS, and meningococcemia, and some merely urgent such as RMSF, Lyme disease, and pemphigus vulgaris. The common thread among these processes, beyond their dermatologic nature, is the importance of prompt recognition. Although all of these conditions do not require emergent transport to a higher level of care, they all require the primary care clinician to have a heightened level of awareness and suspicion concerning potentially serious dermatologic disease.
References [1] Letko E, Papaliodis DN, Papaliodis GN, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Ann Allergy Asthma Immunol 2005;94(4):419–36 [quiz 36–8, 56]. [2] Fritsch PO, Sidoroff A. Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Am J Clin Dermatol 2000;1(6):349–60. [3] Chave TA, Mortimer NJ, Sladden MJ, et al. Toxic epidermal necrolysis: current evidence, practical management and future directions. Br J Dermatol 2005;153(2):241–53. [4] Bachot N, Roujeau JC. Differential diagnosis of severe cutaneous drug eruptions. Am J Clin Dermatol 2003;4(8):561–72. [5] Patel GK, Finlay AY. Staphylococcal scalded skin syndrome: diagnosis and management. Am J Clin Dermatol 2003;4(3):165–75. [6] Ladhani S. Recent developments in staphylococcal scalded skin syndrome. Clin Microbiol Infect 2001;7(6):301–7. [7] Ladhani S, Evans RW. Staphylococcal scalded skin syndrome. Arch Dis Child 1998;78(1): 85–8. [8] Levine G, Norden CW. Staphylococcal scalded-skin syndrome in an adult. N Engl J Med 1972;287(26):1339–40. [9] Patel GK, Varma S, Finlay AY. Staphylococcal scalded skin syndrome in healthy adults. Br J Dermatol 2000;142:1253–5. [10] Richard M, Mathieu-Serra A. Staphylococcal scalded skin syndrome in a homosexual adult. J Am Acad Dermatol 1986;15(2 Pt 2):385–9. [11] Keehn CA, Morgan MB. Clinicopathologic attributes of common geriatric dermatologic entities. Dermatol Clin 2004;22(1):115–23 [vii.]. [12] Black M, Mignogna MD, Scully C. Number II. Pemphigus vulgaris. Oral Dis 2005;11(3): 119–30. [13] Bystryn JC, Rudolph JL. Pemphigus. Lancet 2005;366(9479):61–73. [14] Bickle K, Roark TR, Hsu S. Autoimmune bullous dermatoses: a review. Am Fam Physician 2002;65(9):1861–70.
DERMATOLOGIC EMERGENCIES
695
[15] Blauvelt A, Hwang ST, Udey MC. Allergic and immunologic diseases of the skin. J Allergy Clin Immunol 2003;111(2 Suppl):S560–70. [16] Yeh SW, Sami N, Ahmed RA. Treatment of pemphigus vulgaris: current and emerging options. Am J Clin Dermatol 2005;6(5):327–42. [17] Ferguson LE, Hormann MD, Parks DK, et al. Neisseria meningitidis: presentation, treatment, and prevention. J Pediatr Health Care 2002;16(3):119–24. [18] Salzman MB, Rubin LG. Meningococcemia. Infect Dis Clin North Am 1996;10(4):709–25. [19] Darmstadt GL. Acute infectious purpura fulminans: pathogenesis and medical management. Pediatr Dermatol 1998;15(3):169–83. [20] Hazelzet JA. Diagnosing meningococcemia as a cause of sepsis. Pediatr Crit Care Med 2005; 6(3 Suppl):S50–4. [21] Sexton DJ, Kaye KS. Rocky mountain spotted fever. Med Clin North Am 2002;86(2): 351–60 [vii–viii.]. [22] Masters EJ, Olson GS, Weiner SJ, et al. Rocky Mountain spotted fever: a clinician’s dilemma. Arch Intern Med 2003;163(7):769–74. [23] McGinley-Smith DE, Tsao SS. Dermatoses from ticks. J Am Acad Dermatol 2003;49(3): 363–92 [quiz 93–6]. [24] Bratton RL, Corey R. Tick-borne disease. Am Fam Physician 2005;71(12):2323–30. [25] Drage LA. Life-threatening rashes: dermatologic signs of four infectious diseases. Mayo Clin Proc 1999;74(1):68–72. [26] DePietropaolo DL, Powers JH, Gill JM, et al. Diagnosis of Lyme disease. Am Fam Physician 2005;72(2):297–304. [27] Steere AC. Lyme disease. N Engl J Med 2001;345(2):115–25. [28] Dumler JS, Walker DH. Rocky Mountain spotted feverdchanging ecology and persisting virulence. N Engl J Med 2005;353(6):551–3. [29] Leaute-Labreze C, Lamireau T, Chawki D, et al. Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome. Arch Dis Child 2000;83(4):347–52.
Prim Care Clin Office Pract 33 (2006) 697–710
Skin and Soft Tissue Infections Robert L. Rogers, MD, FAAEM, FACEP, FACP*, Jack Perkins, MD Department of Emergency Medicine, The University of Maryland School of Medicine, 110 South Paca Street, Suite 200, Emergency Medicine, Sixth Floor, Baltimore, MD 21201, USA
Skin and soft tissue infections represent a continuum of symptoms that range from uncomplicated cellulitis to the potentially lethal entity necrotizing fasciitis (NF). The primary care physician will see a myriad of infectious skin disorders in the outpatient setting, and must be capable of discerning which presentations warrant emergency department evaluation and inpatient admission. This article will highlight three entities under the broad umbrella of skin and soft tissue infections. Cellulitis, cutaneous abscess, and NF present not only to the emergency department but also to the outpatient setting. This article aims to help primary physicians recognize patterns of disease that herald significant illness and the need for more extensive evaluation than an outpatient setting can offer. This article discusses the etiology, presentation, evaluation, and management of cellulitis, cutaneous abscess, and NF. Particular attention will be spent addressing the emerging problem with community-acquired methicillin-resistant Staphylococcus aureus (ca-MRSA). Community-acquired MRSA has significantly changed the emergency department approach to cellulitis, and has altered the spectrum of antimicrobials that are used for outpatient treatment of cellulitis. Familiarity with ca-MRSA is essential for the primary care physician, because misdiagnosis and improper antibiotic selection can lead to significant morbidity and mortality [1].
Cellulitis In 1996, cellulitis was estimated as the 28th most common discharge diagnosis in the United States. The actual incidence and prevalence are * Corresponding author. E-mail address:
[email protected] (R.L. Rogers). 0095-4543/06/$ - see front matter Ó 2006 Elsevier Inc. All rights reserved. doi:10.1016/j.pop.2006.06.005 primarycare.theclinics.com
698
ROGERS & PERKINS
difficult to estimate due to the number of outpatient presentations; however, one study reported that cellulitis was responsible for 2.2% of outpatient office visits [2]. Cellulitis is defined as an infection of the dermis with variable extension into the subcutaneous tissues [2]. It usually develops on extremities, but has been documented on every area of the body. Cellulitis generally occurs after the protective barrier of the skin, the epidermis, has been compromised (eg, trauma, ulcers, eczema) allowing bacterial access to the subepidermal tissues. Often, the portal of bacterial entry is unknown. The predilection of cellulitis to occur on areas exposed to the environment (eg, hands, feet) supports the theory that disruption of the epidermis is essential in the development of cellulitis. Factors that predispose to cellulitis include tinea pedis, diabetes mellitus, peripheral vascular disease, peripheral edema, and prior history of cellulitis [3]. Bacterial etiology The majority of cases of cellulitis are caused by beta-hemolytic streptococci, mostly from subtypes A and B. S aureus, and more recently caMRSA, have become increasingly prominent pathogens throughout the United States. Other causes of cellulitis are associated with specific clinical scenarios and are summarized in Table 1 [5–7]. Table 1 Cellulitis key clinical features organism Periorbital cellulitis
Crepitant cellulitis
Must be distinguished from Orbital cellulitis Medical emergency hallmarked by limitation in extraocular movement Must evaluate for underlying Ischial fossa abscess May represent necrotizing fasciitis
Puncture wound Salt water exposure Fresh water exposure Dog bite/Cat bite Cat Scratch Human bite
Often in plantar aspect of foot History of exposure is key element History of exposure is key element Look for puncture wound Look for proximal lymphadenopathy Do NOT suture closed
Orbital cellulitis Perianal cellulitis
Calf cellulitis Foot cellulitis Cellulitis in infants
Suspect underlying DVT Suspect origin as Tinea Pedis Often hematogenous spread; consider osteomyelitis, meningitis, septic joint Immunocompromised HIV, Cancer patients Cell mediated immunity HIV, Leukemia patients, dysfunction may be disseminated Hot tub exposure Cellulitis in bathing suit distribution
Strep and staph in adults, H. influenza in children Strep, staph Group A strep (GAS) GAS, Anaerobes, Clostridia Pseudomonas Vibrio vulnificus Aeromonas hydrophilia Pasteurella multocida Bartonella henselae Anaerobes, Strep pyogenes, Eikenella corrodens Multiple Organisms Multiple organisms Predominantly Group B Strep Consider gram negatives Cryptococcus neoformans Pseudomonas aeruginosa
SKIN AND SOFT TISSUE INFECTIONS
699
Presentation Cellulitis can develop on any area of the body, but is most likely to occur on extremities that are susceptible to microtrauma. The hallmarks of cellulitis include erythema, warmth, swelling, and tenderness of the affected area. The absence of all of these signs would make cellulitis a highly improbable diagnosis [2]. The erythema in cellulites is generally confluent, and leading edges tend to be poorly demarcated. Sharply demarcated borders are more indicative of erysipelas, which is a distinct form of cellulitis due almost exclusively to beta-hemolytic streptococci [4]. Other clinical features of cellulitis include tender lymphadenopathy and occasional abscess formation, especially if S aureus is the causative organism. Although systemic features such as fever, chills, or rigors may be associated with cellulitis, evidence of systemic toxicity should raise suspicion for a more serious pathology such as NF or hematogenous dissemination of the cellulitic organism. Laboratory and radiographic evaluation Laboratory investigation of cellulitis is of limited value because it is unusual to definitively establish a causative organism [2]. Blood culture results are positive in less than 5% of patients [5]. Blood cultures are frequently obtained when patients are admitted to the hospital for cellulitis; however, they just as often represent contamination as a true pathogen. Sending a complete blood count or any other laboratory studies are not recommended in the outpatient setting, and have limited value in the inpatient setting. Occasionally, consideration is given to a punch biopsy of the cellulitic area; however, the results can be quite variable, with culture identifying a likely organism 5% to 40% of the time, depending on the patient population [5]. Radiographic evaluation is recommended in the diagnostic workup of cellulitis only when there is a question of whether another process may be involved. Occasionally, the clinical examination may suggest an occult abscess or perhaps NF. In such cases, it is reasonable to consider plain films to evaluate for gas in the soft tissue or even a CT scan of the area in question with intravenous contrast to evaluate for abscess or muscle involvement. Plain films are also indicated if a retained foreign body is considered as the source of the overlying cellulitis (see Fig. 1). Community acquired MRSA MRSA infections began in the early 1960s, a few years after methicillin was introduced to combat the problem of resistance to penicillin [8]. By the 1980s, MRSA had become a common problem throughout US hospitals. In the 1990s, patients who had no risk factors for hospital-acquired MRSA infection (eg, recent hospitalization, intravenous drug use, hemodialysis, or resident in a chronic care facility) were developing cellulitis from MRSA [9]. Interestingly, this strain of MRSA was susceptible to a broader range of antibiotics
700
ROGERS & PERKINS
Fig. 1. Left lower extremity cellulitis. (Copyright Ó Challenger Corporation (Memphis, TN). 2005. All rights reserved.)
than hospital-associated or -acquired MRSA. This new strain of MRSA was given the name ca-MRSA or community-associated MRSA. The incidence and prevalence of ca-MRSA has risen dramatically over the past decade, and its emergence has changed clinical practice in outpatient settings, urgent care facilities, emergency departments, and inpatient hospital settings. Although anyone may become colonized or present with an illness due to ca-MRSA, there appears to be certain populations that are more susceptible to outbreaks. Prisoners, children (especially in daycare centers), intravenous drug users, sports participants, soldiers, homosexual men, and homeless individuals are at particular risk of ca-MRSA colonization and infection [1]. All of these at-risk populations share the similarities of large numbers of people who convene or habitate in close proximity to others where hygiene may be difficult to maintain. There also seems to be a preponderance of ca-MRSA among children. A few studies have reported ca-MRSA isolates in up to 50% of children in whom S aureus is found on routine colonization cultures [10]. Clinical manifestations of ca-MRSA infection are varied, and include skin and soft tissue infections, osteomyelitis, pneumonia, joint infection, and sepsis. The spectrum of disease presentations can be diverse. Cellulitis is a common presentation of ca-MRSA although it appears less prevalent than abscess formation with or without associated cellulitis. Any patient who presents with cellulitis and an abscess should be considered to have ca-MRSA until proven otherwise. Patients who have cutaneous abscesses due to ca-MRSA tend to have frequent recurrences, and family members are prone to developing similar symptoms. ca-MRSA has recently been reported in association with NF [11]. These case reports are interesting in that ca-MRSA was the only organism isolated in what is generally a polymicrobial infection. Osteomyelitis, septic joints, and severe community-acquired pneumonias have all been documented [1,9]. Mortality in ca-MRSA pneumonia was close to 25% in one study, although most of the patients were previously healthy hosts [11]. Morbidity and mortality are dependent upon proper antibiotic selection, which makes
SKIN AND SOFT TISSUE INFECTIONS
701
it essential for the primary care provider to consider ca-MRSA as a possible pathogen in all skin or soft tissue infections presenting to the outpatient setting. Treatment The treatment of cellulitis has changed significantly in the past several years. Cephalexin (Keflex), amoxicillin-clavulanate (Augmentin), and dicloxacillin (Dynapen) have been staples of treatment for outpatient cellulitis in emergency departments, urgent care, and primary care clinics for many years. The emergence of ca-MRSA has led to a significant increase in the number of treatment failures for skin and soft tissue infections seen in the emergency department. The most important aspect of selecting an appropriate antibiotic involves being familiar with the patient population (eg, intravenous drug users, prisoners) and the susceptibility patterns in the area. Current infectious disease guidelines still recommend beta-lactam (eg, cephalexin, dicloxacillin) antibiotics as first-line treatment for cellulitis that will not require admission [1,12]. Those patients who are more likely to have ca-MRSA as a cause of their cellulitis (eg, high risk populations or cellulitis associated with abscess) should receive trimethoprim–sulfamethoxazole (TMP-SMZ), clindamycin, doxycycline, minocycline, or third- or fourthgeneration fluoroquinolones. Patients who have significant comorbid illnesses such as diabetes mellitus, congestive heart failure, or who are on dialysis should be given agents that will cover ca-MRSA as they may not tolerate 24 to 48 hours of improper antibiotic selection. Recently, clindamycin-inducible resistance has become a problem in some areas, prompting some clinicians to select TMP-SMZ as their initial choice when they suspect ca-MRSA is the pathogen. Clindamycin resistance should be suspected when a ca-MRSA susceptibility pattern reveals sensitivity to clindamycin but resistance to erythromycin. This indicates a high likelihood of ‘‘inducible clindamycin resistance’’ [8]. TMP-SMZ failures are rare when treating cellulitis, usually only occurring with isolates of methicillin-sensitive S aureus (MSSA) [1,5]. No definitive data supports the concept that administration of a single dose of an intravenous antibiotics before discharge from the emergency department or from outpatient clinic has any benefit over oral therapy alone [13]. If patients are well enough to be sent home for treatment, they are likely well enough for oral antibiotic therapy. Admission to the hospital and administration of parenteral antibiotics are recommended for patients with systemic symptoms (eg, fever, rigors, emesis), unstable vital signs (eg, hypotension, tachycardia), or those who have failed an appropriate course of oral antibiotic therapy that should have covered the suspected pathogen [1,5,12]. Consideration should also be given to patients who have serious comorbid conditions (diabetes, congestive heart failure, end-stage renal disease) or those who are immunocompromised from cancer, organ transplantation, or HIV infection.
702
ROGERS & PERKINS
Patients admitted to the hospital should receive parenteral antibiotics. Many authorities conclude that vancomycin is the medication of choice for skin and soft tissue infections when resistant S aureus is considered as a possible pathogen. Cultures from the blood and any wounds should be obtained in these circumstances to try to isolate a pathogen. Other appropriate inpatient medications include quinupristin–dalfopristin (Synercid), linezolid (Zyvox), or daptomycin (Cubicin). All of these antibiotics have strong activity against both hospital-acquired MRSA and ca-MRSA. These medications are prohibitively expensive for routine use, but are appropriate when vancomycin-resistant enterococcus is involved or when the patient has a vancomycin allergy.
Cutaneous abscess The incidence and prevalence of skin abscesses has risen in parallel with the emergence of ca-MRSA [5,14]. The diagnosis of a cutaneous abscess is usually not difficult, and often the patient may complain of spontaneous drainage. The treatment of these abscesses frequently involves incision and drainage. Because this is considered a minor surgical procedure, some primary care physicians will choose to refer for definitive management. In addition, procedures such as these may not be possible in the outpatient setting due to time constraints. The primary care office setting is, however, an ideal location for subsequent follow-up evaluation after a patient has undergone incision and drainage. Patients with these disorders need close followup, and primary care physicians are in a perfect position to play a pivotal role in the patient’s recovery. Microbiology and clinical features S aureus is by far the most common pathogen involved in cutaneous abscess formation [15]. Roughly 50% of cutaneous abscesses are due to S aureus; however, most abscesses are not cultured. Treatment is empirically directed against this organism [14]. Mot skin abscesses result from minor trauma, although in innercity populations, injection drug use is an extremely common portal of entry, especially for ca-MRSA. Occasionally, skin abscesses will be the result of bacteremia. Risk factors for recurrent abscess formation include obesity, diabetes mellitus, corticosteroid use, neutrophil dysfunction, and injection drug use [16]. Presentation of a skin abscess almost always involves pain, swelling, warmth, and erythema [14]. Local lymphadenopathy and signs of systemic involvement (eg, fever, chills) are unusual unless there is an associated cellulitis. Furuncles are a specific type of cutaneous abscess that occur around hair follicles, and are more common in African American populations. Carbuncles are defined as a series of connected furuncles, and are most commonly found in the posterior scalp area. Hidradenitis suppurativa is an
SKIN AND SOFT TISSUE INFECTIONS
703
inflammatory condition where recurrent abscess formation occurs in the buttocks or axillary area largely in connection with excessive perspiration and obesity. Abscesses often drain spontaneously before presentation to the clinic or emergency department, but occasionally may involve deeper tissues requiring CT imaging or ultrasound for diagnosis. Treatment The most important aspect of abscess treatment is drainage of the fluid collection [17,18]. Spontaneous drainage makes the decision for further incision rather straightforward; however, many abscesses will not spontaneously drain, nor will they be pointing and fluctuant. A recommended tactical maneuver to evaluate for a fluid collection is the insertion of a small bore needle (eg, 22 or 25 gauge) into the area of maximum induration and apparent fluctuance. Return of pus indicates that incision and drainage is indicated [14]. The initial incision is best made by use of a #11 blade scalpel. The tip of the scalpel is aimed at the center of fluctuance and directed perpendicular to the skin surface. The incision should be deep enough to fully evacuate the fluid collection. In addition, loculations should be probed and broken up with the use of a hemostat if possible [17,18]. If there is any question about whether the patient is to be admitted, or if they have failed previous antibiotic therapy, a culture of the fluid should be obtained to help identify a causative organism. The cavity should be irrigated after drainage and loosely packed with iodoform gauze. Often, pain is a rate-limiting factor of debridement, especially in intravenous drug users who may have increased tolerance to narcotic analgesics. As a rule of thumb, lidocaine does not work efficiently in acidic environments such as in areas of pus; thus, lidocaine (with epinephrine if in areas other than ears, fingers, toes, nose, or genitalia) should be injected generously throughout the surrounding tissue and in the subcutaneous area overlying the abscess [19]. Patients will sometimes present with an abscess that is not ready for incision and drainage. Induration may be present, but no discrete are of fluctuance may be appreciated. In these cases, antibiotics and warm compresses to the area are indicated to try to bring the abscess to a head for drainage. Although antibiotic therapy has never been shown to be helpful for an uncomplicated abscess, the induration that often precedes discreet abscess formation can be confused for uncomplicated cellulitis. Follow-up should be arranged in 24 to 48 hours, regardless of whether the abscess is drained, so that healing can be evaluated, or to see if drainage is now indicated. Risks of incision and drainage include bleeding, pain at the incision site, scar formation, and bacteremia [18]. The incidence of bacteremia following surgical incision of an abscess is unclear, as data is conflicting. The American Heart Association recommends one intravenous dose of antibiotics to those who are at moderate to high risk for bacterial endocarditis [20,21]. These patients would include
704
ROGERS & PERKINS
those with any type of implanted cardiovascular device, such as stents, grafts, porcine, or mechanical valves. A dose of an antistaphylococcal antibiotic such as cefazolin or nafcillin would be appropriate [20,21]. There has always been some controversy regarding whether antibiotics need to be administered following debridement of an abscess. In those patients who have no evidence of systemic infection and no surrounding cellulitis, antibiotics are not indicated. Available evidence supports withholding antibiotics in these clinical circumstances. Patients who have systemic symptoms, have surrounding cellulitis, are immunocompromised (e.g., diabetes mellitus, HIV), or whose abscess is not ready for drainage should receive an antistaphylococcal antibiotic such as cephalexin (Keflex) or dicloxacillin (Dynapen). However, strong consideration should be given to the presence of ca-MRSA in at risk populations. If ca-MRSA is a possible cause of the abscess and surrounding soft tissue infection, TMP-SMZ, doxycycline, clindamycin, or a third- or fourth-generation fluoroquinolone should be considered [22]. In general, a 7-day course of antibiotics is considered sufficient [17,18]. Abscesses in the oral, perirectal, or genital areas should be considered multibacterial in etiology, and consideration should be given to using agents with Gram-positive, Gram-negative, and anaerobic activity [23]. Suitable medications would include amoxicillin–clavulanate (Augmentin) or third- or fourth-generation fluoroquinolones. The importance of follow-up for any patient who has been treated for skin and soft tissue infections cannot be overstated. The presence of ca-MRSA has significantly increased the number of treatment failures. As many as 61% of ca-MRSA infections are initially treated inappropriately with beta-lactam antibiotics. This may lead to an increased morbidity and mortality rate [14,24].
Necrotizing fasciitis NF is a rare clinical entity accounting for only 500 to 1500 cases of severe soft tissue infections annually in the United States [25]. Although it is a relatively rare clinical entity, its enigmatic presentation and overlap with other more benign skin and soft tissue infections make this a frequently missed diagnosis. The clinical significance of recognizing this disease process early in its course is crucial because mortality is estimated at 24% to 34%. In addition, the associated morbidity (eg, amputations, need for dialysis, multiple surgical procedures, prolonged hospital courses) in those who survive is quite high [25,26]. Primary care physicians may never encounter NF in their clinical careers; however, it is a diagnosis that cannot be missed, as prompt surgical intervention can significantly affect patient outcome. Any case of suspected NF should be referred immediately to the nearest appropriate center that has the capability of caring for the patient. In many cases, the patient will be transferred to the nearest emergency department for surgical evaluation.
SKIN AND SOFT TISSUE INFECTIONS
705
Microbiology and clinical features NF is defined as a rapidly progressing soft tissue infection with fulminant tissue destruction, rapid bacterial spread along tissue planes, thrombosis of blood vessels, systemic signs of toxicity, and high rates of morbidity and mortality [27]. NF is typically divided into two separate categories based on involved organisms. Type I NF is the less common variety, and is due to infection with aerobic and anaerobic bacteria. Frequently, Type I NF is a mixed bacterial infection. Nearly 66% of cases in one study were attributed to a combination of aerobic and anaerobic bacteria [25]. Common isolates from Type I NF include streptococcus (other than Group A, which causes Type II NF), Staphylococcus aureus, enterococcus, peptostreptococcus, Escherichia coli, Bacteroides fragilis, and Clostridium species. Type I NF includes Fournier’s gangrene, which involves the perineal area and can expand rapidly to involve the genitalia and anterior abdominal wall. Patients at risk for Type I NF include diabetics, those with surgical wounds, peripheral vascular disease, alcohol abuse, obesity, hypoalbuminemia (used as a clinical marker of malnutrition) and illicit drug users who ‘‘skin pop’’ or inject into the muscle [25,26]. Type II NF is amonomicrobial infection caused almost exclusively by group A streptococcus (GAS or streptococcus pyogenes) [27]. In the past few years, cases of NF caused by MRSA (mostly ca-MRSA) have been reported [8,28]. The incidence of Type II NF infections increased in the 1990s for unknown reasons. It differs from Type I NF in that any age group is a susceptible host for infection. Some predisposing risk factors include injection drug use, surgical procedures, burns, surgical wounds, blunt trauma, varicella, and even perhaps nonsteroidal anti-inflammatory medications [26,27]. It is hypothesized that hematogenous spread of GAS from a pharyngeal source to the site of muscle or soft tissue injury is one possible explanation for the development of NF. Type II NF is often associated with streptococcal toxic shock syndrome, which is heralded by multiorgan failure and severe shock. The most important clinical symptom of NF is that patients often report pain that is out of proportion to findings during the clinical examination [29]. Patients may complain of extreme pain in an area with few or no cutaneous manifestations. The presence of warmth, erythema, tenderness, or skin discoloration is nonspecific, and their presence or absence does not help significantly in securing a diagnosis of NF. However, the development of bullae, especially hemorrhagic bullae, should be taken as an ominous clinical finding, and should prompt consideration of an aggressive soft tissue infection. Crepitus has often been heralded as a strong clinical sign of NF, but this is only found in 10% of all cases of NF [27]. Fever, malaise, myalgias, rigors, tachycardia, and hypotension may all be seen at presentation or develop in the first 24 hours of the clinical course. Because NF spreads rapidly along tissue planes, one may see rapid progression of erythema or significant
706
ROGERS & PERKINS
change in other clinical symptoms or signs (eg, tachycardia, pain) only hours after presentation (see Fig. 2, 3, and 4 for examples of NF). The key takehome point is to remember to be hypervigilant about skin and soft tissue infections, and to always consider NF in the differential diagnosis. Failure to do so may prove to be disastrous for the patient. Laboratory and radiographic evaluation NF, as opposed to uncomplicated cellulitis, necessitates casting a wider diagnostic net. Laboratory analysis as well as prompt radiographic evaluation, is indicated if NF is a possibility. A peripheral white blood count is frequently elevated, and is typically accompanied by a marked left shift. Hyponatremia, elevated BUN and creatinine, hypocalcemia, hypoalbuminemia, and hyperglycemia are found quite often in cases of NF. One study reported that the combination of a white blood cell count O14,000 cells/mL and serum sodium !135 mEq/L resulted in a 90% sensitivity and specificity of 76% for distinguishing between necrotizing and nonnecrotizing soft tissue infections [25]. Blood cultures are positive in 60% of cases of Type II NF due to the rapid ability of group A strep (GAS) to grow in available culture medium [27]. Type I NF has a lower return of positive cultures due to more fastidious organisms being involved. An elevated lactic acid level reflects the presence of anaerobic metabolism in the involved tissue and muscle. Elevated creatine phosphokinase levels are also a common finding that indicates muscle tissue death. An arterial blood gas will likely reveal a metabolic acidosis (elevated lactic acid level) and perhaps a compensatory respiratory alkalosis. Disseminated intravascular coagulation (elevated prothrombin time [PT], partial thromboplastin time [PTT], international normalized ratio [INR], D-dimer, fibrin split products) can accompany NF, especially if caused by GAS or streptococcal toxic shock syndrome. Radiographic imaging is indicated as soon as NF is suspected to look for evidence of subcutaneous gas.This finding, however, only has a sensitivity of
Fig. 2. Lower extremity necrotizing fasciitis. (Copyright Ó Challenger Corporation (Memphis, TN). 2005. All rights reserved.)
SKIN AND SOFT TISSUE INFECTIONS
707
Fig. 3. Necrotizing fasciitis with hemorrhagic bullae. (Copyright Ó Challenger Corporation (Memphis, TN). 2005. All rights reserved.)
39%, specificity of 95%, and negative predictive value of 88% [25]. CT is superior to plain film for detection of gas. Additionally, CT can reveal fluid collections, muscle necrosis, fat stranding, and fascial thickening suggestive of NF. The potential problem with CT is that it requires the patient to leave the resuscitation area. Also, evaluating for an abscess or fluid collection requires the administration of intravenous dye. This could lead to the development of contrast nephropathy, especially if the patient is already hypotensive. MRI has even higher sensitivity and specificity than CT; however, it is time consuming and will delay definitive treatment. Treatment The treatment of NF can be considered similar to the philosophy that underlies the treatment of an acute ST elevation myocardial infarction, !time equals tissue.’’ No antibiotic or supportive measure will be an adequate substitute for definitive operative debridement. The role of the primary care physician is to identify that NF is a possible diagnosis and refer for rapid,
Fig. 4. Extensive upper extremity necrotizing fasciitis. (Copyright Ó Challenger Corporation (Memphis, TN). 2005. All rights reserved.)
708
ROGERS & PERKINS
definitive treatment. The key mistake made in outpatient clinical practice is assigning a benign diagnosis, such as cellulitis. Again, evidence of systemic toxicity, pain out of proportion, or presence of bullae or crepitus, should be considered NF until proven otherwise. Antibiotics play a key supportive role in treatment but do not provide the same definitive therapy as they do in cellulitis. Intravenous broad-spectrum antibiotics are indicated for either type of NF, and early administration of antibiotics is recommended. An extended spectrum beta-lactam penicillin (eg, piperacillin/tazobactam, ampicillin/sulbactam), combined with clindamycin, is noted as the regimen of choice from most trials [27,30]. Clindamycin is important, as it has been established as effective in suppression of bacterial toxin production (especially GAS toxin). It also enhances synthesis of penicillin-binding protein [29]. Other supportive measures such as aggressive fluid resuscitation and invasive monitoring are important adjunctive measures [30,31]. Summary The spectrum of skin and soft tissue infections seen by the primary care physician can be as benign as folliculitis to as life-threatening as NF. Cellulitis remains the most common skin and soft tissue infection seen in primary care. The ever present danger of ca-MRSA, however, has changed the way primary care physicians approach the common problem of cellulitis. The presence of risk factors for colonization with ca-MRSA and a history or examination finding of skin abscess should raise the suspicion of ca-MRSA, and antibiotic therapy should include TMP-SMZ, clindamycin, doxycycline, or minocycline. Skin abscess may occur independently of cellulitis, and often may safely be incised and drained in the primary care setting as long as timely follow-up is assured to assess for wound healing. Available evidence suggests that abscess formation without accompanying cellulitis does not require oral antibiotic therapy. Finally, although NF is rare as an outpatient clinical presentation, it is a diagnosis that the primary care physician should be familiar with. Failure to consider the diagnosis and refer may lead to significant morbidity and even mortality. References [1] Kowalski TJ, Berbari EF, Osmon DR. Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections. Mayo Clinic Proc 2005; 80(9):1201–7. [2] Baddour LM. Epidemiology, clinical features and diagnosis of cellulitis. In: Rose BD, editor. Wellesley (MA): Up-to-Date; 2005. [3] Lutomski DM, Trott AT, Runyon JM, et al. Microbiology of adult cellulitis. J Fam Prac 1988;26:45–8. [4] Bisno AL, Stevens DL. Streptococcal infections of the skin and soft tissues. N Engl J Med 1996;334:240–6.
SKIN AND SOFT TISSUE INFECTIONS
709
[5] Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005;41:1373–406. [6] Swartz MN. Cellulitis. N Engl J Med 2004;350:904–12. [7] Ginsberg MB. Cellulitis: analysis of 101 cases and review of the literature. South Med J 1981; 74:530–3. [8] Shrock S. Community-associated methicillin-resistant Staphylococcus aureus. Senior resident grand rounds. Baltimore: University of Maryland Medical Systems; 2005. [9] Fridkin SK, Hageman JC, Morrison ME, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352(22):1436–44. [10] Boyce JM. Epidemiology; prevention; and control of methicillin-resistant Staphylococcus aureus in adults. In: Rose BD, editor. Wellesley (MA): Up-to-Date; 2005. [11] Chanbers HF. Community-associated MRSA – resistance and virulence converge. N Engl J Med 2005;352(14):1485–7. [12] Braun LO, Craft DA, Williams RO, et al. Increasing clindamycin resistance among methicillin-resistant Staphylococcus aureus in 57 northeast United States military treatment facilities. Pediatr Infect Dis J 2005;24(7):622–6. [13] Choo EK, Mitchell P, Mehta SD, et al. The utility of initial dose intravenous antibiotics for cellulitis prior to discharge on oral antibiotics from the emergency department. Ann Emerg Med 2005;46(3 Suppl):84. [14] Baddour LM. Skin abscess. In: Rose BD, editor. Wellesley (MA): Up-to-Date. 2005. [15] Stevens DL. Cellulitis, pyoderma, abscesses and other skin and subcutaneous infections. In: Cohen JO, Powderly WI, editors. Infectious diseases. 2nd edition. Philadelphia (PA): Mosby; 2004. [16] Bryan CS, Hawes SJ. Infections of the skin and its appendages, muscle, bones, and joints. In: Bryan CS, editor. Infectious diseases in primary care. Philadelpia (PA): W.B. Saunders; 2002. [17] Halvorson GD, Halvorson JE, Iserson KV. Abscess incision and drainage in the emergency departmentdPart I. J Emerg Med 1985;3:227–32. [18] Halvorson GD, Halvorson JE, Iserson KV. Abscess incision and drainage in the emergency departmentdPart (II). J Emerg Med 1985;3:299–305. [19] Fine BC, Sheckman PR, Bartlett JC. Incision and drainage of soft-tissue abscesses and bacteremia [letter]. Ann Intern Med 1985;103:645. [20] Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 1997;277:1448–58. [21] Bobrow BJ, Pollack CV Jr, Gamble S, et al. Incision and drainage of cutaneous abscesses is not associated with bacteremia in afebrile adults. Ann Emerg Med 1997;29: 404–8. [22] Llera JL, Levy RC. Treatment of cutaneous abscess: a double-blind clinical study. Ann Emerg Med 1985;14(1):15–9. [23] Meislin HW, Lerner SA, Graves MH, et al. Cutaneous abscesses. Anaerobic and aerobic bacteriology and outpatient management. Ann Intern Med 1977;87:145–9. [24] Veser F III, McGary WB, Bush J. Incidence, susceptibility, and antibiotic use in emergency department community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) abscesses. Ann Emerg Med 2005;46(3)(Suppl):1–122. [25] Kuncir EJ, Tillou A, St. Hill CR, et al. Necrotizing soft-tissue infections. Emerg Med Clin North Am 2003;21:1075–87. [26] Anaya DA, McMahon KE, Nathans AB. Predictors of mortality and limb loss in necrotizing soft tissue infections. Arch Surg 2005;140(2):151–7. [27] Stevens DL. Necrotizing infections of the skin and fascia. In: Rose BD, editor. Wellesley (MA): Up-to-Date; 2005. [28] Miller LG, Perdreau-Remington FR, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352(14):1445–53.
710
ROGERS & PERKINS
[29] Kessenich CR, Bahl AS. Necrotizing fasciitis: understanding the deadly results of the uncommon ‘‘flesh-eating bacteria.’’ Am J Nurs 2004;104(9):51–5. [30] Wang TL, Hung CR. Role of tissue oxygen saturation monitoring in diagnosing necrotizing fasciitis of the lower limbs. Ann Emerg Med 2004;44(3):222–8. [31] Wang CH. Tissue oxygen saturation monitoring in diagnosing necrotizing fasciitis of the lower limbs: a valuable tool but only for a select few. Ann Emerg Med 2005;45(4):461–2.
Prim Care Clin Office Pract 33 (2006) 711–725
Emergencies in Diabetic Patients in the Primary Care Setting Susan D. Wolfsthal, MDa,*, Rebecca Manno, MDa, Evonne Fontanilla, MDa a
Department of Medicine, University of Maryland School of Medicine, Education Office, Room N3E09, 22 South Greene Street, Baltimore, MD 21201, USA
The diabetic patient poses a unique set of challenges for the primary care physician. Because these patients often have underlying hyperlipidemia, hypertension, diminished peripheral circulation, and a decreased capacity to combat infections, they have a propensity to develop cardiovascular complications and infections. The primary care physician frequently deals with problems related to glycemic control, heart disease, autonomic dysfunction, and a variety of infections. These patients may present in subtle ways that may belie the severity of the impending condition. Glycemic control Hypoglycemia Current practice guidelines exist to clearly delineate the goals for glycemic control in diabetic patients. Despite best efforts of patients and caregivers, either episodic or chronic problems with glycemic control occur. In response to evidence from the Diabetes Control and Complications Trial Group [1,2] and other studies, caregivers strive to tightly control their patients’ blood glucose levels. Tight control, along with other factors such as decreased oral intake, intercurrent illness, or noncompliance with the timing and amount of medications, may result in hypoglycemia. This problem is more common in Type I rather than Type II diabetes, given the propensity of insulin-dependent diabetics to have deficits in counter-regulatory responses of glucagon and epinephrine [3].
* Corresponding author. E-mail address:
[email protected] (S.D. Wolfsthal). 0095-4543/06/$ - see front matter Ó 2006 Elsevier Inc. All rights reserved. doi:10.1016/j.pop.2006.06.008 primarycare.theclinics.com
712
WOLFSTHAL
et al
Diabetics who have recurrent hypoglycemia may present with a variety of symptoms, from mild cognitive dysfunction to syncope, tachycardia, diaphoresis, or more subtly with nocturnal symptoms of night sweats, nightmares, and early morning hyperglycemia. This latter findingdcalled the Smogyi phenomenondresults from the surge of counter-regulatory hormones after an episode of hypoglycemia occurring during sleep. The hypoglycemia causes release of glucagon, cortisol, and epinephrine that ultimately results in hyperglycemia and elevated early morning blood glucose readings. Because the episode of nocturnal hypoglycemia may also be associated with accumulation of acetone from relative starvation, this condition may be differentiated from chronic hyperglycemia by checking for acetone in an early morning urine sample. The primary care physician should consider the possibility of intermittent hypoglycemia in any patient presenting with episodic nondescript symptoms of tachycardia, confusion, or other vague symptoms accompanied by a relief of symptoms with administration of glucose. Patients at risk for hypoglycemia include those who have had a previous episode of hypoglycemia, adolescents, males, those consuming alcohol, those using higher doses of insulin and oral hypoglycemic agents, and those using beta-blockers [4]. Baseline glycohemoglobin levels do not predict the incidence of hypoglycemic episodes [5]. Although obtaining a blood glucose level at the time of symptoms helps to solidify the diagnosis, this is often not available. For patients presenting with classic acute hypoglycemia in the office setting, the management is straightforward, and includes oral or intravenous administration of high concentrations of glucose (25–50 mg of 50% dextrose) or 0.5 to 1 mg of subcutaneous or intramuscular glucagon. Most patients will respond rapidly, and can be observed in the office with hourly glucose levels for 2 or 3 hours before allowing them to go home. Hypoglycemia can recur if it is caused by overuse of sulfonylureas and excess longacting insulin. For patients who have recurring hypoglycemia observed in the office setting, management in an emergency department or inpatient setting is prudent. For patients in whom hypoglycemia seems a likely cause of their intermittent symptoms, closer scrutiny of the glucose pattern is indicated. Patients should monitor their glucose levels before every meal and at bedtime, being certain to obtain levels during a symptomatic phase. Obtaining an early morning urine specimen to identify ketonuria helps to evaluate for nocturnal hypoglycemia. Those diabetics who have very tight control and recurrent hypoglycemia may have dulled their counter-regulatory response, and hence have more difficulty raising their blood sugar during a crisis. These patients may benefit from allowing more loose control of their blood sugars, thus allowing a return of critical counter-regulatory hormone responses. Patients should be counseled to always carry glucose tablets to stave off symptoms at first onset, and to have glucagons kits for more severe episodes. In patients who have syncope or dizziness, further evaluation for arrhythmias and silent ischemia is indicated. Family and
EMERGENCIES IN DIABETIC PATIENTS
713
friends should be trained in the management of hypoglycemia, and patients should be counseled against driving or using heavy machinery until their glycemic control is stabilized. Hyperglycemia Patients who have Type II diabetes are particularly susceptible to hyperglycemia. Although some patients have chronically elevated blood glucose levels, others develop hyperglycemia in response to infections or other severe stress. The primary care physician must distinguish early between these two scenarios. As discussed in the coming sections on cardiovascular disease and infectious problems in diabetic patients, hyperglycemia may accompany these complications. The actual level of hyperglycemia is less important than the etiology or associated abnormalities of the elevated blood sugars. In addition, early diagnosis of diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemia early is critical to successful patient management [6]. DKA is a serious complication that occurs most commonly in Type I diabetics, but can also be seen in Type II diabetics who have severe hyperglycemia, infections, use of drugs such as steroids or thiazide diuretics, alcohol or substance abuse, or underlying pancreatic pathology, such as a pancreatic cancer [7]. These patients frequently present with shortness of breath caused by the metabolic acidosis, dizziness due to volume depletion and severe polyuria and polydipsia, nausea with vomiting, abdominal pain, and weight loss [6]. Rapid diagnosis involves obtaining serum glucose levels, serum acetone and determination of the anion gap. Once diagnosed, these patients must be admitted to an acute care facility for further management. A search for precipitating factors such as myocardial infarction (MI) or an infectious process should be undertaken. Hyperosmolar nonketot